Gregory Lip
#26,133
Most Influential Person Now
British cardiologist
Gregory Lip's AcademicInfluence.com Rankings
Gregory Lipphilosophy Degrees
Philosophy
#789
World Rank
#1522
Historical Rank
Logic
#80
World Rank
#218
Historical Rank
Download Badge
Philosophy
Gregory Lip's Degrees
- PhD Cardiology Imperial College London
Why Is Gregory Lip Influential?
(Suggest an Edit or Addition)According to Wikipedia, Gregory Lip is a clinical researcher and Price-Evans Chair of Cardiovascular Medicine, at the University of Liverpool. He is Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital.
Gregory Lip's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012]. (2012) (7792)
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. (2010) (5669)
- 2018 ESC/ESH Guidelines for the management of arterial hypertension. (2018) (5481)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (4221)
- A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. (2010) (3809)
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012) (3704)
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (3518)
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (2020) (3378)
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. (2012) (3356)
- 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) (2445)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) (1949)
- Apixaban in patients with atrial fibrillation. (2011) (1889)
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) (1844)
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. (2006) (1786)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (2018) (1684)
- Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial (2007) (1564)
- Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study (2011) (1268)
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. (2016) (1176)
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) (1010)
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (2012) (993)
- Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (982)
- Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. (2011) (970)
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (2017) (949)
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. (2013) (909)
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
- Underuse of oral anticoagulants in atrial fibrillation: a systematic review. (2010) (897)
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited (2009) (846)
- Stroke and bleeding in atrial fibrillation with chronic kidney disease. (2012) (795)
- Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (789)
- Antithrombotic therapy for atrial fibrillation (2002) (753)
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) (738)
- Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012) (637)
- Inflammation in atrial fibrillation. (2012) (637)
- Quality of life in patients with atrial fibrillation: a systematic review. (2006) (607)
- How the Read a Paper: The Basics of Evidence Based Medicine (1998) (576)
- Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] (2011) (570)
- Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (2014) (550)
- Warfarin and aspirin in patients with heart failure and sinus rhythm. (2012) (511)
- Platelet activation: assessment and quantification. (2001) (510)
- Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort (2010) (495)
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016) (478)
- 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. (2018) (476)
- The adhesion molecule P-selectin and cardiovascular disease. (2003) (470)
- The hypercoagulable state of malignancy: pathogenesis and current debate. (2002) (456)
- Mortality and Quality of Life 12 Months After Myocardial Infarction: Effects of Depression and Anxiety (2001) (452)
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study (2011) (445)
- Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study (2012) (442)
- von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? (1997) (441)
- The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study (2012) (436)
- Endothelial progenitor cells in cardiovascular disorders. (2007) (433)
- Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. (2013) (432)
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry (2013) (431)
- Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. (1997) (429)
- Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration (2017) (417)
- Outcome parameters for trials in atrial fibrillation: executive summary. (2007) (413)
- Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014) (399)
- Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial (2007) (398)
- Circulating endothelial cells (2005) (396)
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. (2006) (396)
- A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. (2005) (391)
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III) (2013) (385)
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (2016) (384)
- Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. (2013) (383)
- Metabolism: Partial leptin deficiency and human adiposity (2001) (383)
- Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. (2015) (381)
- Does heart failure confer a hypercoagulable state? Virchow's triad revisited. (1999) (375)
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature (2012) (371)
- Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data (2008) (365)
- The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. (2012) (353)
- Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. (2012) (348)
- Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. (2013) (340)
- Cancer and the prothrombotic state. (2002) (336)
- EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (2014) (333)
- Monocytes in coronary artery disease and atherosclerosis: where are we now? (2013) (328)
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting (2009) (326)
- Indications for the use of diagnostic implantable and external ECG loop recorders. (2009) (324)
- The pathophysiology of hypertension (2001) (318)
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study (2011) (317)
- The role of monocytes in angiogenesis and atherosclerosis. (2014) (315)
- The ABC pathway: an integrated approach to improve AF management (2017) (314)
- Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. (1995) (312)
- Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. (2015) (306)
- A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. (2014) (306)
- Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. (2012) (306)
- Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. (2004) (302)
- Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation (2003) (293)
- Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation (2012) (291)
- Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. (2008) (288)
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis (2020) (283)
- Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (2017) (279)
- Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. (2004) (277)
- Fibrinogen: biochemistry, epidemiology and determinants. (2003) (273)
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice (2011) (273)
- Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey (2012) (272)
- Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. (2007) (269)
- Atenolol and fetal growth in pregnancies complicated by hypertension. (1999) (269)
- Blood pressure measurement (2001) (268)
- Psychological factors in heart failure: a review of the literature. (2002) (267)
- New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. (2012) (265)
- Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. (2014) (264)
- Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary (2016) (263)
- The role of aspirin in cardiovascular prevention: implications of aspirin resistance. (2008) (259)
- Depression, anxiety, and quality of life in patients with atrial fibrillation. (2007) (258)
- Stroke prevention in atrial fibrillation: a systematic review. (2015) (258)
- Oxidative stress and hypertension (2006) (257)
- Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. (2010) (256)
- Atrial fibrillation and stroke prevention (2007) (256)
- Does atrial fibrillation confer a hypercoagulable state? (1995) (255)
- 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (2018) (254)
- Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. (2003) (254)
- Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant: A Nationwide Cohort Study (2014) (253)
- Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. (2006) (252)
- The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. (2017) (252)
- Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) (2013) (251)
- Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study (2012) (250)
- Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. (2015) (248)
- Bleeding risk assessment and management in atrial fibrillation patients (2011) (247)
- Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin (2016) (244)
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials (2015) (243)
- Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a (2010) (242)
- Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. (2012) (241)
- Stroke prevention in atrial fibrillation: An Asian perspective (2014) (241)
- Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. (1996) (238)
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. (2021) (238)
- New oral anticoagulant drugs in cardiovascular disease (2010) (238)
- Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? (2015) (237)
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice (2012) (237)
- ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. (2001) (236)
- Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. (2015) (235)
- New Oral Anticoagulants in Elderly Adults: Evidence from a Meta‐Analysis of Randomized Trials (2014) (234)
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group (2019) (232)
- Hypothesis: is soluble P-selectin a new marker of platelet activation? (1997) (231)
- Is atrial fibrillation an inflammatory disorder? (2006) (230)
- Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. (2007) (229)
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. (2016) (229)
- Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. (2007) (226)
- Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study (2015) (226)
- EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. (2016) (225)
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT 2 R 2 Score (223)
- Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial (2016) (223)
- Stroke prevention in atrial fibrillation: Past, present and future (2017) (222)
- Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. (2005) (218)
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. (2011) (216)
- Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. (2006) (216)
- Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). (2014) (215)
- Free radicals and antioxidants in cardiovascular disease. (2003) (213)
- Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. (2004) (212)
- Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. (2006) (212)
- Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. (2011) (211)
- Endothelial Dysfunction and Damage in Congestive Heart Failure: Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide (2004) (208)
- Circulating endothelial cells in cardiovascular disease. (2006) (207)
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort (2011) (205)
- Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. (2015) (205)
- A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. (1997) (204)
- Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. (2009) (204)
- Stroke prevention in atrial fibrillation (2016) (204)
- The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. (2007) (204)
- Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. (2009) (202)
- Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors (2002) (201)
- Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation (2013) (201)
- EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. (2014) (201)
- Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension (2012) (200)
- Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. (1998) (200)
- [Guidelines for cardiac pacing and cardiac resynchronization therapy]. (2008) (199)
- Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104 (2013) (199)
- ABC of heart failure. (2000) (198)
- Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm: Effects of Angiotensin-Converting Enzyme Inhibitor and &bgr;-Blocker Therapy (2001) (197)
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). (2012) (196)
- Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial (2013) (195)
- Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus: Relationships to Cardiovascular Disease and Risk Factor Intervention (2004) (195)
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
- The prevalence and persistence of depression and anxiety following myocardial infarction. (2002) (193)
- Fibrin D-dimer: a useful clinical marker of thrombogenesis? (1995) (193)
- Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial (2017) (192)
- High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis (2007) (192)
- Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients (2018) (191)
- RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome (2011) (191)
- Quality of life in adults with congenital heart disease (2002) (190)
- Improving stroke risk stratification in atrial fibrillation. (2010) (190)
- Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation (2010) (189)
- Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis. (2006) (189)
- Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study (2013) (188)
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2020) (186)
- Predictors of attendance at cardiac rehabilitation after myocardial infarction. (2001) (186)
- Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (186)
- Angiogenesis: basic pathophysiology and implications for disease. (2003) (186)
- Angiogenin: a review of the pathophysiology and potential clinical applications (2006) (186)
- Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. (2013) (186)
- Plasma Angiopoietin-1, Angiopoietin-2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute Coronary Syndromes (2004) (185)
- The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. (2013) (184)
- The role of monocytes and inflammation in the pathophysiology of heart failure (2011) (184)
- Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. (2015) (183)
- 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European (2018) (183)
- Early management of atrial fibrillation to prevent cardiovascular complications. (2014) (182)
- The potential impact of periodontal disease on general health: a consensus view (2008) (180)
- Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. (2006) (179)
- Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. (2002) (179)
- Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care (2017) (179)
- The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. (2013) (178)
- Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. (1997) (178)
- Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. (2013) (177)
- Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring (2011) (177)
- Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial (2012) (176)
- Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation (2019) (175)
- The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. (2003) (174)
- Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2004) (174)
- Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (2015) (174)
- ABC of Hypertension (1981) (174)
- Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology (2011) (173)
- Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study (2018) (173)
- General mechanisms of coagulation and targets of anticoagulants (Section I) (2013) (172)
- Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy: The West Birmingham Atrial Fibrillation Project (2001) (172)
- The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. (2011) (172)
- Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2016) (170)
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis (2017) (170)
- Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. (2000) (170)
- Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. (2015) (170)
- Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. (1998) (170)
- Soluble E-selectin in cardiovascular disease and its risk factors (2003) (169)
- Bleeding risks of antithrombotic therapy (2002) (168)
- History and epidemiology (2000) (168)
- The CD14++CD16+ monocyte subset and monocyte‐platelet interactions in patients with ST‐elevation myocardial infarction (2012) (168)
- Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis (2010) (167)
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data (2015) (166)
- Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. (1999) (164)
- Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation. (2014) (163)
- Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. (2015) (163)
- Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study (2018) (163)
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). (2015) (162)
- Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel (2014) (161)
- Soluble P-selectin in Atherosclerosis: A Comparison with Endothelial Cell and Platelet Markers (1997) (160)
- ABC of Atrial Fibrillation: HISTORY, EPIDEMIOLOGY, AND IMPORTANCE OF ATRIAL FIBRILLATION (1995) (160)
- Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? (2013) (159)
- Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. (2008) (159)
- Is hypertension an inflammatory process? (2006) (158)
- Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect (2017) (158)
- Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. (2004) (158)
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. (2015) (158)
- Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation (2006) (158)
- The Birmingham rehabilitation uptake maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation (2008) (158)
- Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society (2018) (157)
- Stroke prevention in atrial fibrillation: Past, present and future. (2017) (157)
- Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. (2004) (157)
- Effect of atenolol on birth weight. (1997) (157)
- Complications and survival of 315 patients with malignant-phase hypertension (1995) (157)
- Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. (2020) (156)
- Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark (2017) (156)
- Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. (2015) (156)
- Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. (2004) (156)
- [2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]. (2016) (155)
- Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. (2016) (154)
- Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. (2015) (154)
- Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. (2017) (153)
- Adherence to oral anticoagulant therapy in patients with atrial fibrillation (2016) (151)
- Effect of hypertension on anticoagulated patients with atrial fibrillation. (2007) (151)
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study (2015) (151)
- Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. (2015) (151)
- Treatment of atrial fibrillation in a district general hospital. (1994) (150)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2004) (149)
- Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial (2007) (149)
- Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF (2016) (149)
- 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. (2014) (149)
- Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). (2015) (149)
- Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. (2003) (149)
- CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation (2013) (148)
- Self-care and adherence to medication: a survey in the hypertension outpatient clinic (2008) (146)
- Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation (2008) (146)
- Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. (2006) (146)
- Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. (2011) (145)
- Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. (2001) (145)
- Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. (2001) (144)
- Angioedema due to ACE inhibitors: increased risk in patients of African origin. (2001) (144)
- The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors (2017) (144)
- The role of monocytes in thrombotic disorders (2009) (143)
- Stroke and thromboembolism in atrial fibrillation. (2012) (143)
- Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. (2001) (142)
- Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal. (2015) (142)
- Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice (2003) (142)
- Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients (2021) (141)
- Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (2017) (141)
- Virchow's triad revisited. (2004) (140)
- Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. (2013) (140)
- [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. (2009) (140)
- Safety and efficacy of well managed warfarin (2015) (140)
- Non-Vitamin K Antagonist Oral Anticoagulants (2014) (139)
- A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. (2012) (139)
- Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. (2005) (139)
- Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation (2017) (138)
- Hemoxygenase-1 in cardiovascular disease. (2008) (138)
- A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. (2016) (137)
- Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. (2015) (137)
- Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study (2019) (136)
- Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy (2004) (136)
- Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. (2005) (136)
- Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. (2008) (135)
- Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. (2018) (135)
- Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials. (2015) (135)
- Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. (2003) (135)
- Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). (2016) (133)
- Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study (2015) (133)
- Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. (2016) (132)
- Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. (2011) (132)
- Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisi (2015) (132)
- Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. (2010) (132)
- Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation (2012) (131)
- Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis (2012) (130)
- Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials (2018) (130)
- Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. (2011) (130)
- Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management (2007) (130)
- Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. (2016) (130)
- Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. (2014) (129)
- Virchow’s Triad Revisited: Blood Constituents (2003) (128)
- Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (128)
- Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. (2016) (128)
- The role of aspirin for stroke prevention in atrial fibrillation (2011) (127)
- Venous thromboembolism: pathophysiology, clinical features, and prevention (2002) (127)
- SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. (2014) (127)
- Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate (2010) (127)
- ESC Council on hypertension position document on the management of hypertensive emergencies. (2018) (126)
- A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. (2007) (125)
- Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. (2015) (125)
- A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations (2015) (125)
- The impact of statin therapy on plasma levels of von Willebrand factor antigen (2015) (124)
- Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 (2021) (124)
- Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. (2009) (123)
- Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. (2001) (123)
- Antithrombotic treatment in atrial fibrillation (2005) (123)
- Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (2018) (123)
- Physician variation in the management of patients with atrial fibrillation. (1996) (123)
- Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. (2019) (122)
- Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? (2000) (122)
- Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. (2015) (122)
- Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials. (2015) (121)
- Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? (2010) (121)
- Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc? (2018) (121)
- Microvesicles in vascular homeostasis and diseases (2017) (121)
- Clinical features and complications (2000) (121)
- Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation. (2014) (121)
- Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. (2004) (119)
- The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England (1994) (119)
- Assessment of mean platelet volume in coronary artery disease - what does it mean? (2007) (119)
- ABC of heart failure. Pathophysiology. (2000) (119)
- Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. (2014) (119)
- Blood pressure measurement (2001) (119)
- Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. (2016) (119)
- Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). (2017) (118)
- Plasma angiopoietin‐1, angiopoietin‐2 and Tie‐2 in breast and prostate cancer: a comparison with VEGF and Flt‐1 (2003) (118)
- Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation (2015) (118)
- The CD40-CD40L system in cardiovascular disease (2011) (118)
- Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison (2006) (118)
- Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. (1997) (118)
- Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. (2016) (118)
- Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. (2018) (117)
- The potential role of platelet microparticles in atherosclerosis (2005) (117)
- Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation: The Belgrade Atrial Fibrillation Study (2012) (117)
- Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2013) (116)
- Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. (2007) (116)
- Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? (2008) (116)
- Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors (2018) (116)
- An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality (2010) (116)
- Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project (2015) (116)
- Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? (2013) (116)
- Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. (2014) (116)
- Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (2018) (115)
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation (2017) (115)
- Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. (2009) (115)
- Role and analysis of monocyte subsets in cardiovascular disease (2016) (114)
- Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). (2013) (114)
- The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia (2012) (114)
- Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study (2012) (114)
- A randomized trial of the addition of home‐based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM‐CHF) study (2009) (114)
- Ischemic Stroke in South Asians: A Review of the Epidemiology, Pathophysiology, and Ethnicity-Related Clinical Features (2009) (113)
- Atrial fibrillation (2012) (113)
- Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. (2000) (113)
- Effects of short-term glucocorticoids on cardiovascular biomarkers. (2005) (112)
- Endothelial dysfunction: methods of assessment and application to hypertension. (2004) (112)
- The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. (1998) (112)
- Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. (2007) (112)
- Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. (2014) (112)
- Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials (2015) (112)
- Novel Risk Markers and Risk Assessments for Cardiovascular Disease (2017) (112)
- Association between statin use and plasma D-dimer levels (2015) (112)
- Microvesicles in vascular homeostasis and diseases. (2017) (111)
- Guidelines for the management of atrial fibrillation (Europace (2010) 12, (1360-1420)) (2011) (111)
- Atrial fibrillation (2016) (111)
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. (2019) (111)
- Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study. (2007) (110)
- Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. (2009) (110)
- The role of monocytes in atherosclerotic coronary artery disease (2010) (109)
- Hormone replacement therapy and blood pressure in hypertensive women. (1994) (109)
- Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis (2016) (109)
- Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan. (2015) (109)
- Sudden Death in Epilepsy: An Avoidable Outcome? (1992) (108)
- Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2012) (108)
- A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects (2019) (108)
- Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. (2000) (108)
- Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project (2012) (108)
- 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary (2021) (107)
- Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. (2020) (107)
- Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. (1996) (107)
- Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. (2000) (107)
- Does hypertension confer a prothrombotic state? Virchow's triad revisited. (2000) (107)
- Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke (2020) (106)
- Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States (2016) (106)
- Edoxaban: a focused review of its clinical pharmacology. (2014) (105)
- Patient outcomes using the European label for dabigatran (2013) (105)
- Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí (2017) (105)
- Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. (2008) (105)
- An overview of antithrombotic therapy (2002) (105)
- Platelets and heart failure. (2006) (105)
- Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores (2016) (105)
- Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. (2016) (105)
- Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation (2014) (104)
- Improving survival of malignant hypertension patients over 40 years. (2009) (104)
- Platelet microparticles and soluble P selectin in peripheral artery disease: Relationship to extent of disease and platelet activation markers (2005) (104)
- Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. (2000) (104)
- A reliable plasma marker of platelet activation: Does it exist? (2002) (104)
- Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score (2015) (104)
- Investigation (2000) (104)
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis (2017) (104)
- Low volume–high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans (2016) (104)
- ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (103)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (103)
- The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation (2020) (103)
- Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. (2017) (103)
- Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). (2003) (102)
- Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (2019) (102)
- Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. (2009) (101)
- High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation (2012) (101)
- Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial (2013) (101)
- Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. (2005) (100)
- A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. (2000) (100)
- Assessment of endothelial damage and dysfunction: observations in relation to heart failure. (2003) (99)
- Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. (2006) (99)
- Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis (2013) (99)
- Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. (2016) (99)
- Atrial Fibrillation and the Prothrombotic State in the Elderly: The Rotterdam Study (2003) (99)
- Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options (2011) (98)
- Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy (2017) (98)
- Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor (2001) (97)
- Epidemiology of atrial fibrillation (2018) (97)
- Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. (1995) (97)
- Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin: Impact of Quality of Anticoagulation Control (2015) (97)
- Abnormal angiopoietins 1&2, angiopoietin receptor Tie‐2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT)] (2005) (97)
- Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage (2016) (97)
- Prognostic value of interleukin‐6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure (2003) (97)
- Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. (2019) (97)
- A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels (2007) (97)
- Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation (2014) (96)
- Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice (2017) (96)
- One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry (2014) (96)
- Stroke in atrial fibrillation: epidemiology and thromboprophylaxis (2011) (96)
- Paroxysmal atrial fibrillation. (2001) (96)
- Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1? (2003) (96)
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists (2009) (95)
- The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease (2020) (95)
- Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (2016) (95)
- Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. (2012) (95)
- Ethnic differences in blood pressure and the prevalence of hypertension in England (2002) (95)
- Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (2018) (94)
- Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation (2004) (94)
- A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. (2013) (94)
- Infectious agents and atherosclerotic vascular disease. (1996) (94)
- Dipyridamole (1992) (93)
- von Willebrand factor and its relevance to cardiovascular disorders. (1995) (93)
- Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015 (2018) (93)
- Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type (2016) (93)
- Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma (2004) (92)
- Autonomic function and rheumatoid arthritis: a systematic review. (2014) (92)
- 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation. (2007) (92)
- Ideal Blood Pressure in Patients With Atrial Fibrillation. (2018) (92)
- Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project (2002) (92)
- 10‐year nationwide trends of the incidence, prevalence, and adverse outcomes of non‐valvular atrial fibrillation nationwide health insurance data covering the entire Korean population (2018) (91)
- [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
- Body mass index and adverse events in patients with incident atrial fibrillation. (2013) (91)
- Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels (2005) (91)
- Circulating microparticles: new insights into the biochemical basis of microparticle release and activity (2011) (91)
- Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?: A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials (2017) (91)
- Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial (2012) (91)
- Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis (2015) (91)
- Plasma markers of angiogenesis in pregnancy induced hypertension (2005) (90)
- Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). (2012) (90)
- Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. (2019) (90)
- P-Wave Indices and Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis (2017) (89)
- Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study (2017) (89)
- Psychological interventions for depression in heart failure. (2005) (89)
- Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis (2012) (89)
- Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice (2010) (89)
- Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation (2019) (89)
- Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study (2018) (89)
- Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals (2019) (88)
- High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. (2005) (88)
- Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation. (2004) (88)
- Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. (2004) (88)
- Management of pericardial effusion by drainage: a survey of 10 years' experience in a city centre general hospital serving a multiracial population (2000) (88)
- Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study. (2015) (88)
- Platelet activation in acute, decompensated congestive heart failure. (2007) (88)
- Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. (2013) (88)
- Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry (2015) (88)
- Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. (2014) (88)
- Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. (2015) (88)
- Obstructive sleep apnea and cardiovascular disease. (2010) (87)
- CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study (2017) (87)
- Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. (1999) (87)
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2019) (87)
- Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (2015) (87)
- Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. (2012) (86)
- EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication☆☆☆ (2016) (86)
- Circulating endothelial cells: markers of vascular dysfunction. (2005) (86)
- Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score? (2012) (86)
- Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark (2016) (86)
- Pharmacological Modulation of Platelet Function in Hypertension (2003) (86)
- Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) (2002) (85)
- Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? (2005) (85)
- New insights on endothelial progenitor cell subpopulations and their angiogenic properties. (2008) (85)
- Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. (2008) (84)
- Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study (2016) (84)
- Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry (2017) (84)
- A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. (2002) (84)
- Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. (2014) (84)
- Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? (2017) (83)
- CD14++CD16+ monocytes in patients with acute ischaemic heart failure (2013) (83)
- Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. (2020) (83)
- Thrombo‐embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (2012) (83)
- Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation. (2014) (83)
- Atrial Fibrillation in the United Kingdom: Predicting Costs of an Emerging Epidemic Recognising and Forecasting the Cost Drivers of Atrial Fibrillation-related costs. (2020) (83)
- Thrombo‐embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (2012) (83)
- Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. (2008) (83)
- Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic (2020) (82)
- Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project (2012) (82)
- Stroke Risk Stratification in a “Real‐World” Elderly Anticoagulated Atrial Fibrillation Population (2011) (82)
- Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study. (2019) (81)
- Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study (2018) (81)
- Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. (2016) (81)
- Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients (2009) (81)
- European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (81)
- Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity (2005) (81)
- Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry. (2016) (81)
- Circulating endothelial cells in acute ischaemic stroke (2005) (81)
- Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. (2013) (81)
- Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. (2013) (81)
- Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. (1996) (81)
- Management of atrial fibrillation (2007) (81)
- Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. (2009) (81)
- Metabolic syndrome and renal disease. (2013) (81)
- Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. (2006) (80)
- Oxidative stress in malignant and non-malignant phase hypertension (2002) (80)
- Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. (2020) (80)
- Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke (2004) (80)
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. (2016) (80)
- From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency (2016) (80)
- Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. (2012) (80)
- Atrial fibrillation—the growing epidemic (2007) (80)
- European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2017) (79)
- Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe (2011) (79)
- Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. (2014) (79)
- Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety. (2018) (79)
- Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation (2016) (79)
- Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. (2011) (78)
- Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. (2013) (78)
- Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study (2016) (78)
- ‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (2016) (77)
- Left Ventricular Systolic and Diastolic Function in Obstructive Sleep Apnea: Impact of Continuous Positive Airway Pressure Therapy (2012) (77)
- Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. (2019) (77)
- Ferritinophagy and ferroptosis in the management of metabolic diseases (2021) (77)
- What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? (2011) (77)
- Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? (2003) (76)
- European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (2016) (76)
- Thromboprophylaxis for atrial fibrillation (1999) (76)
- ABC of Atrial Fibrillation: ANTITHROMBOTIC TREATMENT FOR ATRIAL FIBRILLATION (1996) (76)
- Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. (2013) (75)
- Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? (2010) (75)
- Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. (2004) (75)
- Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. (2012) (75)
- Angiotensin-converting-enzyme inhibitors in early pregnancy (1997) (75)
- Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort (2020) (75)
- Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. (2004) (75)
- Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor? (2002) (75)
- Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin. (2014) (75)
- Abnormalities of rheology and coagulation in hypertension. (1994) (75)
- In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. (2002) (75)
- Systolic vs diastolic blood pressure and the burden of hypertension (2002) (74)
- Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation (2014) (74)
- Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. (2007) (74)
- Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments. (2010) (74)
- Management of atrial fibrillation (2007) (74)
- The management of hypertensive disease in black patients. (1999) (74)
- Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis (2003) (74)
- Recent developments in atrial fibrillation (2005) (74)
- Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. (2016) (74)
- Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study (2015) (74)
- Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study. (2017) (73)
- Do Indo-Asians have smaller coronary arteries? (1999) (73)
- Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and &bgr;-Thromboglobulin Levels in Atrial Fibrillation (2002) (73)
- Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. (2012) (73)
- Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care (2016) (73)
- Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials. (2015) (73)
- Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. (2012) (73)
- Peripheral vascular disease and hypertension: a forgotten association? (2001) (73)
- Fibrinogen and cardiovascular disorders. (1995) (73)
- Chlamydia pneumoniae antibodies in severe essential hypertension. (1998) (73)
- Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients (2010) (73)
- Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease. (2019) (73)
- d-Dimer elevation and adverse outcomes (2014) (72)
- Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade (2004) (72)
- Ethnic differences in hypertension and blood pressure control in the UK. (2001) (72)
- The prothrombotic state in hypertension and the effects of antihypertensive treatment. (2003) (72)
- Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm (2012) (72)
- Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis (2018) (72)
- The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment (2015) (72)
- A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation. (2002) (72)
- A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin (2014) (72)
- Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. (2005) (72)
- Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation (2015) (72)
- Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. (1995) (71)
- Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study (2016) (71)
- Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation (2017) (71)
- Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials (2015) (71)
- Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation (2017) (71)
- Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study (2016) (70)
- Target organ damage in hypertension: pathophysiology and implications for drug therapy. (2006) (70)
- Retinal vessel tortuosity measures and their applications. (2013) (70)
- Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial (2016) (70)
- Heart Failure in East Asia (2013) (70)
- Patent foramen ovale and migraine attacks: a systematic review. (2014) (70)
- Experiences of living with congestive heart failure: a qualitative study. (2008) (70)
- Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. (2005) (70)
- Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population (2019) (70)
- Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension? (2003) (69)
- Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). (2004) (69)
- A prospective study of changes in the quality of life of patients following mitral valve repair and replacement. (2001) (69)
- A contemporary view on endothelial function in heart failure (2012) (69)
- Cardiac arrhythmias in patients with COVID‐19 (2020) (69)
- Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. (2001) (68)
- Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke (2016) (68)
- Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review (2016) (68)
- Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. (2012) (68)
- Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Stroke Project. (1997) (68)
- Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers. (2009) (68)
- Monocytes in Acute Coronary Syndromes (2009) (67)
- ACUTE ADMISSIONS WITH ATRIAL FIBRILLATION IN A BRITISH MULTIRACIAL HOSPITAL POPULATION (1997) (67)
- Role of Monocytes in Heart Failure and Atrial Fibrillation (2018) (67)
- Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study (2015) (67)
- Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high‐risk’ patients with hypertension (2007) (67)
- Lone atrial fibrillation: what is known and what is to come (2011) (67)
- Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10‐year follow‐up study (2012) (67)
- Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis? (2003) (67)
- Role of microRNAs in cardiac remodelling: new insights and future perspectives. (2013) (67)
- The optimal management of patients on oral anticoagulation undergoing coronary artery stenting (2014) (67)
- Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. (2002) (66)
- A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2014) (66)
- Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? (2000) (66)
- Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. (2006) (66)
- Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians (1995) (66)
- Bleeding risk assessment and management in atrial fibrillation patients. (2012) (66)
- Atrial high-rate episodes and stroke prevention (2016) (66)
- Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association (2018) (66)
- Management of atrial fibrillation (2006) (66)
- Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk (1998) (66)
- 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. (2016) (66)
- Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction (2018) (66)
- Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study (2017) (66)
- Cardioversion of atrial fibrillation. (1995) (65)
- How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. (2012) (65)
- Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. (2006) (65)
- Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Hear (2019) (65)
- Peripheral vascular disease and Virchow's triad for thrombogenesis. (2002) (65)
- Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. (2018) (65)
- Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study (2016) (65)
- Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. (2013) (65)
- Regular bleeding risk assessment associated with reduction in bleeding outcomes: The mAFA II randomised trial. (2020) (65)
- Type 2 diabetes mellitus: a cardiovascular perspective (2005) (65)
- Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association (2020) (65)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (65)
- Dietary fat purchasing habits in whites, blacks and Asian peoples in England--implications for heart disease prevention. (1995) (65)
- Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (2017) (65)
- Platelet‐derived VEGF, Flt‐1, Angiopoietin‐1 and P‐selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis (2004) (64)
- Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. (2011) (64)
- Angiopoietin‐2 levels as a biomarker of cardiovascular risk in patients with hypertension (2008) (64)
- Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial (2019) (64)
- A longitudinal population‐based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990–1999 (2006) (64)
- Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. (2013) (64)
- Lone atrial fibrillation: what do we know? (2009) (64)
- Idiopathic orbital pseudotumour. (2011) (63)
- Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. (2015) (63)
- Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation (2015) (63)
- Corrigendum to: ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’ [Eur J Heart Fail 2012;14: 803–869] (2013) (63)
- Best practice for atrial fibrillation patient education. (2014) (63)
- Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis. (2005) (63)
- A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (2003) (63)
- Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. (1995) (62)
- Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. (2018) (62)
- Current Understanding of Atherogenesis. (2017) (62)
- Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation (2012) (62)
- Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis (2018) (62)
- Circulating microparticles: challenges and perspectives of flow cytometric assessment (2014) (62)
- Coagulopathic complications in breast cancer (2003) (62)
- Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients (2011) (61)
- Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system (2019) (61)
- Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease (2014) (61)
- Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score (2017) (61)
- Patients' understanding of anticoagulant therapy in a multiethnic population. (2003) (60)
- Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. (2015) (60)
- Association of Helicobacter pylori infection with coronary heart disease (1996) (60)
- C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study (2019) (60)
- Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated? (2016) (60)
- Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies (2020) (60)
- CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. (2014) (60)
- Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial (2020) (60)
- ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. (2019) (60)
- Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source (2016) (60)
- Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease (2003) (60)
- Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score. (2015) (60)
- Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study) (2014) (60)
- Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. (2015) (59)
- Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. (2016) (59)
- Hypertension and the prothrombotic state (2000) (59)
- Does hypertension confer a hypercoagulable state? (1998) (59)
- Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation. (2019) (59)
- Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. (2004) (59)
- CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study (2017) (59)
- Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. (2013) (59)
- Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight. (2019) (59)
- A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. (2016) (59)
- Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. (1999) (59)
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis (2021) (59)
- Treatment of hypertension in peripheral arterial disease. (2009) (58)
- Apixaban, an oral, direct inhibitor of activated Factor Xa. (2008) (58)
- Stroke Risk Factors Beyond the CHA₂DS₂-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation? (2015) (58)
- ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. (2001) (58)
- Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. (2008) (58)
- Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores (2016) (58)
- Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan. (2018) (58)
- Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study (2012) (58)
- Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation (2008) (58)
- Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial (2011) (58)
- Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis (2020) (58)
- Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. (2019) (58)
- Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial (2015) (58)
- The prothrombotic state in atrial fibrillation: pathophysiological and management implications (2018) (58)
- Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea (2011) (57)
- The wearable cardioverter-defibrillator: current technology and evolving indications (2017) (57)
- Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes (2017) (57)
- Chemical cardioversion of atrial fibrillation with intravenous dofetilide. (1995) (57)
- The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. (2015) (57)
- Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events (2018) (57)
- Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials (2016) (57)
- The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review. (2014) (57)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy. (2004) (57)
- The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods (2015) (57)
- “Unreal world” or “real world” data in oral anticoagulant treatment of atrial fibrillation (2016) (57)
- Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. (2020) (56)
- A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation (2002) (56)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (56)
- Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure (2013) (56)
- ABC of Atrial Fibrillation: AETIOLOGY, PATHOPHYSIOLOGY, AND CLINICAL FEATURES (1995) (56)
- Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database (2012) (56)
- Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. (2015) (56)
- Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. (2020) (56)
- Renal Dysfunction, Stroke Risk Scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry (2013) (55)
- Atrial flutter and thromboembolic risk: a systematic review (2015) (55)
- Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study. (2014) (55)
- Safety of new oral anticoagulant drugs: a perspective (2014) (55)
- Ethnicity and peripheral artery disease. (2009) (55)
- Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. (2000) (55)
- Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). (2002) (55)
- The immunological axis in heart failure: importance of the leukocyte differential (2013) (55)
- Hypertension, left ventricular hypertrophy, and sudden death (2002) (55)
- Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment (2010) (55)
- Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease (2016) (55)
- Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. (2000) (55)
- Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. (2014) (55)
- Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews (2021) (54)
- Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. (2008) (54)
- Markers of inflammation in acute coronary syndromes: Association with increased heart rate and reductions in heart rate variability (2005) (54)
- Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. (2007) (54)
- Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review (2017) (54)
- Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions? (2014) (54)
- Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis (2015) (54)
- Coronary risk factors, endothelial function, and atherosclerosis: a review. (1997) (54)
- Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology (2015) (54)
- Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor (2018) (54)
- Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. (2014) (54)
- Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. (2005) (53)
- Added Predictive Ability of the CHA2DS2VASc Risk Score for Stroke and Death in Patients With Atrial Fibrillation: The Prospective Danish Diet, Cancer, and Health Cohort Study (2012) (53)
- Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. (2002) (53)
- ABC of atrial fibrillation (1996) (53)
- Blood pressure measurement (2001) (53)
- Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? (2006) (53)
- Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation (2008) (53)
- Evidence of platelet activation in hypertension (1997) (53)
- Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes (2014) (53)
- Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. (2008) (53)
- Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study (2012) (53)
- The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review (2017) (53)
- Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors. (2008) (53)
- Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF‐App) II randomised trial (2019) (53)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (53)
- The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal (2019) (53)
- Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial (2021) (52)
- Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation (2014) (52)
- Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial (2016) (52)
- Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial (2017) (52)
- Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardí (2017) (52)
- A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage. (2001) (52)
- Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. (2018) (52)
- Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment (2018) (52)
- Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort (2016) (52)
- Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease. (2001) (51)
- Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E‐selectin (2006) (51)
- Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study (2013) (51)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (51)
- Atrial Fibrillation and Hypertension (2017) (51)
- Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients. (2018) (51)
- Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients (2019) (51)
- Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure (2009) (51)
- Corrigendum to: ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (51)
- Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. (2012) (51)
- Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263] (2003) (51)
- The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants. (2017) (51)
- Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review (2016) (51)
- Atrial Fibrillation in Older People: Concepts and Controversies (2019) (50)
- Stroke prevention in Atrial Fibrillation. (2017) (50)
- Anticoagulation versus placebo for heart failure in sinus rhythm. (2014) (50)
- Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2014) (50)
- Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation. (2013) (50)
- LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention. (2015) (50)
- Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio (2019) (49)
- Impact of non-vitamin k antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation. (2014) (49)
- Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269] (2003) (49)
- Circulating Endothelial Cells: Realities and Promises in Vascular Disorders (2003) (49)
- Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches? (2014) (49)
- Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. (2007) (49)
- Endothelial integrity, soluble adhesion molecules and platelet markers in Type 1 diabetes mellitus (1998) (49)
- Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. (2019) (49)
- Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management (2019) (49)
- Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation. (2017) (49)
- Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow‐up of 4.5 million Danish adults (2014) (49)
- Angiogenesis in myocardial infarction. An acute or chronic process? (2002) (49)
- Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis? (2007) (48)
- Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension (2011) (48)
- Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project (2017) (48)
- Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use. (2019) (48)
- A proposal for new clinical concepts in the management of atrial fibrillation. (2012) (48)
- Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS2, CHA2DS2‐VASc, R2CHADS2, HAS‐BLED, ATRIA, and More) (2014) (48)
- Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. (2012) (48)
- Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation (2005) (48)
- ABC of heart failure: aetiology. (2000) (48)
- Increased Platelet Glycoprotein V Levels in Patients with Coronary and Peripheral Atherosclerosis (2001) (48)
- Prevalence of Heart Failure and Atrial Fibrillation in Minority Ethnic Subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (2011) (48)
- Venous thromboembolism: treatment strategies (2002) (48)
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies (2018) (48)
- Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation). (2015) (48)
- Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. (2011) (47)
- Measurement of the soluble angiopoietin receptor tie‐2 in patients with coronary artery disease: development and application of an immunoassay (2003) (47)
- Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study (2022) (47)
- Acute coronary syndromes: Virchow's triad revisited (2003) (47)
- Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS) (2016) (47)
- Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke (2017) (47)
- The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis (2008) (47)
- Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997–2005) (2008) (47)
- Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). (2003) (47)
- Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study (2015) (47)
- Antiplatelet agents and anticoagulants for hypertension. (2004) (47)
- Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry (2018) (47)
- Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. (2015) (47)
- Quality indicators for the care and outcomes of adults with atrial fibrillation. (2020) (47)
- Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project (2004) (47)
- Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited. (2003) (47)
- Smoking and recurrent attacks of acute intermittent porphyria. (1991) (46)
- Chlamydia pneumoniae and acute arterial thrombotic disease. (1995) (46)
- THE PREVALENCE OF PRE‐ECLAMPSIA AND OBSTETRIC OUTCOME IN PREGNANCIES OF NORMOTENSIVE AND HYPERTENSIVE WOMEN ATTENDING A HOSPITAL SPECIALIST CLINIC (2001) (46)
- Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. (2013) (46)
- The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. (2014) (46)
- Soluble CD40L in peripheral artery disease (2005) (46)
- Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’ (2004) (46)
- Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project. (1998) (46)
- Increased 5‐year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: The West Birmingham Stroke Project (2007) (46)
- Compliance with pharmacological therapy in hypertension: can we do better, and how? (2004) (46)
- Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. (2016) (46)
- Psychology in coronary care. (1999) (46)
- Oral anticoagulation in atrial fibrillation: A pan-European patient survey. (2007) (46)
- Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. (2010) (46)
- Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study (2021) (45)
- Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention. (1996) (45)
- Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. (2018) (45)
- Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. (2016) (45)
- The effects of exercise and diurnal variation on monocyte subsets and monocyte‐platelet aggregates (2012) (45)
- Peripheral arterial disease and Virchow’s triad (2009) (45)
- Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume (2004) (45)
- Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis. (1998) (45)
- Rationale and design of the Chinese Atrial Fibrillation Registry Study (2016) (45)
- Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID‐19 patients (2021) (45)
- Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays. (2001) (45)
- Alcohol intake and prognosis of atrial fibrillation (2013) (45)
- Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial. (2001) (45)
- Platelets and atrial fibrillation. (2001) (45)
- Continuous retinal vessel diameter measurements: the future in retinal vessel assessment? (2010) (45)
- Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. (2008) (45)
- Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. (2017) (45)
- Quality of life in older people with atrial fibrillation (2009) (44)
- Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation. (2008) (44)
- Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. (2015) (44)
- Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. (2016) (44)
- Effects of atorvastatin on circulating CD34+/CD133+/ CD45− progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus (2010) (44)
- Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. (2015) (44)
- Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology? (2002) (44)
- Can We Predict Stroke in Atrial Fibrillation? (2012) (44)
- Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. (2007) (44)
- Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries (2004) (44)
- Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 2020 (2020) (44)
- New anticoagulant treatments to protect against stroke in atrial fibrillation (2012) (44)
- Clinical outcomes of acute stroke patients with atrial fibrillation (2009) (44)
- Percutaneous balloon dilatation of aortic coarctation in adults. (1996) (44)
- Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation (2013) (44)
- Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. (2019) (44)
- Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis (2016) (44)
- The endothelium and atrial fibrillation (2008) (44)
- Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2‐VASc Scores (2017) (44)
- Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. (2014) (44)
- Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score (2016) (43)
- Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation (2005) (43)
- Collateralization and the response to obstruction of epicardial coronary arteries. (2004) (43)
- Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban (2018) (43)
- Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients (2018) (43)
- Atrial fibrillation post-cardiac surgery: changing perspectives (2006) (43)
- Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban (2018) (43)
- Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation. (2016) (43)
- Anticoagulation Resumption After Intracerebral Hemorrhage (2018) (43)
- Management: diuretics, ACE inhibitors, and nitrates (2000) (43)
- Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence (2016) (43)
- Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease (2005) (43)
- Targeting the renin–angiotensin–aldosterone system in atrial fibrillation: from pathophysiology to clinical trials (2005) (43)
- Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. (2000) (43)
- Stroke and Bleeding Risk in Atrial Fibrillation (2014) (43)
- Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma (2002) (43)
- The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review (2013) (43)
- New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation (2012) (43)
- Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study (2018) (43)
- Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation (2020) (42)
- Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (2016) (42)
- Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation (2014) (42)
- Atrial fibrillation and risk of stroke: a nationwide cohort study. (2016) (42)
- Biomarkers in atrial fibrillation: an overview (2014) (42)
- Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. (2013) (42)
- Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study. (2013) (42)
- Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (2016) (42)
- Blood pressure demographics: nature or nurture ... ... genes or environment? (2005) (42)
- Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. (2015) (42)
- Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. (1997) (42)
- Acute and chronic management strategies (2000) (42)
- Left ventricular fibrosis in atrial fibrillation. (2013) (42)
- Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation. (2005) (42)
- Cell adhesion molecules in cardiovascular disease and its risk factors--what can soluble levels tell us? (2000) (42)
- Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials (2016) (42)
- Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. (2019) (42)
- Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact? (2013) (42)
- ABC of heart failure - Clinical features and complications (2000) (42)
- Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study (2017) (42)
- Optimizing atrial fibrillation management: from ICU and beyond. (2015) (42)
- Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. (2004) (42)
- The coagulation system is activated in idiopathic cardiomyopathy. (1995) (42)
- Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. (2017) (41)
- Matrix metalloproteinase‐1 and its inhibitor, TIMP‐1, in systolic heart failure: relation to functional data and prognosis (2007) (41)
- Anti‐oxidative properties of beta‐blockers and angiotensin‐converting enzyme inhibitors in congestive heart failure (2003) (41)
- Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. (1996) (41)
- Acute management of atrial fibrillation. (2009) (41)
- Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. (2013) (41)
- Endothelial progenitor cells: what use for the cardiologist? (2010) (41)
- Glycemic Status Underlies Increased Arterial Stiffness and Impaired Endothelial Function in Migrant South Asian Stroke Survivors Compared to European Caucasians: Pathophysiological Insights From the West Birmingham Stroke Project (2009) (41)
- TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT) (2010) (41)
- Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation (2003) (41)
- Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial. (2016) (41)
- Angiogenic factors in atrial fibrillation: A possible role in thrombogenesis? (2005) (41)
- Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis (2008) (41)
- The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood (2008) (41)
- Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. (2017) (41)
- Plasma and platelet‐derived vascular endothelial growth factor and angiopoietin‐1 in hypertension: effects of antihypertensive therapy (2004) (41)
- Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study (2018) (41)
- Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study (2011) (41)
- Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey (2016) (40)
- Anticoagulation in hospitals and general practice (2003) (40)
- Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. (2017) (40)
- The emerging role of biomarkers in atrial fibrillation. (2013) (40)
- Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. (2012) (40)
- Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation (2018) (40)
- The role of inflammation in atrial fibrillation (2005) (40)
- What are the costs of atrial fibrillation? (2011) (40)
- Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. (2019) (40)
- Short-Term Adjuvant Atorvastatin Improves Frequency Domain Indices of Heart Rate Variability in Stable Systolic Heart Failure (2005) (40)
- Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (2017) (40)
- Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation. (2010) (40)
- Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation (2005) (40)
- Hypertension and the prothrombotic state. (2003) (40)
- Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis (2017) (40)
- Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a 'real world' anticoagulated atrial fibrillation population. (2012) (40)
- Towards understanding the aetiology and pathophysiology of human hypertension: where are we now? (2006) (40)
- ACUTE ADMISSIONS WITH HEART FAILURE TO A DISTRICT GENERAL HOSPITAL SERVING A MULTIRACIAL POPULATION (1997) (40)
- Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice. (2017) (39)
- Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (2021) (39)
- Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension. (1999) (39)
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Clinical Outcomes in Asian Patients with Atrial Fibrillation. (2020) (39)
- The CHADS2 and CHA2DS2–VASc scores predict new occurrence of atrial fibrillation and ischemic stroke (2013) (39)
- Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. (2014) (39)
- Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis (2021) (39)
- Effect of acute exercise on the raised plasma fibrinogen, soluble P‐Selectin and von willebrand factor levels in chronic atrial fibrillation (2001) (39)
- The Impact of New and Emerging Clinical Data on Treatment Strategies for Atrial Fibrillation (2010) (39)
- Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial (2016) (39)
- A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial (2017) (39)
- Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (2004) (39)
- Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores (2017) (39)
- Red vs white thrombi: treating the right clot is crucial. (2003) (39)
- Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry (2018) (39)
- Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based? (2007) (39)
- Non-drug management (2000) (39)
- Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey. (2014) (39)
- Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension: Relationship to Endothelial Dysfunction and Effects of Treatment* (2002) (39)
- Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: A multicenter retrospective study (2021) (39)
- A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. (2001) (39)
- Updated NICE guideline: management of atrial fibrillation (2014) (2014) (39)
- Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. (2015) (38)
- Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study. (2017) (38)
- Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. (2015) (38)
- Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus. (2019) (38)
- Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly. (2013) (38)
- Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation. (2011) (38)
- Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis (2014) (38)
- Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. (2016) (38)
- Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. (2015) (38)
- Age- and sex-specific analysis of patients with embolic stroke of undetermined source (2017) (38)
- Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic Capabilities in Implantable Cardioverter-Defibrillators: The Multicentre Italian ANGELS of AF Project (2012) (38)
- Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation (2011) (38)
- Microalbuminuria and cardiovascular risk. (1998) (38)
- Prognostic value of plasma soluble P‐selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high‐risk patients with hypertension: a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (2007) (38)
- Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. (1998) (38)
- Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. (2003) (38)
- Cardiovascular risk in women: the cardiologist's perspective. (2000) (38)
- Endothelial function and its assessment (2005) (38)
- The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study. (2014) (38)
- Eosinophil count predicts mortality following percutaneous coronary intervention. (2012) (38)
- Effects of Aspirin on Endothelial Function and Hypertension (2016) (38)
- Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease (2014) (37)
- European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (2015) (37)
- Recurrent Stroke: The Value of the CHA2DS2VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort (2015) (37)
- Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. (2012) (37)
- Drug-drug interactions of non-vitamin K oral anticoagulants (2016) (37)
- Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. (2009) (37)
- An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium (2012) (37)
- Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation: A Nationwide Cohort Study (2018) (37)
- Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation (2017) (37)
- Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation (2014) (37)
- Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation. (2015) (37)
- Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study (2013) (37)
- Ambulatory blood pressure monitoring in atrial fibrillation. (1996) (37)
- Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? (2017) (37)
- Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals (2002) (37)
- Malignant Hypertension Revisited—Does This Still Exist? (2017) (37)
- Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. (2004) (37)
- Platelet activation in pregnancy-induced hypertension. (2005) (37)
- Hypercoagulability and haemodynamic abnormalities in atrial fibrillation. (1997) (36)
- Atrial fibrillation, arrhythmia burden and thrombogenesis. (2012) (36)
- Recruitment of ethnic minority patients to a cardiac rehabilitation trial: The Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263] (2005) (36)
- Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. (2015) (36)
- ANOMALOUS CORONARY ARTERIES OF AORTIC ORIGIN (2000) (36)
- Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials (2017) (36)
- The value of the CHA 2 DS 2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS 2 score 0 – 1 : A nationwide cohort study (2018) (36)
- Assessment of the CHA 2 DS 2-VASc Score in Predicting Ischemic Stroke , Thromboembolism , and Death in Patients With Heart FailureWith andWithout Atrial Fibrillation (2015) (36)
- Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus. (2008) (36)
- Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation (2020) (36)
- Acute versus habitual exercise, thrombogenesis and exercise intensity (2004) (36)
- Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function (2008) (36)
- Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation. (2011) (36)
- Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients (2019) (35)
- Target organ damage and the prothrombotic state in hypertension. (2000) (35)
- Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants (2013) (35)
- Fibrinolytic function and atrial fibrillation. (2003) (35)
- Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy (2007) (35)
- Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy (2017) (35)
- Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach (2018) (35)
- Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. (2002) (35)
- Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (2014) (35)
- Hospital morbidity and mortality and changes in quality of life following mitral valve surgery in the elderly. (1999) (35)
- Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study (2018) (35)
- Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There? (2016) (35)
- Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension (2011) (35)
- Rate control in the medical management of atrial fibrillation (2006) (35)
- Body Mass Index Variability and Long‐term Risk of New‐Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study (2019) (35)
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes (2012) (35)
- Viewpoint: The prothrombotic state in heart failure: A maladaptive inflammatory response? (2007) (34)
- Platelet activation in the hypertensive disorders of pregnancy (2004) (34)
- Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials (2016) (34)
- Psychological interventions for depression in adolescent and adult congenital heart disease. (2013) (34)
- Blood pressure measurement (2001) (34)
- Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. (2015) (34)
- ABC of antithrombotic therapy: Antithrombotic therapy for atrial fibrillation (2002) (34)
- Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance (2012) (34)
- β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study. (2016) (34)
- Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin (2016) (34)
- Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies (2011) (34)
- Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor (2011) (34)
- Novel oral anticoagulants in non-valvular atrial fibrillation. (2013) (34)
- Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary (2013) (34)
- Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation (2015) (34)
- A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. (2015) (34)
- Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. (2013) (34)
- Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. (2005) (34)
- Malignant hypertension in the elderly. (1995) (34)
- EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (2019) (34)
- Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial (2007) (34)
- Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial. (2014) (34)
- Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study (2015) (34)
- White blood cell count and hypertension (2006) (34)
- Prognostic role of plasma von Willebrand factor and soluble E‐selectin levels for future cardiovascular events in a ‘real‐world’ community cohort of patients with atrial fibrillation (2013) (34)
- Venous thromboembolism (2006) (34)
- Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes (2005) (34)
- Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage (2019) (34)
- Is hypertension a prothrombotic state? (2005) (34)
- Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. (1995) (34)
- Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia (2018) (34)
- Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. (2013) (33)
- WOMEN'S AWARENESS OF, AND ATTITUDES TOWARDS, HORMONE REPLACEMENT THERAPY: ETHNIC DIFFERENCES AND EFFECTS OF AGE AND EDUCATION (1998) (33)
- Antihypertensive therapy and endothelial function. (2004) (33)
- Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. (2007) (33)
- An observational study of endothelial function in early arthritis (2012) (33)
- Left Ventricular Thrombosis: New Perspectives on an Old Problem. (2020) (33)
- Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups. (1998) (33)
- Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation. (2005) (33)
- Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis (2017) (33)
- Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: Yes Even 1 Stroke Risk Factor Confers a Real Risk of Stroke (2016) (33)
- Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients (2006) (33)
- Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. (2002) (33)
- The endothelium and thrombotic risk in heart failure (2009) (33)
- Risk factors for new-onset atrial fibrillation: A focus on Asian populations. (2018) (33)
- Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials (2016) (33)
- Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function (2019) (33)
- Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry). (2017) (33)
- Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? (2016) (33)
- Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease. (2020) (33)
- Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand (2012) (33)
- Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis (2006) (33)
- Ankle-Brachial Index and cardiovascular events in atrial fibrillation (2016) (33)
- Anticoagulation for heart failure in sinus rhythm. (2000) (32)
- Oral Omega n3-PUFA Therapy (Omacor) Has No Impact on Indices of Heart Rate Variability in Stable Post Myocardial Infarction Patients (2006) (32)
- Drug-eluting stents: a comprehensive appraisal. (2009) (32)
- The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment (2005) (32)
- Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain. (2005) (32)
- Antithrombotic therapy for atrial fibrillation. (2002) (32)
- Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation. (2012) (32)
- Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study (2016) (32)
- Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells (2003) (32)
- Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study (2019) (32)
- Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making (2015) (32)
- Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage (2020) (32)
- Guideline‐Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community‐Based Darlington Atrial Fibrillation Registry (2017) (32)
- The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients. (2020) (32)
- Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices (2019) (32)
- ALCOHOL, HYPERTENSION, CORONARY DISEASE AND STROKE (1995) (32)
- Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study (2018) (32)
- Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke * (2007) (32)
- The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure (2005) (32)
- Peripheral artery disease and atrial fibrillation: a potentially dangerous combination (2012) (32)
- Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis (2016) (32)
- Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis. (2017) (32)
- Aspirin and aspirin resistance in coronary artery disease. (2013) (32)
- Ximelagatran: an eulogy. (2006) (32)
- Neurovascular coupling and cerebral autoregulation in atrial fibrillation (2019) (32)
- Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score (2017) (32)
- Antithrombotic therapy in acute coronary syndromes (2002) (32)
- Doctors, nurses, pharmacists and patients--the Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery. (1997) (32)
- Atrial fibrillation (2022) (32)
- Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity. (2003) (32)
- Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation – meta-analysis. (2015) (32)
- Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain – the Healthy Hearts Project (2007) (31)
- Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 (2021) (31)
- Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis (2015) (31)
- Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm (2001) (31)
- Heart failure—the importance of ethnicity (2004) (31)
- Arterial stiffness: beyond pulse wave velocity and its measurement (2008) (31)
- Obesity and Atrial Fibrillation: Making inroads through fat. (2020) (31)
- Stroke Care during the COVID-19 Pandemic: International Expert Panel Review (2021) (31)
- Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics. (2021) (31)
- The CHA 2 DS 2-VASc score identifies those patients with atrial fibrillation and a CHADS 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy (2012) (31)
- Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban (2012) (31)
- Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation. (2019) (31)
- Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications (2013) (31)
- Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis (2019) (31)
- High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. (2014) (31)
- A New Landscape for Stroke Prevention in Atrial Fibrillation: Focus on New Anticoagulants, Antiarrhythmic Drugs, and Devices (2011) (31)
- Salt intake and Helicobacter pylori infection (2004) (31)
- Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. (2018) (31)
- Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. (2015) (31)
- Psychological interventions for depression in adolescent and adult congenital heart disease. (2003) (31)
- Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study (2015) (31)
- Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans (2008) (31)
- Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. (2005) (31)
- Can we treat coronary artery disease with antibiotics? (1997) (31)
- Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications (2011) (31)
- A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. (2005) (31)
- Diagnosis and treatment of digoxin toxicity. (1993) (31)
- Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study. (2014) (30)
- Antithrombotic treatment in atrial fibrillation. (2006) (30)
- What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? (2005) (30)
- Microparticles and cardiovascular diseases (2019) (30)
- Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation (2011) (30)
- Genotype‐guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta‐analysis of randomized controlled trials (2018) (30)
- Effects of Coenzyme Q 10 on Statin-Induced Myopathy : A Meta-analysis of Randomized Controlled Trials (2014) (30)
- Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers? (2007) (30)
- Valvar heart disease and prosthetic heart valves (2002) (30)
- Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity (2005) (30)
- Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation (2012) (30)
- The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis. (2015) (30)
- Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation (2015) (30)
- Novel Oral Anticoagulants in Cardiovascular Disease (2014) (30)
- Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study. (2017) (30)
- Tissue inhibitor of metalloproteinse‐1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension (2005) (30)
- Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project (2020) (30)
- Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk. (2011) (30)
- Ambulatory blood pressure monitoring in heart failure: a systematic review (2005) (30)
- Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells (2003) (30)
- Aspirin resistance: what, why and when? (2007) (30)
- Lone atrial fibrillation – an overview (2014) (30)
- Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. (2015) (29)
- Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. (2008) (29)
- Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention. (2016) (29)
- Comparison of primary coronary artery bypass surgery in a British Indo-Asian and white Caucasian population. (1999) (29)
- The impact of statin use on atrial fibrillation. (2008) (29)
- Ethnic differences in pre-admission levels of physical activity in patients admitted with myocardial infarction. (1996) (29)
- Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation (2018) (29)
- Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. (2007) (29)
- Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial (2013) (29)
- Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study (2017) (29)
- Arterial stiffness in diabetes and hypertension (2004) (29)
- Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. (2016) (29)
- Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin? (2008) (29)
- Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report (2018) (29)
- Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. (2008) (29)
- Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. (2013) (29)
- Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
- A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. (2012) (29)
- Antithrombotic therapy for cerebrovascular disorders (2002) (29)
- Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials (2016) (29)
- Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. (2021) (29)
- Coagulation activity is increased in the left atrium of patients with mitral stenosis. (1995) (29)
- Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension (2004) (29)
- Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex). (2015) (29)
- Do we still need dipyridamole? (1998) (29)
- Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors. (2015) (29)
- Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry (2018) (28)
- Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. (2006) (28)
- Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity (2008) (28)
- Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT) (2003) (28)
- Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt‐1, in haematological cancers: A comparison with breast cancer (2001) (28)
- Atrial Fibrillation and Vascular Disease—A Bad Combination (2012) (28)
- Elevated angiogenin levels in chronic heart failure (2008) (28)
- Inflammation and atrial fibrillation: cause or effect? (2008) (28)
- An 8‐year follow‐up study of acute admissions with heart failure in a multiethnic population (2004) (28)
- Novel oral anticoagulants (2009) (28)
- Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. (2008) (28)
- Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment (2010) (28)
- Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience. (1998) (28)
- Statin treatment is associated with improved prognosis in patients with AF-related stroke. (2014) (28)
- Patients’ Understanding of Anticoagulant Therapy in a Multiethnic Population (2003) (28)
- Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. (2019) (28)
- Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality. (2019) (28)
- Does renal function improve after diagnosis of malignant phase hypertension? (1997) (28)
- CXCR4 positive and angiogenic monocytes in myocardial infarction (2012) (28)
- Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. (2016) (28)
- The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study. (2020) (28)
- Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial (2021) (28)
- Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study. (2016) (28)
- Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation: A Nationwide Study (2014) (28)
- Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes (2008) (27)
- The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation (2021) (27)
- Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation (2014) (27)
- Peri‐operative management of ophthalmic patients taking antithrombotic therapy (2011) (27)
- Anger rumination, social support, and cardiac symptoms in patients undergoing angiography. (2010) (27)
- Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function (2020) (27)
- Laboratory monitoring of the non-vitamin K oral anticoagulants. (2014) (27)
- Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study (2020) (27)
- Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process. (2019) (27)
- Safety of coronary artery bypass surgery during therapeutic oral anticoagulation. (2011) (27)
- Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis (2018) (27)
- Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy (2007) (27)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). (2017) (27)
- Monocyte diversity in myocardial infarction. (2009) (27)
- Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis. (2018) (27)
- Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy? (2005) (27)
- Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta‐analysis of risk‐modifying drugs (2013) (27)
- Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study (2016) (27)
- Identification, diagnosis and assessment of atrial fibrillation (2006) (27)
- Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment (2006) (27)
- Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation (2012) (27)
- Regression of left ventricular hypertrophy and improved prognosis: some hope now . . . or hype? (2001) (27)
- Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial (2010) (27)
- A prospective study of changes in patients' quality of life after aortic valve replacement. (2001) (27)
- The effects of exercise stress testing on soluble E‐selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction (2008) (27)
- The endothelium, inflammation, and coagulation in sepsis (2006) (27)
- Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences (2014) (27)
- TLR4 expression on monocyte subsets in myocardial infarction (2013) (27)
- Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension (2002) (27)
- Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk? (2007) (27)
- The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE (2016) (27)
- Coronary spasm in acute myocardial infarction (1998) (27)
- The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project. (2015) (26)
- Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry (2015) (26)
- Management of paroxysmal atrial fibrillation. (1993) (26)
- Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure (2011) (26)
- Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFlt-1) in human breast cancer. (2004) (26)
- Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (2021) (26)
- Small‐size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P‐selectin (2014) (26)
- Antihypertensive Therapy and Cancer Risk (2001) (26)
- Stroke prevention strategies in high-risk patients with atrial fibrillation (2020) (26)
- Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study (2021) (26)
- Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study (2019) (26)
- A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732] (2004) (26)
- Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives. (2006) (26)
- Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population (2018) (26)
- Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19 (2020) (26)
- The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations (2018) (26)
- Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project (2016) (26)
- Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS2 and CHA2DS2-VASc Scores in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study (2013) (26)
- Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation (2014) (26)
- Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study. (2011) (26)
- Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO2 in young and older men (2017) (26)
- Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (2014) (26)
- Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban. (2017) (26)
- Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. (2015) (26)
- Evaluation of the Sorin bicarbon bileaflet valve in 488 patients (519 prostheses). (1999) (26)
- Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation (2019) (26)
- Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. (2018) (26)
- Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry (2017) (26)
- Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. (2014) (26)
- Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP‐AF audit tool (2015) (26)
- Brugada syndrome: A general cardiologist's perspective. (2017) (26)
- Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation (2015) (26)
- Antithrombotic therapy in hypertension: a Cochrane Systematic review (2005) (26)
- Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK (2013) (26)
- Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction. (2014) (26)
- Managing atrial fibrillation in the Accident and Emergency department. (2001) (25)
- Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. (2017) (25)
- ABC of antithrombotic therapy (2003) (25)
- Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. (2015) (25)
- Angiopoietin/tie‐2 as mediators of angiogenesis: a role in congestive heart failure? (2004) (25)
- Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting. (2016) (25)
- Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling (2009) (25)
- The renin-angiotensin-aldosterone system and fibrinolysis (2000) (25)
- The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years (2020) (25)
- Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. (2016) (25)
- The prognostic value of biomarkers after a premature myocardial infarction. (2010) (25)
- Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation. (2020) (25)
- Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (2016) (25)
- Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials. (2016) (25)
- The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target? (2004) (25)
- Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines (2006) (25)
- Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. (2007) (25)
- Plasma YKL-40 levels are elevated in patients with chronic heart failure (2010) (25)
- The prothrombotic state in atrial fibrillation: the atrium, the endothelium... And tissue factor? (2003) (25)
- The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation (2016) (25)
- Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis (2020) (25)
- Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study (2019) (25)
- Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer (2013) (25)
- Endothelial damage/dysfunction and hypertension in pregnancy. (2011) (25)
- Alcohol and hypertension: an old relationship revisited. (2006) (25)
- Comparing the Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. (2019) (25)
- Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). (2015) (25)
- Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. (2016) (25)
- Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. (2015) (25)
- Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans (2015) (25)
- Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study (2018) (25)
- Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography? (2017) (25)
- New antiplatelet drugs: beyond aspirin and clopidogrel (2009) (25)
- The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation (2013) (24)
- Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction. (2007) (24)
- Omega‐3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise? (2010) (24)
- Coronary artery disease and ischemic stroke in atrial fibrillation. (2007) (24)
- Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants (2020) (24)
- The prothrombotic state in atrial fibrillation: new insights, more questions, and clear answers needed. (2000) (24)
- “Novel Clinical Concepts in Thrombosis”: Integrated Care for Stroke Management—Easy as ABC (2021) (24)
- Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers (2011) (24)
- Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials). (2016) (24)
- Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms (2021) (24)
- Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score). (2017) (24)
- Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention. (2014) (24)
- Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. (2017) (24)
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage (2019) (24)
- Bleeding risk in patients with atrial fibrillation: the AMADEUS study. (2011) (24)
- Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis (2017) (24)
- Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. (2013) (24)
- Post-stroke inflammatory response: Effects of stroke evolution and outcome (2003) (24)
- Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study (2018) (24)
- Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons (2014) (24)
- Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases. (2010) (24)
- Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study (2006) (24)
- Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2017) (24)
- Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. (2018) (24)
- Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. (2018) (24)
- Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. (2015) (24)
- Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease (2017) (24)
- Aortic coarctation diagnosed after hypertension in pregnancy. (1998) (24)
- Measurement of rivaroxaban and apixaban in serum samples of patients (2014) (24)
- Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry (2017) (24)
- Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation (2005) (24)
- Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2‐VASc Score of 1 (Men) or 2 (Women)? (2016) (24)
- Growth hormone therapy and the heart. (2006) (23)
- The ‘Birmingham Hypertension Square’ for the optimum choice of add-in drugs in the management of resistant hypertension (1998) (23)
- Comparative Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients (2021) (23)
- Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception. (1997) (23)
- Warfarin or novel oral anticoagulants for atrial fibrillation? (2014) (23)
- Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. (2013) (23)
- Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study (2021) (23)
- A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real‐World” vs Clinical Trials (2018) (23)
- Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles (2016) (23)
- Digoxin revisited. (1998) (23)
- External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest. (2017) (23)
- Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study (2020) (23)
- A systematic review of the prothrombotic effects of an acute change in posture: a possible mechanism underlying the morning excess in cardiovascular events? (2007) (23)
- Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control (2004) (23)
- Atrial Fibrillation Management (2013) (23)
- Asymptomatic Atrial Fibrillation on Device Interrogation (2008) (23)
- Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants. (2013) (23)
- A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation? (2012) (23)
- Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers (2018) (23)
- Changes in von Willebrand factor and soluble ICAM, but not soluble VCAM, soluble E selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis. (2002) (23)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. (2018) (23)
- Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project (2001) (23)
- How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management (2021) (23)
- Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. (2013) (23)
- Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? (1997) (23)
- Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria (2004) (23)
- Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry. (2018) (23)
- 'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications? (2008) (23)
- Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis (2021) (23)
- Platelet activation and cardiovascular outcomes in acute coronary syndromes (2006) (23)
- THE ACUTE PORPHYRIAS (1993) (23)
- What do we do about atrial high rate episodes? (2020) (23)
- Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (2007) (23)
- Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe (2018) (23)
- Maintaining therapeutic anticoagulation: the importance of keeping "within range". (2007) (23)
- Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms (2021) (22)
- Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: GLORIA-AF Registry (2017) (22)
- Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy. (1996) (22)
- Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany (2015) (22)
- Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients (2018) (22)
- How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (2022) (22)
- C0589: Relationship of the SAME-TT2R2 Score to Poor Quality Anticoagulation, Stroke, Clinically Relevant Bleeding and Mortality in Patients with Atrial Fibrillation (2014) (22)
- Hypertension: Principles and Practice (2005) (22)
- Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic - Echocardiographic Heart of England Screening Study) (2009) (22)
- Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? (2007) (22)
- Assessment of endothelial (dys)function in atrial fibrillation (2009) (22)
- Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (2018) (22)
- Circulating endothelial cells: from bench to clinical practice (2008) (22)
- Salt and Cardiovascular Disease: Clinical and Epidemiological Evidence (2000) (22)
- A contemporary viewpoint on ‘aspirin resistance’ (2012) (22)
- Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease (2014) (22)
- Heart failure in general practice (2000) (22)
- Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey. (2020) (22)
- Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta‐analysis of observational studies (2016) (22)
- Blood pressure measurement in atrial fibrillation: goodbye mercury? (2006) (22)
- Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. (2013) (22)
- Monocyte‐derived and CD34+/KDR+ endothelial progenitor cells in heart failure (2012) (22)
- Depression, indirect clinical markers of cardiac disease severity, and mortality following myocardial infarction (2005) (22)
- Thrombogenesis and fibrinolysis in acute coronary syndromes. Important facets of a prothrombotic or hypercoagulable state? (2000) (22)
- Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation (2016) (22)
- Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation (2019) (22)
- Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension (2005) (22)
- Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation. (2014) (21)
- The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries. (2012) (21)
- Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more (2006) (21)
- Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists’ Collaboration meta-analysis (2005) (21)
- Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation (2019) (21)
- Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach (2015) (21)
- Management: digoxin and other inotropes, β blockers, and antiarrhythmic and antithrombotic treatment (2000) (21)
- Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. (2018) (21)
- Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation (2017) (21)
- Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. (2007) (21)
- RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers (2012) (21)
- Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. (2015) (21)
- Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial. (2016) (21)
- Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin. (2013) (21)
- Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs. (2012) (21)
- What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension? (2008) (21)
- A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. (2016) (21)
- Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme (2019) (21)
- Plasma haemoxygenase-1 in coronary artery disease (2010) (21)
- What has happened to malignant hypertension? A disease no longer vanishing (2000) (21)
- Assessment of hemostatic risk factors in predicting arterial thrombotic events. (2005) (21)
- The prognostic role of the adiponectin levels in atrial fibrillation (2013) (21)
- Ambulatory blood pressure and long-term risk for atrial fibrillation (2018) (21)
- Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk". (2015) (21)
- International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives (2016) (21)
- COVID‐19 and ischemic stroke (2021) (21)
- Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximisation study (BRUM) (2005) (21)
- Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology. (2014) (21)
- Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease (2009) (21)
- Prognosis in patients with atrial fibrillation and a presumed “temporary cause” in a community-based cohort study (2017) (21)
- Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis (2019) (21)
- Thromboprophylaxis for atrial fibrillation (1999) (21)
- Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment. (2005) (21)
- Antiplatelet agents and anticoagulants for hypertension. (2011) (21)
- Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype. (2006) (21)
- Balancing thromboembolic and bleeding risk with non‐vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta‐analysis on gender differences (2017) (21)
- Poisoning with anti-hypertensive drugs: calcium antagonists. (1995) (21)
- Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2015) (21)
- Dronedarone: An overview (2012) (20)
- Psychological Factors in Heart Failure (2002) (20)
- The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure (2008) (20)
- Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. (2015) (20)
- Coronary artery disease and risk of adverse cardiac events and stroke (2017) (20)
- Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. (2019) (20)
- Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation (2020) (20)
- Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema. (2006) (20)
- Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood (2006) (20)
- Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study). (2014) (20)
- Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia (2020) (20)
- Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. (2015) (20)
- Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting. (2013) (20)
- Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF) (2018) (20)
- European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). (2018) (20)
- Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients? (2016) (20)
- Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. (2015) (20)
- Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. (2007) (20)
- Atrial fibrillation post-myocardial infarction: Frequency, consequences, and management (2004) (20)
- Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches (2018) (20)
- Validation of a Modified CHA 2 DS 2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation A Nationwide Cohort Study (2016) (20)
- Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. (2017) (20)
- Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations. (2010) (20)
- The endotheliome: a new concept in vascular biology. (2011) (20)
- Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study (2020) (20)
- Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation (2017) (20)
- Atrial fibrillation (acute onset). (2011) (20)
- The Association of CHA2DS2-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study (2014) (20)
- Two‐year follow‐up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long‐Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA‐AF) registry (2018) (20)
- Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile? (2010) (20)
- Endothelial (dys)function in lone atrial fibrillation. (2014) (20)
- Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. (2009) (20)
- Diurnal variation in stroke onset in atrial fibrillation. (2001) (20)
- Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management (2019) (20)
- Atrial fibrillation in primary aldosteronism (2009) (20)
- Rhythm control and cardioversion (2006) (20)
- Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach (2021) (20)
- Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions? (2013) (20)
- Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. (2013) (20)
- Altered blood vessel responses in the eye and finger in coronary artery disease. (2011) (20)
- New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. (2015) (20)
- Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease (2013) (20)
- Wytyczne ESC/ESH dotyczące postępowania w nadciśnieniu tętniczym (2018) (2018) (20)
- Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries (2017) (20)
- The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction. (2006) (20)
- Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study (2019) (20)
- Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia. (2000) (20)
- Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint (1995) (20)
- Impact of polymorphisms in the renin–angiotensin–aldosterone system on hypertrophic cardiomyopathy (2011) (20)
- Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease (2004) (20)
- 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (2021) (20)
- Etiologic Workup in Cases of Cryptogenic Stroke (2020) (20)
- (8th Edition) Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Antithrombotic Therapy in Atrial Fibrillation: (2008) (20)
- ABC of Atrial Fibrillation: ATRIAL FIBRILLATION IN GENERAL AND HOSPITAL PRACTICE (1996) (20)
- Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. (2017) (20)
- Anticoagulant therapy after venous thromboembolism and 10-year mortality. (2016) (19)
- White coat hypertension and carotid atherosclerosis. (1999) (19)
- Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial. (2013) (19)
- Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study (2015) (19)
- Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence? (2016) (19)
- Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation (2015) (19)
- Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. (2021) (19)
- Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. (2012) (19)
- Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention (2011) (19)
- Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice (2011) (19)
- Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry (2017) (19)
- CHA2DS2‐VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm (2016) (19)
- Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X. (2007) (19)
- Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis (2019) (19)
- Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure (2010) (19)
- Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. (2017) (19)
- von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. (2000) (19)
- The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey (2017) (19)
- Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration (2022) (19)
- Overweight and obesity in patients with atrial fibrillation: Sex differences in 1‐year outcomes in the EORP‐AF General Pilot Registry (2018) (19)
- Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies (2020) (19)
- Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study (2018) (19)
- ER stress in obesity pathogenesis and management. (2021) (19)
- More evidence on blocking the renin–angiotensin–aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2) (2003) (19)
- sFlt-1, a potential antagonist for exogenous VEGF. (2000) (19)
- Premature coronary artery disease: An inferred cardiovascular variant or a South Asian genetic disorder? (2008) (19)
- Stroke Prevention in Atrial Fibrillation: Focus on Latin America. (2016) (19)
- Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study (2020) (19)
- Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. (2021) (19)
- Time‐trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study (2010) (19)
- Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) (2017) (19)
- Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic (2015) (19)
- Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. (2017) (19)
- Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries. (2012) (19)
- Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients. (2021) (19)
- A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England. (2001) (19)
- Exercise and hypertension (2005) (19)
- Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis (2020) (19)
- Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes. (2013) (19)
- Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state? (2004) (19)
- Brachial plexus injury as an unusual complication of coronary artery bypass graft surgery (2003) (19)
- Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF. (2019) (19)
- Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. (2018) (19)
- Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. (2007) (19)
- Malignant hypertension in association with primary aldosteronism. (1996) (18)
- Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways (2012) (18)
- ABC of antithrombotic therapy: Venous thromboembolism: pathophysiology, clinical features, and prevention (2002) (18)
- Higher Mortality of Ischaemic Stroke Patients Hospitalized with COVID-19 Compared to Historical Controls (2021) (18)
- The effect of statin therapy withdrawal on monocyte subsets (2013) (18)
- Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. (2015) (18)
- Secular trends in cardiovascular disease (2002) (18)
- Thrombotic complications in heart failure: an underappreciated challenge. (2014) (18)
- Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. (2019) (18)
- Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project (2018) (18)
- Vascular endothelial growth factor and angiogenesis in heart failure. (2005) (18)
- sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation (2015) (18)
- Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control. (2018) (18)
- Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study (2016) (18)
- An analysis of factors that predict patient consent to take part in a randomized controlled trial. (2007) (18)
- Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: The Birmingham Factory Screening Project (2005) (18)
- Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis (2017) (18)
- Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function (2018) (18)
- Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry (2019) (18)
- A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry (2018) (18)
- Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age (2016) (18)
- Knowledge, communication and expectancies of cardiac catheterization: The patient's perspective (2002) (18)
- Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). (2016) (18)
- Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? (2015) (18)
- High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study (2020) (18)
- Integrated Care Systems and the Aortovascular Hub (2021) (18)
- Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. (2017) (18)
- Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment (2018) (18)
- Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom (2016) (18)
- Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study (2020) (18)
- Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation (2019) (18)
- Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function. (2019) (18)
- Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study. (2015) (18)
- Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection. (2003) (18)
- Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly. (2002) (18)
- CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation. (2018) (18)
- Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation (2014) (18)
- Assessment of endothelial dysfunction (2010) (17)
- Malnutrition in hospital. (2000) (17)
- Thrombogenesis in Mitral Regurgitation and Aortic Stenosis (1996) (17)
- Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy. (2018) (17)
- 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). (2019) (17)
- Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation. (2019) (17)
- Does non-malignant essential hypertension cause renal damage? A clinician's view. (1996) (17)
- Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke (2009) (17)
- Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery. (2012) (17)
- Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study (2018) (17)
- Raised leptin concentrations among South Asian patients with chronic heart failure. (2007) (17)
- Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation (2006) (17)
- Review article: proton pump inhibitors with clopidogrel – evidence for and against a clinically‐important interaction (2011) (17)
- Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry (2020) (17)
- Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (2007) (17)
- Mobile health solutions for atrial fibrillation detection and management: a systematic review (2021) (17)
- Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension (2005) (17)
- The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited. (2008) (17)
- Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry (2020) (17)
- Vernakalant hydrochloride for the treatment of atrial fibrillation (2009) (17)
- Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. (2013) (17)
- Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation (2015) (17)
- Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients (2021) (17)
- Circulating endothelial cells in malignant disease. (2005) (17)
- Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. (2009) (17)
- Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf SAFE registry. (2013) (17)
- Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation (2017) (17)
- Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range. (2016) (17)
- Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. (2014) (17)
- The effect of multi‐factorial intervention on plasma von Willebrand factor, soluble E‐selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease (2005) (17)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (2020) (17)
- Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes (2019) (17)
- Stroke prevention in atrial fibrillation: do we still need warfarin? (2012) (17)
- Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease (2019) (17)
- Circulating levels of adiponectin, leptin, and tumour necrosis factor α in hypertension (2009) (17)
- Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension. (2002) (17)
- Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation (2020) (17)
- Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus RhythmClinical Perspective (2013) (17)
- Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk (2008) (17)
- The Effect of Integrated Care Management on Dementia in Atrial Fibrillation (2020) (17)
- Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry (2017) (17)
- Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy (2013) (17)
- Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy (2009) (17)
- Evaluation of the C2HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study). (2019) (17)
- Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye (2014) (17)
- Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction (2000) (17)
- Antithrombotic therapy in special circumstances. II—In children, thrombophilia, and miscellaneous conditions (2003) (17)
- Treatment of hypertension in peripheral arterial disease. (2013) (17)
- Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients. (2017) (17)
- Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial (2017) (17)
- Anticoagulation for elderly patients with atrial fibrillation: not to be neglected. (2007) (16)
- Bed sharing and smoking in the sudden infant death syndrome (1994) (16)
- Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen. (2001) (16)
- Contra: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation” (2009) (16)
- Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota (2021) (16)
- Hypertension in pregnancy: pathophysiology and management strategies. (2007) (16)
- Risk predictors for lone atrial fibrillation. (2007) (16)
- Emerging Tools for Stroke Prevention in Atrial Fibrillation (2016) (16)
- Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation (2020) (16)
- Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review (2018) (16)
- Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. (2016) (16)
- Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation: An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial (2014) (16)
- Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot). (2016) (16)
- Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. (1995) (16)
- Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure. (2015) (16)
- Comparative Efficacy and Safety of the Non–Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation (2015) (16)
- Malignant hypertension: a rare problem or is it underdiagnosed? (2010) (16)
- Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. (2021) (16)
- Recurrent myocardial infarction with angina and normal coronary arteries. (1995) (16)
- Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. (2007) (16)
- May your New Year be happy and prosperous with “Thrombosis and Haemostasis” (2016) (16)
- Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry (2017) (16)
- Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world (2021) (16)
- Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation. (2019) (16)
- Ventricular optimization of biventricular pacing: a systematic review. (2008) (16)
- Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19 (2021) (16)
- Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? (2019) (16)
- Fibrin D-Dimer and Beta-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation: Effects of Warfarin and Aspirin (1995) (16)
- Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. (2017) (16)
- How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? (2010) (16)
- Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation (2016) (16)
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature Running title: Dentali et al.; Novel oral anticoagulants in atrial fibrillation (2012) (16)
- Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer (2021) (16)
- Metabolic syndrome: a definition in progress. (2004) (16)
- The first prognostic model for stroke and death in patients with systolic heart failure. (2016) (16)
- Atrial fibrillation and human immunodeficiency virus type‐1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy (2019) (16)
- Atrial Fibrillation in Patients With Hypertension: Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage. (2016) (16)
- Anticoagulation for stroke prevention in atrial fibrillation: is gender important? (2006) (16)
- The measurement of blood pressure and the detection of hypertension in children and adolescents (2001) (16)
- Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program (2018) (16)
- Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. (2020) (16)
- Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation. (2009) (16)
- The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. (2015) (16)
- IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial (2016) (16)
- Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. (1995) (16)
- Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (2014) (16)
- Atrial fibrillation and upper limb thromboembolectomy: a national cohort study (2011) (16)
- Platelet adhesion in atrial fibrillation. (2007) (15)
- The new NICE guideline on atrial fibrillation management (2006) (15)
- Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation (2019) (15)
- Antagonism to calcium antagonists (1996) (15)
- Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation. (2017) (15)
- Peripheral arterial disease: A high risk – but neglected – disease population (2005) (15)
- Endothelial function in patients with atrial fibrillation (2020) (15)
- Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries (2017) (15)
- Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry (2019) (15)
- Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme (2017) (15)
- Stroke prevention in atrial fibrillation: State of the art. (2019) (15)
- Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA (2019) (15)
- Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta‐regression analysis of randomized controlled trials (2018) (15)
- A pilot study of streptokinase‐induced endothelial injury and platelet activation following acute myocardial infarction (2000) (15)
- Relation of the CHA2DS2-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study). (2019) (15)
- Endotoxemia, inflammation, and atrial fibrillation. (2007) (15)
- Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation. (2020) (15)
- Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study. (2017) (15)
- Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference (2015) (15)
- Assessing Bleeding Risk With the HAS‐BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding‐Risk Assessment (2015) (15)
- Should patients with hypertension receive antithrombotic therapy? (2001) (15)
- Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study (2021) (15)
- Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility (2004) (15)
- An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. (2011) (15)
- Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (2014) (15)
- The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. (2020) (15)
- Vascular and platelet responses to aspirin in patients with coronary artery disease (2013) (15)
- Endotoxemia as a trigger of thrombosis in cirrhosis (2016) (15)
- Unilateral pulmonary artery agenesis: a rare cause of haemoptysis and pleuritic chest pain. (1993) (15)
- Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype (2008) (15)
- Does acetaminophen damage the heart? (1996) (15)
- Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure. (2008) (15)
- New insights into complement C3 and inflammation in hypertension (2007) (15)
- Impact of High-Dose Atorvastatin on Endothelial, Platelet, and Angiogenic Indices (2011) (15)
- Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation (2013) (15)
- Relationship between lipoproteins, thrombosis, and atrial fibrillation (2021) (15)
- Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry (2021) (15)
- Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week. (2019) (15)
- Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation. (2021) (15)
- Statin use and mortality in atrial fibrillation: a systematic review and meta-analysis of 100,287 patients. (2021) (15)
- Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study (2017) (15)
- Management of atrial fibrillation: the NICE guidelines (2007) (15)
- Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey (2018) (15)
- Acute Stroke Treatment (1997) (15)
- Platelets, atherosclerosis and the endothelium: new therapeutic targets? (2003) (15)
- Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention. (2013) (15)
- Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes (2013) (15)
- Atrial fibrillation and stroke prevention: brief observations on the last decade (2014) (15)
- Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study (2020) (15)
- Idiopathic Orbital Inflammation Syndrome with Retro-Orbital Involvement: A Retrospective Study of Eight Patients (2013) (15)
- Integrated care and outcomes in patients with atrial fibrillation and comorbidities (2021) (14)
- Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients (2022) (14)
- Hypertension and the heart. (1994) (14)
- Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study (2014) (14)
- Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). (2017) (14)
- Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation (2019) (14)
- Echocardiographic changes in patients with malignant phase hypertension: The West Birmingham Malignant Hypertension Register (2005) (14)
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
- Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale (2007) (14)
- Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor (2016) (14)
- Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey (2018) (14)
- A Phase II, double‐blind, randomized, parallel group, dose‐finding study of the safety and tolerability of darexaban compared with warfarin in patients with non‐valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL‐2) (2015) (14)
- Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities. (2008) (14)
- Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation (2021) (14)
- Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. (2010) (14)
- ETHNIC DIFFERENCES IN PERIPHERAL VASCULAR DISEASE (2002) (14)
- Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami (2017) (14)
- Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. (2021) (14)
- Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study (2019) (14)
- Imaging of the unstable plaque. (2008) (14)
- Atrial fibrillation in low- and middle-income countries: a narrative review (2020) (14)
- Oxidative stress after thrombolysis (1998) (14)
- Atrial fibrillation in low- and middle-income countries: a narrative review (2020) (14)
- Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease. (2019) (14)
- Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: A descriptive nationwide cohort study. (2020) (14)
- Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality (2021) (14)
- Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound (2013) (14)
- Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study. (2015) (14)
- Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association (2022) (14)
- Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty (2007) (14)
- Blood leukocytes in heart failure with preserved ejection fraction: impact on prognosis. (2012) (14)
- Plasma CX3CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project (2014) (14)
- Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (14)
- Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis (2018) (14)
- Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study. (2021) (14)
- Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey. (2016) (14)
- Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty (2000) (14)
- Renal function and aspirin resistance in patients with coronary artery disease. (2012) (14)
- Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). (2018) (14)
- Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. (2018) (14)
- The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention. (2004) (14)
- New approaches to therapy with omega-3 fatty acids (2008) (14)
- Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients (2019) (14)
- Biomarkers for Atrial Fibrillation Detection After Stroke (2021) (14)
- Factor X inhibitors (2003) (14)
- Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint. (2010) (14)
- An audit of emergency echocardiography in a district general hospital. (1993) (14)
- Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. (2016) (14)
- Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes (2015) (14)
- The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study. (2010) (14)
- Arterial disease and venous thromboembolism: A modern paradigm? (2006) (14)
- The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set (2018) (14)
- Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men (2018) (14)
- Hypertension, anti-hypertensive therapy and neoplasia. (2007) (14)
- High‐risk myocardial infarction patients appear to derive more mortality benefit from short door‐to‐balloon time than low‐risk patients (2009) (14)
- Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis (2018) (14)
- Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation. (2010) (14)
- Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort (2020) (14)
- Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. (2011) (14)
- White coat hypertension: not so benign after all? (2003) (14)
- Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options. (2011) (14)
- Renin‐angiotensin blockade in diabetic retinopathy (2011) (13)
- Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores (2018) (13)
- Increased levels of plasma haemoxygenase-1 in prostate cancer (2011) (13)
- β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. (2013) (13)
- Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage (2020) (13)
- The angiome: a new concept in cancer biology (2011) (13)
- Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. (2019) (13)
- Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study (2016) (13)
- Metabolically healthy obesity and cardiovascular events: A nationwide cohort study (2021) (13)
- Population health status of South Asian and African-Caribbean communities in the United Kingdom (2012) (13)
- Systolic heart failure in South Asians (2011) (13)
- Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China‐AF Study (2018) (13)
- Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. (2006) (13)
- Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials. (2018) (13)
- ABC of Atrial Fibrillation: CARDIOVERSION OF ATRIAL FIBRILLATION (1996) (13)
- Stroke Prevention in Atrial Fibrillation: Where are We Now? (2012) (13)
- Stroke in atrial fibrillation and improving the identification of ‘high‐risk’ patients: the crossroads of immunity and thrombosis (2015) (13)
- Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis (2020) (13)
- Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation (2017) (13)
- Atrial fibrillation in 2011: Stroke prevention in AF. (2012) (13)
- Haemoconcentration and the hypercoagulable state associated with mental stress. (2005) (13)
- Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study (2020) (13)
- Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention (2020) (13)
- Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study (2018) (13)
- A Survey of Heart Failure in General Practice (1997) (13)
- Stanowisko ESC dotyczace toksycznego wplywu leczenia onkologicznego na uklad sercowo-naczyniowy w 2016 roku, opracowane pod auspicjami Komisji ESC do spraw Wytycznych Postepowania. (2016) (13)
- Assessment of Arterial Stiffness in Patients with Resistant Hypertension: Additional Insights into the Pathophysiology of this condition? (2019) (13)
- Adherence to the ABC (Atrial fibrillation Better Care) Pathway in the Balkan region: the BALKAN-AF Survey. (2020) (13)
- Platelet and haemorheological markers in ‘high risk’ hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT) (2004) (13)
- Oxidised LDL lipids, statins and a blood-brain barrier. (2014) (13)
- Atrial fibrillation and ethnicity. (1999) (13)
- A very happy new year 2014 from Thrombosis and Haemostasis! (2014) (13)
- Revisiting the dynamic risk profile of cardiovascular/non‐cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non‐cardiovascular outcomes: A machine‐learning approach (2021) (13)
- Effects of dietary fat intake in sudden death: Reduction of death with omega-3 fatty acids (2004) (13)
- Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial (2020) (13)
- Percutaneous balloon valvuloplasty for congenital pulmonary valve stenosis in adults (1999) (13)
- Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. (2005) (13)
- Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. (2020) (13)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (13)
- Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial (2015) (13)
- Should oral glucose tolerance testing be mandatory following acute myocardial infarction? (2007) (13)
- Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program. (2019) (13)
- Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. (2017) (13)
- Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard? (2013) (13)
- Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation (2021) (13)
- Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (2018) (13)
- Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study (2012) (13)
- Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study. (2018) (13)
- Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review. (2022) (13)
- Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation. (2019) (13)
- The counterintuitive role of exercise in the prevention and cause of atrial fibrillation. (2020) (13)
- The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity (2021) (13)
- Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study. (2020) (13)
- Fondaparinux: an overview (2009) (13)
- Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke (2022) (13)
- Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk (2010) (13)
- Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins. (2005) (13)
- One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry. (2019) (13)
- Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans (2015) (13)
- Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics (2015) (13)
- Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. (2006) (13)
- Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting (2006) (13)
- The quest for new anticoagulants: from clinical development to clinical practice. (2011) (13)
- Assessment of endothelial (2010) (13)
- The pathophysiology of target organ damage in hypertension. (2006) (13)
- Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation (2019) (13)
- Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials (2019) (13)
- Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated (2018) (13)
- Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation. (2019) (13)
- Candidate circulating biomarkers for the cardiovascular disease continuum. (2008) (13)
- Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation (2018) (12)
- Antioxidant protection: yet another function of endothelial progenitor cells? (2007) (12)
- Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. (2022) (12)
- A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial. (2007) (12)
- Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. (2019) (12)
- Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation (2018) (12)
- Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation. (2021) (12)
- Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in atrial fibrillation patients on warfarin (2015) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- ABC of Atrial Fibrillation: DRUGS FOR ATRIAL FIBRILLATION (1995) (12)
- Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. (2018) (12)
- Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal. (2006) (12)
- Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. (2015) (12)
- TransBridge: A Lightweight Transformer for Left Ventricle Segmentation in Echocardiography (2021) (12)
- Bleeding‐related hospital admissions and 30‐day readmissions in patients with non‐valvular atrial fibrillation treated with dabigatran versus warfarin (2017) (12)
- Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. (2019) (12)
- Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) (2018) (12)
- The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review (2021) (12)
- Drugs for atrial fibrillation. (1996) (12)
- Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points? (2016) (12)
- The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution? (2011) (12)
- Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke (2016) (12)
- Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort (2021) (12)
- The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? (2010) (12)
- Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban (2012) (12)
- Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation - The Fushimi AF Registry. (2017) (12)
- How to Manage Atrial Fibrillation Secondary to Ibrutinib (2021) (12)
- Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? (2006) (12)
- Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study (2018) (12)
- Management of pulmonary thrombo-embolism using catheter manipulation: a report of four cases and review of the literature (1999) (12)
- New Oral Anticoagulants in Elderly Adults: Evidence from a MetaAnalysis of Randomized Trials (2014) (12)
- Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry (2019) (12)
- Hypertension management in cardio-oncology (2020) (12)
- Aspirin and endothelial function in hypertension (2005) (12)
- A comprehensive insight of novel antioxidant therapies for atrial fibrillation management (2015) (12)
- Lone Atrial Fibrillation: Where Are We Now? (2011) (12)
- Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (2017) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation (2019) (12)
- Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1. (2019) (12)
- Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population (2020) (12)
- Mechanisms of thrombogenesis in atrial fibrillation – Authors' reply (2009) (12)
- White coat hypertension: a recognised syndrome with uncertain implications (1999) (12)
- Hypertension and breast cancer: an association revisited? (2006) (12)
- Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding. (2021) (12)
- Antithrombotic therapy in myocardial infarction and stable angina (2002) (12)
- Thromboprophylaxis for atrial flutter. (2001) (12)
- Endothelium‐dependent and endothelium‐independent vasodilatation of the cutaneous circulation in sickle cell disease (2011) (12)
- Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. (2019) (12)
- Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. (2014) (12)
- Patterns in atrial fibrillation management and ‘real-world’ adherence to guidelines in the Balkan Region: an overview of the Balkan–atrial fibrillation survey. (2015) (12)
- Increased stroke risk in atrial fibrillation patients with heart failure: does ejection fraction matter? (2015) (12)
- C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial (2021) (12)
- Circulating Levels of Vegf-A, VEGF-D and soluble VEGF-A Receptor (sFlt-1) in Human Breast Cancer (2004) (12)
- Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction. (2017) (12)
- Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection (2017) (12)
- Hypertension Burden and the Risk of New-Onset Atrial Fibrillation: A Nationwide Population-Based Study. (2021) (12)
- Heart-type fatty acid-binding protein: an overlooked cardiac biomarker (2020) (12)
- Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk (2010) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry. (2018) (12)
- Tedisamil: a new novel antiarrhythmic (2004) (12)
- Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes without Cardiovascular Disease: A Danish Cohort Study. (2020) (12)
- Increased membrane and soluble P-selectin in atrial fibrillation. (1999) (12)
- Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing. (2009) (12)
- Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow‐up electrophysiology study (2017) (12)
- Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation. (2000) (12)
- Using the MB‐LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project (2018) (12)
- Anticoagulation versus placebo for heart failure in sinus rhythm. (2012) (12)
- Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation (2014) (12)
- New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds (2018) (12)
- Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study (2021) (12)
- Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study (2002) (11)
- A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project. (2013) (11)
- Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. (2021) (11)
- Common Carotid Artery Intima-Media Thickness and Intracranial Pulsatility Index in Non-ST-Elevation Acute Coronary Syndromes (2007) (11)
- Cohort profile The ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. (2020) (11)
- Stroke prevention in Asian patients with atrial fibrillation. (2014) (11)
- Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis (2021) (11)
- Interleukin-15 in hypertension: further insights into inflammation and vascular disease. (2005) (11)
- A brief history of 'lone' atrial fibrillation: from 'a peculiar pulse irregularity' to a modern public health concern. (2014) (11)
- Atrial fibrillation in cryptogenic stroke: look harder, look longer, but just keep looking. (2014) (11)
- Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE? (2003) (11)
- Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey (2020) (11)
- Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation: Nationwide Cohort Study. (2022) (11)
- Should patients with hypertension receive antithrombotic therapy (2001) (11)
- Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study (2018) (11)
- Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation. (2020) (11)
- Interactions between clopidogrel and proton pump inhibitors: a review of evidence. (2011) (11)
- Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies (2021) (11)
- Cardioversion for atrial fibrillation: does inflammation matter? (2007) (11)
- Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor based approach. (2020) (11)
- Using the CHADS2 and CHA2DS2-VASc Scores for Stroke Risk Prediction as well as the Identification of Stroke Outcomes and Cardiac Complications in Patients with and without Atrial Fibrillation (2013) (11)
- Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease (2010) (11)
- A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial (2018) (11)
- Goodbye mercury? Blood pressure measurement and its future. (2005) (11)
- Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives (2013) (11)
- Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation (2020) (11)
- Atrial fibrillation (chronic). (2007) (11)
- Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (2018) (11)
- Chronic Kidney Disease and Cerebrovascular Disease (2021) (11)
- Nebivolol for the treatment of heart failure (2011) (11)
- The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia. (2012) (11)
- Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. (2019) (11)
- Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us? (1999) (11)
- Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation (2018) (11)
- Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. (2010) (11)
- Congestive Heart Failure and Virchow’s Triad: A Neglected Association (2003) (11)
- Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. (2019) (11)
- Risk Stratification Models in Atrial Fibrillation (2017) (11)
- Time trends in use of the CHADS2 and CHA2DS2VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference (2018) (11)
- Renal, endothelial function, warfarin management, and the CHADS2, CHA2DS2VASc and HAS-BLED scores in predicting MACE in AF (2015) (11)
- Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia (2013) (11)
- Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials (2021) (11)
- Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study (2020) (11)
- Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants (2021) (11)
- Endotoxemia enhances circulating endothelial cells in humans (2006) (11)
- Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants (2021) (11)
- Restenosis after coronary stenting: the 'gender paradox'. (2003) (11)
- Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology. (2009) (11)
- Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry (2019) (11)
- Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial (2015) (11)
- Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation (2007) (11)
- Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients (2021) (11)
- DO CLINICIANS PRESCRIBE HRT FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN? (1995) (11)
- State of play and future direction with NOACs: An expert consensus. (2018) (11)
- Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study (2020) (11)
- Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (2021) (11)
- Atrial fibrillation and stroke risk prevention in real-life clinical practice (2009) (11)
- Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes (2021) (11)
- Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study (2019) (11)
- Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation. (2014) (11)
- The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms. (2020) (11)
- Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (2021) (11)
- Stroke Prevention in Atrial Fibrillation: Concepts and Controversies (2012) (11)
- Stroke And Bleeding Risk Assessment: Where Are We Now? (2014) (11)
- Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2. (2019) (10)
- Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. (2019) (10)
- Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease (2013) (10)
- 4S‐AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients (2022) (10)
- Atrial high-rate episodes and stroke prevention. (2016) (10)
- Short-Term Effects of Screening for Cardiovascular Risk in the Deaf Community: A Pilot Study (2011) (10)
- Ethnicity and heart failure. (1999) (10)
- Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome (2015) (10)
- HAVE WE IDENTIFIED THE FACTORS AFFECTING PROGNOSIS FOLLOWING CORONARY ARTERY BYPASS SURGERY? (1994) (10)
- Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology? (2003) (10)
- Management of Hypertension in Pregnancy (2001) (10)
- Platelet adhesion in hypertension: Application of a novel assay of platelet adhesion (2005) (10)
- Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE). (2019) (10)
- Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation? (2009) (10)
- Is uric acid really an independent cardiovascular risk factor? (1998) (10)
- Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. (2018) (10)
- Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study (2021) (10)
- Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review (2016) (10)
- Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation (2021) (10)
- NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. (2018) (10)
- How Would I Manage a 60–year-old Woman Presenting with Atrial Fibrillation? (1999) (10)
- Stroke/thromboembolism and intracranial hemorrhage in a real-world atrial fibrillation population: the Complications of Atrial Fibrillation in the Bologna Area (CAFBO) study. (2014) (10)
- Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation? (2020) (10)
- Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases (2021) (10)
- Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care: A South Korean Nationwide Cohort Study. (2019) (10)
- Real‐World Comparative Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country (2020) (10)
- Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality. (2018) (10)
- Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation. (2000) (10)
- Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet. (2015) (10)
- Thromboembolic risk and pacemakers (1997) (10)
- Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement. (2012) (10)
- Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. (2016) (10)
- Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus? (2003) (10)
- Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial (2019) (10)
- The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation. (2014) (10)
- New Anticoagulation Drugs for Atrial Fibrillation (2011) (10)
- Mitral regurgitation and atrial fibrillation: milder the disease, higher the risk? (2000) (10)
- Towards improving the clinical assessment and management of human hypertension: an overview from this Journal (2006) (10)
- Management of atrial fi brillation (2007) (10)
- Frontiers in Medicinal Chemistry (2016) (10)
- Thromboembolism associated with new anti-cancer treatment strategies in combination with conventional chemotherapy: new drugs, old risks? (2003) (10)
- ETHNICITY AND PERIPHERAL VASCULAR DISEASE (2002) (10)
- Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] study☆ (2003) (10)
- Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression (2018) (10)
- Longer term stroke risk in intracerebral haemorrhage survivors (2020) (10)
- New biomarkers and risk stratification in atrial fibrillation: simplicity and practicality matter. (2014) (10)
- Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction (2013) (10)
- Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. (2016) (10)
- Stroke prevention in atrial fibrillation: comparison of recent international guidelines (2020) (10)
- Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation. (2017) (10)
- Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application. (2015) (10)
- Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control. (2015) (10)
- A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation (2016) (10)
- Sex differences in risk of incident venous thromboembolism in heart failure patients (2018) (10)
- Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal (2020) (10)
- Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy. (2016) (10)
- Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study (2021) (10)
- Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference (2022) (10)
- Overview of the treatment of lower extremity deep vein thrombosis ( DVT ) (2017) (10)
- Impact of Mon2 monocyte‐platelet aggregates on human coronary artery disease (2018) (10)
- Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses (2016) (10)
- Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design. (2009) (10)
- Cardiac Electronic Devices: Future Directions and Challenges (2020) (10)
- Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study (2021) (10)
- Antithrombotic and anticoagulant therapy for atrial fibrillation. (2014) (10)
- ALGORITHM FOR THE MANAGEMENT OF ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN UPDATED PROPOSAL BASED ON EFFICACY CONSIDERATIONS. (2020) (10)
- Anticoagulants as anticancer agents? (2002) (10)
- Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X (2007) (10)
- Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner (2014) (10)
- Anticoagulation and atrial fibrillation (2001) (10)
- Free light chains in patients with acute heart failure secondary to atherosclerotic coronary artery disease. (2014) (9)
- Changes in renal function with percutaneous transluminal coronary angioplasty. (1999) (9)
- Soluble Fas and Fas Ligand in Pregnancy (2012) (9)
- Ximelagatran: a clinical perspective. (2005) (9)
- ABC of heart failure: Management: digoxin and other inotropes, ß blockers, and antiarrhythmic and antithrombotic treatment (2000) (9)
- Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use (2020) (9)
- Circulating endothelial cells in health and disease: how do we best quantify them? (2008) (9)
- Factors influencing coronary artery bypass graft patency. (1994) (9)
- Preventing Stroke in Atrial Fibrillation: The SPORTIF Programme (2005) (9)
- Illustrated State‐of‐the‐Art Capsules of the ISTH 2019 Congress in Melbourne, Australia (2019) (9)
- Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. (2021) (9)
- Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials (2018) (9)
- White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction (2016) (9)
- The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells (2009) (9)
- Effectiveness and Safety of Oral Anticoagulants Among Non-Valvular Atrial FibrillationPatients with Polypharmacy. (2020) (9)
- Laboratory investigation of platelets (2001) (9)
- Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. (2017) (9)
- Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population‐based cohort study (2021) (9)
- Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. (2016) (9)
- The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. (2016) (9)
- Alcohol and Hypertension - Does it Matter? (No!) (2003) (9)
- HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism. (2016) (9)
- Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies (2020) (9)
- Plasma von Willebrand factor levels and surrogates of atherosclerosis (2005) (9)
- Do alpha blockers cause heart failure and stroke? Observations from ALLHAT (2000) (9)
- Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. (2017) (9)
- Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. (2011) (9)
- How Can We Avoid a Stroke Crisis? Working Group Report: Stroke Prevention in Patients with Atrial Fibrillation (2009) (9)
- Epidemiology of aortic aneurysm and peripheral vascular disease may show ethnic differences (1996) (9)
- Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not? (2006) (9)
- Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation (2021) (9)
- Acute ischemic stroke management: concepts and controversies.A narrative review (2020) (9)
- Systemic inflammation as a driver of vascular calcification: a proof of concept (2009) (9)
- Which drug should we use for stroke prevention in atrial fibrillation? (2014) (9)
- Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2019) (9)
- Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial (2022) (9)
- Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy (2022) (9)
- Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus (2017) (9)
- Management of cardiovascular complications of bruton tyrosine kinase inhibitors (2021) (9)
- Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. (2016) (9)
- Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis. (2015) (9)
- Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (2021) (9)
- Contamination of the surgeon's bare and gloved fingertips in cardiac operations. (1998) (9)
- Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry (2020) (9)
- Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy. (2014) (9)
- ACE inhibitors in vascular disease: some PROGRESS, more HOPE (2001) (9)
- Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022) (9)
- Dyslipidaemia in patients with malignant-phase hypertension. (2001) (9)
- Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function. (2015) (9)
- Current and emerging drug treatment strategies for peripheral arterial disease (2020) (9)
- Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells (2007) (9)
- Understanding the global burden of atrial fibrillation and regional variations: we need improvement. (2020) (9)
- Breast density as a predictor of breast cancer risk (2010) (9)
- Ischemic Stroke and Atrial Fibrillation – A DeadlySerious Combination (2011) (9)
- Measurement of defect angle in superior semicircular canal dehiscence. (2009) (9)
- Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: A sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study (2011) (9)
- Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis (2021) (9)
- Antithrombotic therapy for heart failure in sinus rhythm (2009) (9)
- Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention (2018) (9)
- CHOICES IN ANTITHROMBOTIC MANAGEMENT FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. QUESTIONS (AND ANSWERS) IN CHRONOLOGICAL SEQUENCE. (2020) (9)
- Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer. (2005) (9)
- Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: Observations from Val-HeFT and CALM (2001) (9)
- Hibernating myocardium in heart failure (2005) (9)
- Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study (2013) (9)
- The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) study (2017) (9)
- Dabigatran in clinical practice: Contemporary overview of the evidence. (2016) (9)
- Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013) (9)
- Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension (2006) (9)
- Ventricular-arterial coupling in obstructive sleep apnea. (2014) (9)
- The safety of NOACs in atrial fibrillation patient subgroups: A narrative review (2018) (9)
- COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. (2022) (9)
- Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project. (2007) (9)
- Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation. (2004) (9)
- REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN (2016) (9)
- Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUA (2019) (9)
- Development and validation of a new assay for assessing clot integrity. (2015) (9)
- Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study (2018) (9)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: relationship to cardiovascular risk and treatment (2004) (9)
- Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project (2018) (9)
- Primary hyperaldosteronism. (2003) (9)
- Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry). (2019) (9)
- Antidotes to non-vitamin K oral anticoagulants: necessary or not? (2015) (9)
- Effect of Warfarin and Aspirin Therapy on Plasma Fibrinogen and Fibrin d-Dimer levels in Patients with chronic Atrial Fibrillation (1993) (9)
- Severe hypertension with lone bilateral papilloedema: a variant of malignant hypertension. (1995) (9)
- Alpha 1-microglobulin: a further insight into inflammation in hypertension? (2007) (9)
- Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs? (1999) (9)
- Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus (2021) (9)
- Atrial fibrillation and the thyroid (1997) (9)
- Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World". (2017) (9)
- Relation of platelet activation to coronary angiographic severity and collateralization. (2005) (8)
- ABC of heart failure: Investigation (2000) (8)
- Hypertension, stroke and the impact of atrial fibrillation (2008) (8)
- Cognitive Impairment Before Atrial Fibrillation–Related Ischemic Events: Neuroimaging and Prognostic Associations (2020) (8)
- Predictive value of atrial high‐rate episodes for arterial stiffness and endothelial dysfunction in dual‐chamber pacemaker patients (2014) (8)
- Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis (2017) (8)
- Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit (2020) (8)
- Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death (2018) (8)
- Heart Failure and Stroke (2018) (8)
- Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI. (2019) (8)
- Atrial fibrillation and mortality. (1999) (8)
- Symptom-to-door times in patients presenting with ST elevation myocardial infarction--do ethnic or gender differences exist? (2016) (8)
- Antihypertensive treatment, adiponectin and cardiovascular risk (2007) (8)
- Effects of Acute Exercise on Haemorheological and Endothelial Markers in Patients with Chronic Heart Failure (2000) (8)
- Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis. (2017) (8)
- Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism (2016) (8)
- Novel therapies for the prevention of stroke (2004) (8)
- CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis. (2016) (8)
- Platelet adhesion in congestive heart failure. (2008) (8)
- Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices. (2018) (8)
- Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. (2010) (8)
- Cerebrovascular Dysfunction in Atrial Fibrillation (2020) (8)
- Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone (2009) (8)
- Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation. (2018) (8)
- Mobile health technology in atrial fibrillation (2022) (8)
- Hormone replacement therapy and cardiovascular risk: do abnormalities of coagulation and fibrinolysis matter? (2001) (8)
- Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines (2019) (8)
- Treatment of hypertension in peripheral arterial disease. (2003) (8)
- Atrial fibrillation is more frequently associated with non-obstructive coronary lesions: The Bialystok Coronary Project. (2020) (8)
- Dabigatran and myocardial infarction. (2015) (8)
- Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients (2012) (8)
- Quality of anticoagulation control in atrial fibrillation (2010) (8)
- Benefit-Risk Assessment of Dronedarone in the Treatment of Atrial Fibrillation (2013) (8)
- Interleukin-8 and atrial fibrillation. (2008) (8)
- The risk of thromboembolism in heart failure: does it merit anticoagulation therapy? (2011) (8)
- Malignant hypertension: does this still exist? (2019) (8)
- Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification. (2005) (8)
- Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation. (2017) (8)
- Heart rate variability in patients with atrial fibrillation and hypertension (2020) (8)
- Prediction of long‐term net clinical outcomes using the TIMI‐AF score: Comparison with CHA2DS2‐VASc and HAS‐BLED (2018) (8)
- Angiogenin and apoptosis in hypertension in pregnancy. (2011) (8)
- Patients with atrial fibrillation undergoing percutaneous coronary intervention: current concepts and concerns: part II. (2014) (8)
- A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team (2015) (8)
- Statins and intra-plaque angiogenesis in carotid artery disease. (2007) (8)
- Peripheral Arterial Disease in Patients with Atrial Fibrillation: The AFFIRM Study (2020) (8)
- Markers of Thrombosis and Hemostasis in Acute Coronary Syndromes: Relationship to Increased Heart Rate and Reduced Heart‐Rate Variability (2009) (8)
- Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study (2020) (8)
- Warfarin and aspirin as thromboprophylaxis in atrial fibrillation. (1996) (8)
- Atrial fi brillation and stroke prevention (2007) (8)
- Cardiac rehabilitation and all-cause mortality in patients with heart failure: a retrospective cohort study. (2021) (8)
- Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'. (2022) (8)
- Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions (2020) (8)
- Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project. (2015) (8)
- Mortality in patients with atrial fibrillation: improving or not? (2008) (8)
- Significance of Soluble P-Selectin, Von Willebrand Factor, and Other Adhesion Molecules in Hypercholesterolemia and Peripheral Artery Disease (1999) (8)
- Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice (2010) (8)
- Atrial Fibrillation and Stroke. (2021) (8)
- Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III (2022) (8)
- Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke (2017) (8)
- The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study (2022) (8)
- Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension (2000) (8)
- Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants (2013) (8)
- Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology. (2005) (8)
- Atrial fibrillation: should we target platelets or the coagulation pathway? (2003) (8)
- Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes (2021) (8)
- Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). (2019) (8)
- Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state? (2008) (8)
- Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. (2016) (8)
- Adrenaline in allergic emergencies. (1992) (8)
- The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management. (2006) (8)
- REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS (2016) (8)
- Atrial fibrillation in 2011: Stroke prevention in AF (2012) (8)
- Platelet adhesion in breast cancer: development and application of a novel assay (2004) (8)
- Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up (2020) (8)
- Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation (2015) (8)
- Usefulness of the NULL-PLEASE Score to predict survival in out-of-hospital cardiac arrest. (2020) (8)
- Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. (2022) (8)
- A Comparison of Plasma Versus Histologic Indices of Angiogenic Markers in Breast Cancer (2007) (8)
- How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis (2005) (8)
- Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk. (2006) (8)
- Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry. (2018) (8)
- Oral anticoagulants for stroke prevention in atrial fibrillation. (2014) (8)
- Psychosocial functioning of adults with congenital heart disease: a neglected area. (2003) (8)
- Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry (2019) (8)
- Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials (2021) (8)
- Atrial High‐Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta‐Analysis (2021) (8)
- Oral Anticoagulants in Extremely High Risk Very Elderly (>90 years) Patients with Atrial Fibrillation. (2021) (8)
- Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation. (2013) (8)
- Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis (2020) (7)
- Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation (2020) (7)
- Antithrombotic therapy for congestive heart failure (2005) (7)
- Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial (2019) (7)
- The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors? (2012) (7)
- Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from ELSA-Brasil. (2021) (7)
- Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. (2015) (7)
- Anticoagulation of older patients. (2000) (7)
- Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C2HEST Score: The West Birmingham Atrial Fibrillation Project (2021) (7)
- Patient care pathway, implementation and audit criteria for patients with atrial fibrillation (2006) (7)
- Stroke prevention in atrial fibrillation patients (2010) (7)
- Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry. (2016) (7)
- Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry (2016) (7)
- Ethnicity and arrhythmias. (2003) (7)
- Atrial fibrillation begets trouble (1997) (7)
- Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death (2021) (7)
- Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage (2021) (7)
- Chapter 21 – Platelet and Coagulation Abnormalities (2007) (7)
- Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely (2007) (7)
- Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment (2001) (7)
- Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation (2021) (7)
- Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study. (2021) (7)
- Rheumatoid disease and the heart: from epidemiology to echocardiography (2005) (7)
- A Happy New Year 2013 for Thrombosis and Haemostasis ….. (2013) (7)
- Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study. (2019) (7)
- β-Blockers in Atrial Fibrillation Patients With or Without Heart FailureCLINICAL PERSPECTIVE (2016) (7)
- Poisoning with anti-hypertensive drugs: methyldopa and clonidine. (1995) (7)
- Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study. (2020) (7)
- Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes. (2020) (7)
- ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19 (2020) (7)
- Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine (2002) (7)
- Angiogenin and Hemoxygenase in Pregnancy (2012) (7)
- Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence (2018) (7)
- Ambulatory blood pressure monitoring and stroke: more questions than answers. (1998) (7)
- Thrombosis in clinical practice (2005) (7)
- Prediction of stroke in patients without atrial fibrillation using the CHADS2 and CHA2DS2-VASc scores: a justification for more widespread thromboprophylaxis? (2014) (7)
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. (2022) (7)
- Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study (2021) (7)
- Thoracoscopic Left Atrial Appendage Excision plus Ablation for Atrial Fibrillation to Prevent Stroke. (2020) (7)
- The ECG and left ventricular hypertrophy in primary care hypertensives (2001) (7)
- Relationship between multimorbidity and outcomes in atrial fibrillation (2021) (7)
- Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications (2021) (7)
- Duration of cough following cessation of ACE inhibitor therapy. (1995) (7)
- Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study). (2020) (7)
- Abstract 18465: Real World Comparison of Major Bleeding Risk Among Non-valvular Atrial Fibrillation Patients Newly Initiated on Warfarin versus Apixaban 5mg BID, Dabigatran 150 mg BID, or Rivaroxaban 20 mg QD (2015) (7)
- In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation (2018) (7)
- Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction? (2016) (7)
- Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. (2022) (7)
- Risks and Outcomes of Gastrointestinal Malignancies in Anticoagulated Atrial Fibrillation Patients Experiencing Gastrointestinal Bleeding - A Nationwide Cohort Study. (2020) (7)
- Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. (2019) (7)
- Atrial Fibrillation Efficacy and Safety of Dabigatran Etexilate and Warfarin in “ Real-World ” Patients With Atrial Fibrillation (7)
- Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (7)
- Rhythm outcomes after catheter ablation of atrial fibrillation (2013) (7)
- A PRESENTATION OF ANAPLASTIC CARCINOMA OF THE THYROID WITH SYMPTOMATIC INTRA‐ABDOMINAL METASTASES (1992) (7)
- Ximelagatran for stroke prevention in atrial fibrillation (2005) (7)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (2018) (7)
- Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials (2010) (7)
- Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation (2018) (7)
- Resource Utilization and Outcomes in Patients with Atrial Fibrillation (2012) (7)
- Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes (2020) (7)
- Effect of Discontinuing Dabigatran in Patients with Atrial Fibrillation (From the Dabigatran Cohort of the GLORIA-AF Registry) (2019) (7)
- Relationship of plasma von Willebrand factor with stroke risk factors in 1,321 patients with Atrial Fibrillation (2002) (7)
- ACUTE MYOCARDIAL INFARCTION: A RARE COMPLICATION OF THE THROMBOTIC TENDENCY IN NEPHROTIC SYNDROME (1994) (7)
- Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited. (2007) (7)
- The assessment of platelet activation in antiplatelet drug development. (2005) (7)
- Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis (2010) (7)
- Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. (2016) (7)
- Anticoagulation for Atrial Fibrillation Patients with CHADS2 Score of 1 (2010) (7)
- Statins and inflammation: reciprocal effectors to endothelial progenitors? (2008) (7)
- Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation (2015) (7)
- Influence of the Risk Factors for Atherosclerosis on Levels of Soluble Adhesion Molecules and Endothelial Markers in Peripheral Vascular Disease (2002) (7)
- Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial (2011) (7)
- Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function (2016) (7)
- Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise? (2009) (7)
- Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (2021) (7)
- Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation. (2016) (7)
- Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐AF registry (2020) (7)
- Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker? (2013) (7)
- What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? (2012) (7)
- Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks. (2017) (7)
- Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression. (2020) (7)
- Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting. (2017) (7)
- Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study (2016) (7)
- Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey. (2012) (7)
- Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study (2020) (7)
- Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation? (2006) (7)
- Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program. (2020) (7)
- Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022) (7)
- Drug-induced liver injury with oral anticoagulants: a threat or not? (2017) (7)
- Searching for Atrial Fibrillation Poststroke (2019) (7)
- Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study (2021) (7)
- The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes (2018) (7)
- How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring. (2016) (7)
- Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: Differences in central versus peripheral levels (2007) (7)
- Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF‐PCI and RE‐DUAL PCI trial (2018) (7)
- Circulating matrix metalloproteinase‐9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology? (2008) (7)
- Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile (2019) (7)
- Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect. (2010) (7)
- Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries. (2019) (7)
- Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome (2022) (7)
- Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part I. (2015) (7)
- Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co‐morbidity profiles/multi‐morbidity in a large US adult cohort (2021) (7)
- Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders. (2012) (7)
- Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke. (2005) (7)
- Relation between endothelial-cell activation and infection, inflammation, and infarction (1997) (7)
- ATRIAL FIBRILLATION, THROMBOEMBOLISM AND ANTITHROMBOTIC THERAPY (1999) (7)
- Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study. (2019) (7)
- miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients. (2016) (7)
- Monocytes in Coronary Artery Disease and Atherosclerosis (6)
- Female sex is associated with a lower risk of stroke in patients with heart failure. (2015) (6)
- Hypertension and cardiac arrhythmias. (2017) (6)
- Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). (2019) (6)
- Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. (2015) (6)
- Effects of discontinuing hormone replacement therapy in patients with uncontrolled hypertension. (1995) (6)
- Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis (2020) (6)
- Recent advances in management of atrial fibrillation in patients with heart failure (2013) (6)
- Early rhythm control and the risks of ischaemic stroke, heart failure, mortality and adverse events when performed early (<3 months). (2022) (6)
- Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study. (2020) (6)
- Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity. (2009) (6)
- Device-Pocket Hematoma after Cardiac Implantable Electronic Devices. (2020) (6)
- Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting. (2010) (6)
- Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population‐Based Study (2021) (6)
- Peripheral artery disease and hypertension: the relation between ankle–brachial index and mortality (2007) (6)
- Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study (2020) (6)
- Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding (2021) (6)
- Stroke prevention in elderly patients with non‐valvular atrial fibrillation in the BALKAN‐AF survey (2020) (6)
- Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease (2007) (6)
- Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range (2008) (6)
- Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting. (2008) (6)
- Burden of atrial fibrillation. (2009) (6)
- Hormone replacement therapy and hypertension. (2000) (6)
- Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database (2022) (6)
- Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer (2014) (6)
- Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers? (2006) (6)
- Secondary prevention of cardiovascular disease and diabetes: still suboptimal in patients with myocardial infarction (2001) (6)
- Malignant Hypertension: Current Perspectives and Challenges (2022) (6)
- Endothelial dysfunction and vascular maladaptation in atrial fibrillation (2021) (6)
- The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores. (2017) (6)
- Statin therapy in South-Asian patients: clinical implications beyond lipid lowering? (2007) (6)
- Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. (2007) (6)
- Recommendations on stroke prevention for patients having a CHA2DS2-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines. (2019) (6)
- Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial (2020) (6)
- Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry (2022) (6)
- Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project. (2015) (6)
- Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. (2018) (6)
- Atrial fibrillation: Blockade of the renin–angiotensin system in atrial fibrillation (2010) (6)
- Prevalence and risk factors of silent brain infarcts in the population. (2002) (6)
- Is depression following acute myocardial infarction an independent risk for mortality? (2004) (6)
- What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population? (2020) (6)
- Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the fushimi AF registry. (2020) (6)
- Atorvastatin and its collateral effects on microparticles (2011) (6)
- The METHRO trials (2003) (6)
- Response to Ansell et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel” (2014) (6)
- MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage (2022) (6)
- Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema—a mechanism for regulating angiogenesis? (2011) (6)
- Fondaparinux : Cardiovascular and hematological agents (2005) (6)
- Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants (2018) (6)
- Focus on modification of risk factors and patients' perception of lifestyle (1995) (6)
- Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study (2021) (6)
- Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. (2021) (6)
- Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range? (2010) (6)
- Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications (2021) (6)
- The improved but unfinished business of stroke risk stratification in atrial fibrillation. (2011) (6)
- Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation (2019) (6)
- Stroke prevention in non-valvular atrial fibrillation: Can warfarin do better? (2011) (6)
- The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure (2013) (6)
- Improving the diagnosis of heart failure in patients with atrial fibrillation (2021) (6)
- Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function. (2010) (6)
- Indices of Thrombogenesis, Endothelial Damage and Platelet Function following Percutaneous Peripheral Artery Angiography and Angioplasty for Peripheral Vascular Disease (2003) (6)
- Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? a nationwide cohort study. (2021) (6)
- Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry). (2020) (6)
- Atrial fibrillation and abnormalities of hemostatic factors. (2001) (6)
- Oxford Desk Reference Cardiology (2011) (6)
- ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II) (2015) (6)
- Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy (2008) (6)
- Is atrial fibrillation an inflammatory disorder?: reply (2006) (6)
- STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol (2022) (6)
- An epidemic of atrial fibrillation? (2011) (6)
- Commencing 2011 with Thrombosis and Haemostasis – and looking to the future (2011) (6)
- Thrombosis and Haemostasis: Past, present and future (2017) (6)
- Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients (2015) (6)
- Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus (2009) (6)
- Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation. (2019) (6)
- Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry (2021) (6)
- Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy? (1998) (6)
- INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY (2012) (6)
- Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention (2008) (6)
- Challenges facing anticoagulation among the elderly and frail. (2008) (6)
- What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation? (2011) (6)
- Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin? (2008) (6)
- Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation : design and rationale of the Birmingham Uptake Maximisation Study ( BRUM ) : a randomised controlled trial (2003) (6)
- Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter? (2004) (6)
- Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers. (2000) (6)
- Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation. (2020) (6)
- Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care. (2018) (6)
- Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries. (2019) (6)
- Circulating monocytes and atherogenesis: From animal experiments to human studies (2010) (6)
- Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. (2009) (6)
- Atrial fibrillation and mortality: the impact of antithrombotic therapy. (2010) (6)
- Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range. (2008) (6)
- The CHA2DS2-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse? (2020) (6)
- Antiplatelet therapy in stroke prevention. (2012) (6)
- Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction (2009) (6)
- Platelet microparticles and platelet adhesion: Therapeutic implications for the prevention and treatment of stroke (2006) (6)
- Antithrombotic therapy in peripheral vascular disease (2002) (6)
- Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. (2015) (6)
- Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation. (2012) (6)
- Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis (2016) (6)
- Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation (2022) (6)
- Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection (2022) (6)
- Hyperlipidaemia Management after Primary Coronary Artery Bypass Surgery: A Survey of Patients and General Practitioners (1999) (6)
- Microalbuminuria in hypertension: Is it up to measure? (1997) (6)
- Increased Soluble Adhesion Molecule P-Selectin, Von Willebrand Factor and Fibrinogen in Acute Stroke: Evidence for Early Endothelial and Haemorheological Dysfunction (1996) (5)
- CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF (2017) (5)
- Sunday, 26 August 2012 (2012) (5)
- Sunday, 26 August 2012 (2012) (5)
- Sunday, 26 August 2012 (2012) (5)
- The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension. (2000) (5)
- Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF (2021) (5)
- D-dimer tests for assessment of patients with suspected pulmonary embolism. (2003) (5)
- Perceptions and behaviour of hypertensive patients: a divine intervention or a case for Hippocrates? (2001) (5)
- Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy (2010) (5)
- Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention. (2020) (5)
- Sarcoid Heart Disease: A Rare Cause of Chest Pain and Malignant Cardiac Arrhythmia in a Young Asian Man (1996) (5)
- WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE (2019) (5)
- Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study. (2021) (5)
- Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention (2016) (5)
- New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. (2017) (5)
- Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (2018) (5)
- Antiplatelet therapy and anticoagulants (2013) (5)
- Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. (2021) (5)
- Implications of the LIFE trial (2003) (5)
- One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry☆ (2020) (5)
- Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal. (2017) (5)
- Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation. (2020) (5)
- Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry (2020) (5)
- Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation. (2003) (5)
- Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation (2019) (5)
- A happy and prosperous New Year 2017 with “Thrombosis and Haemostasis” …. and our 60th Anniversary! (2017) (5)
- THE ‘VASOVAGAL EFFECT’ OF NITRATES: AN UNDER‐RECOGNISED COMPLICATION OF NITRATE USE (1998) (5)
- Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease. (2013) (5)
- Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan. (2016) (5)
- Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence (2021) (5)
- Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study (2021) (5)
- Welcome to a new year in Thrombosis and Haemostasis….. (2012) (5)
- Arrhythmias in adults following repair of tetralogy of Fallot. (2001) (5)
- Monitoring in the management of atrial fibrillation. (2012) (5)
- Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study. (2013) (5)
- Heart failure: treatment and ethnic origin (2003) (5)
- Blood pressure in different ethnic groups. (2001) (5)
- Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial (2020) (5)
- Short Runs of Atrial Arrhythmia and Stroke Risk: A European-Wide Online Survey among Stroke Physicians and Cardiologists (2016) (5)
- Renal Disease and Atrial Fibrillation. (2021) (5)
- Alterations of Thrombogenesis, Endothelial Damage and Oxidative Stress with Reperfusion during Femoral Artery Bypass Surgery for Peripheral Vascular Disease (2002) (5)
- Management of patients with myocardial infarction and hypertension. (2000) (5)
- Association between exercise habit changes and mortality following a cardiovascular event (2022) (5)
- Defibrillation testing in patients with atrial fibrillation. (2009) (5)
- Effect of Exercise on Haemostatic Markers in Patients with Atrial Fibrillation (Non-Mrs Member) (2000) (5)
- Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act. (2019) (5)
- Anticoagulation control with vitamin K antagonists: how well are we doing? (2006) (5)
- The left atrium in hypertension, an appendage often forgotten (1997) (5)
- Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source (2020) (5)
- Levosimendan – a calcium sensitising agent with potential anti‐arrhythmic properties (2010) (5)
- Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions (2002) (5)
- The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT? (2003) (5)
- Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry. (2019) (5)
- Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation Prediction (2021) (5)
- Association between relative wall thickness of left ventricle and incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry. (2020) (5)
- [Guidelines in cardiac pacing and resynchronization therapy]. (2007) (5)
- Atrial fi brillation 1 Stroke prevention in atrial fi brillation (2016) (5)
- Preventing Thrombosis to Improve Outcomes in Heart Failure Patients. (2016) (5)
- Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation (2022) (5)
- Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study (2021) (5)
- Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. (2021) (5)
- Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials (2021) (5)
- A comparative study of risk factors for acute myocardial infarction amongst men of Indo-origin in Trinidad and the UK. (1994) (5)
- Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (2015) (5)
- Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation (2020) (5)
- The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation. (2020) (5)
- Quality indicators in the management of elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. (2021) (5)
- Recurrent malignant hypertension: a report of two cases and review of the literature (1999) (5)
- Editors’ Choice 2016 papers in Thrombosis and Haemostasis (2017) (5)
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment (2015) (5)
- Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation (2022) (5)
- An unusual cause of palpitations requiring atrioventricular node ablation and pacemaker therapy. (1997) (5)
- [Stroke: secondary prevention]. (2004) (5)
- EUR Observational research programme: atrial fibrillation general registry pilot phase. (2013) (5)
- Impact of smoking cessation after the new diagnosis of atrial fibrillation on the risk of stroke: a nationwide cohort study (2020) (5)
- Conventional and new oral anticoagulants in the treatment of chest disease and its complications. (2013) (5)
- Myocardial Strain Imaging in Resistant Hypertension (2021) (5)
- Comparative Dose Titration Responses to the Introduction of Bisoprolol or Carvedilol in Stable Chronic Systolic Heart Failure (2007) (5)
- Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease? (2008) (5)
- PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II) (2015) (5)
- Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation (2013) (5)
- Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study (2019) (5)
- Malignant hypertension: not quite an obsolete diagnosis yet. (2019) (5)
- Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease. (1999) (5)
- Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. (2014) (5)
- N‐terminal pro‐brain natriuretic peptide and coronary artery disease (2007) (5)
- Case report: fatal verapamil overdosage despite intensive therapy and use of high dose intravenous calcium. (1996) (5)
- Resistant hypertension and the birmingham hypertension square (2001) (5)
- Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers. (2006) (5)
- Radiofrequency Catheter Ablation of Atrial Fibrillation: A Review of Techniques. (2022) (5)
- New oral anticoagulants in heart failure (2013) (5)
- Optimising stroke prevention in patients with atrial fibrillation. (2015) (5)
- Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised? (2004) (5)
- Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta-Analysis. (2017) (5)
- Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding (2019) (5)
- Direct Oral Anticoagulants in Atrial Fibrillation Patients with Concomitant Hyperthyroidism. (2020) (5)
- Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants. (2018) (5)
- Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study (2019) (5)
- Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromobembolic events in the elderly : The importance of keeping within range (2007) (5)
- Abnormal circulating neutrophil linked matrix metalloproteinase –9 in stable coronary artery disease (2006) (5)
- Stroke prevention in atrial fibrillation: changing concepts. (2015) (5)
- Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation (2012) (5)
- Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). (2018) (5)
- Assessment of endothelial function using plasma markers. (1997) (5)
- Diabetes, the renin-angiotensin system and heart disease. (2003) (5)
- The detection of endothelial dysfunction in patients with essential hypertension. (1997) (5)
- One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry. (2020) (5)
- One‐year Follow‐up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (2021) (5)
- Do protein Z levels influence the prothrombotic state in atrial fibrillation? (2002) (5)
- Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon? (2021) (5)
- Atrial fibrillation in hypertension: under recognised or over diagnosed? (1997) (5)
- Mon2 predicts poor outcome in ST‐elevation myocardial infarction (2019) (5)
- Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies (2005) (5)
- Vascular damage in impaired glucose tolerance: an unappreciated phenomenon? (2009) (5)
- Using the CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective (2013) (5)
- Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores (2020) (5)
- Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation. (2019) (5)
- Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. (2000) (5)
- Cardiovascular risk prediction: balancing complexity against simple practicality. (2015) (5)
- The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden (2017) (5)
- Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy (2022) (5)
- Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials. (2013) (5)
- Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation (2015) (5)
- Burden of atrial fibrillation (2009) (5)
- Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion. (2016) (5)
- Management of Atrial Fibrillation in Patients With Kidney Disease. (2014) (5)
- Long term anticoagulation or antiplatelet treatment. Inclusion criteria determine results of review. (2001) (5)
- Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J‐RHYTHM registry (2021) (5)
- Integrated care for the management of atrial fibrillation: what are the key components and important outcomes? (2019) (5)
- Hospital patients need open access echocardiography (1995) (5)
- Drug Interactions Affecting Oral Anticoagulant Use (2022) (5)
- New pharmacological strategies for the treatment of heart failure. (2001) (5)
- Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry (2022) (5)
- Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation (2021) (5)
- Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation (2022) (5)
- Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration (2022) (5)
- Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule. (2008) (5)
- Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings. (2019) (5)
- Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. (2019) (5)
- The oral direct thrombin inhibitor AZD0387 for the prevention of stroke and systemic embolism in patients with atrial fibrillation: a phase II randomized dose-guiding, safety and tolerability study (2009) (5)
- Antihypertensive therapy before, during, and after stroke (1998) (5)
- Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach (2022) (5)
- The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B. (2021) (5)
- Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke (2018) (4)
- Falls in old age: inevitable or preventable? (1998) (4)
- Clinical outcomes following rhythm control for atrial fibrillation: is early better? (2021) (4)
- Dabigatran (Pradaxa) for stroke prevention in atrial fibrillation (2012) (4)
- Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention. (2016) (4)
- Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation (2020) (4)
- Optimizing stroke prevention in elderly patients with atrial fibrillation (2016) (4)
- Tackling malignant hypertension: not so desperate now. (2002) (4)
- Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry (2022) (4)
- Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. (2018) (4)
- Risk Factors for Systemic and Venous Thromboembolism, Mortality and Bleeding Risks in 1125 Patients with COVID-19: Relationship to Anticoagulation Status (2020) (4)
- Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study (2022) (4)
- Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients (2012) (4)
- Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention. (2017) (4)
- The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study (2021) (4)
- Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial (2020) (4)
- Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand (2020) (4)
- Predictors of diastolic dysfunction in ethnic groups: Observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (2018) (4)
- Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases (2022) (4)
- P5306The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies (2017) (4)
- Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting (2020) (4)
- Diet, lifestyle and blood pressure (1997) (4)
- Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones (2009) (4)
- STIMULATE-ICP-CAREINEQUAL - Defining usual care and examining inequalities in Long Covid support: protocol for a mixed-methods study (part of STIMULATE-ICP: Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways). (2022) (4)
- Arrhythmias: abstractsRelationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation☆ (2004) (4)
- New advances in the treatment of atrial fibrillation: focus on stroke prevention (2014) (4)
- Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation (2019) (4)
- Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (2020) (4)
- The SAMe-TT 2 R 2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists (2015) (4)
- Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation (2018) (4)
- Intracerebral hemorrhage and warfarin: perceived versus actual risk. (2011) (4)
- Thrombosis and Haemostasis 2020 Editors' Choice Papers (2021) (4)
- APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage (2022) (4)
- Hypercalcemia and the cardiovascular system (2006) (4)
- Coarctation of aorta (1997) (4)
- Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle (2020) (4)
- Breaking the rules for studies using real-world observational data: The case of direct-acting anticoagulants and antiepileptic drugs. (2020) (4)
- Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN‐AF survey (2021) (4)
- Difficult situations in anticoagulation after stroke: between Scylla and Charybdis. (2016) (4)
- THE IMPACT OF CORONARY HEART DISEASE IN DETERMINING USE OF HORMONE REPLACEMENT THERAPY IN A GENERAL PRACTICE POPULATION (2001) (4)
- Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study. (2013) (4)
- Use of Novel Oral Anticoagulants in Patients With Heart Failure (2014) (4)
- Nonatrial Fibrillation Patients With Complete P Wave Disappearance: An Overlooked Population With High Stroke Risk. (2021) (4)
- Antihypertensive drug treatment and fibrinolytic function. (1998) (4)
- WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN (2016) (4)
- Diastolic heart failure: recognition, diagnosis and management (2004) (4)
- Predicting recurrent atrial fibrillation after catheter ablation. (2018) (4)
- Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity (2021) (4)
- European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2018) (4)
- Poisoning with anti-hypertensive drugs: beta-adrenoceptor blocker drugs. (1995) (4)
- Management of atrial fibrillation : an overview of the NICE guidance on AF management (2007) (4)
- Targeted atrial fibrillation detection in COVID-19 vaccination clinics (2021) (4)
- Atrial fibrillation: Can it be as easy as CC to ABC? (2020) (4)
- Predictors of Attendance at Cardiac Rehabilitation after Myocardial Infarction (2001) (4)
- Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation. (2018) (4)
- Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction. (2020) (4)
- Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source (2018) (4)
- Safety and Efficacy of New Anticoagulants in Patients with Heart Failure (2013) (4)
- Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation (2021) (4)
- Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (4)
- Managing acute and recent-onset atrial fibrillation. (2003) (4)
- Towards Assigning Diagnosis Codes Using Medication History (2020) (4)
- Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction? (2006) (4)
- Review: angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation (2006) (4)
- Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey (2019) (4)
- Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry. (2019) (4)
- Abnormal baseline endothelial dysfunction and thrombogenesis are related to prognosis in hypertension (1999) (4)
- Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke (2022) (4)
- Statins and the assessment of endothelial function (2002) (4)
- Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
- A SURVEY OF HOSPITAL MORBIDITY, MORTALITY AND QUALITY OF LIFE FOLLOWING CORONARY ARTERY BYPASS SURGERY IN A UK INDO‐ASIAN POPULATION (1999) (4)
- Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19 (2021) (4)
- Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials (2020) (4)
- Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study. (2016) (4)
- Antithrombotic treatment in atrial fibrillation (2006) (4)
- My Approach to the use of NOACs for stroke prevention in patients with atrial fibrillation. (2014) (4)
- Predicting stroke in patients without atrial fibrillation (2019) (4)
- The assessment of stroke and bleeding risk in atrial fibrillation: where are we now? (2010) (4)
- 34 Ethnic and Gender Differences in Symptom-to-Door Times in Patients Presenting with St Elevation Myocardial Infarction (2014) (4)
- Pharmacokinetic considerations for antithrombotic therapies in stroke (2013) (4)
- Regulation of Fluid and Electrolyte Balance in Hypertension: Role of Hormones and Peptides (2005) (4)
- Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation. (2016) (4)
- Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices. (2019) (4)
- Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry (2018) (4)
- Moving forward with a new Editorial team for Thrombosis and Haemostasis (2010) (4)
- Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors (2020) (4)
- Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin (2016) (4)
- Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review. (2020) (4)
- Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS? (2019) (4)
- Stroke: ethnic differences do exist (2006) (4)
- Overdose of diltiazem (1994) (4)
- Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study (2017) (4)
- Lipoprotein(a) in atrial fibrillation. (2000) (4)
- Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease (2016) (4)
- Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer levels in acute-onset nonrheumatic atrial fibrillation (2003) (4)
- Aalborg Universitet Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation (2017) (4)
- Associations of hypertension burden on subsequent dementia: a population-based cohort study (2021) (4)
- Ischemic stroke risk in East Asian patients with CHA2DS2-VASc score of 1: systematic review and meta-analysis (2017) (4)
- Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure (2021) (4)
- Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism (2021) (4)
- ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (4)
- Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk? (2021) (4)
- Vascular Remodeling in Hypertension (2005) (4)
- Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (2021) (4)
- Many patients are ineligible (1996) (4)
- Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST elevation myocardial infarction: results from the randomised RE-DUAL PCI trial. (2020) (4)
- Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study (2021) (4)
- Calcium channel blockers in hypertension: the debate reawakens (2001) (4)
- Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project (2016) (4)
- Aetiology (2000) (4)
- Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. (2022) (4)
- Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. (2001) (4)
- Do Electrophysiological Interventions Confer a Prothrombotic State? (2001) (4)
- Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin? (2011) (4)
- Why is atrial fibrillation so frequent in hypertensive patients? (2020) (4)
- Predicting thrombotic events: Creating a complex approach for a complex condition (2008) (4)
- Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population. (2016) (4)
- Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link? (2008) (4)
- Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery. (2020) (4)
- Edoxaban in venous thromboembolism and stroke prevention: an appraisal (2016) (4)
- The heart in hypertension (2020) (4)
- Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
- Atrial Fibrillation in Clinical Practice (2000) (4)
- Baseline factors associated with early and late death in intracerebral haemorrhage survivors (2020) (4)
- Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry (2017) (4)
- Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population (2016) (4)
- Pathophysiological insights into atrial fibrillation: revisiting electrophysiological substrate, anatomical substrate, and possible insights from proteomics. (2020) (4)
- Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events. (2020) (4)
- Altered cardiac function. (2001) (4)
- Chemotherapy induced arrythmia - Under recognized and undertreated. (2021) (4)
- Helicobacter pylori as the cause of coronary artery restenosis following angioplasty--is the way to a man's heart disease through his stomach? (2001) (4)
- Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality (2018) (4)
- Subclinical Atherosclerosis and Risk of Atrial Fibrillation (2017) (4)
- 2049Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study (2017) (4)
- What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation? (2016) (4)
- Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort. (2019) (4)
- Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry. (2019) (4)
- Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors (2000) (4)
- Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? (2013) (4)
- Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta‐analysis of controlled trials (2017) (4)
- Hemostatic cardiovascular risk factors, common carotid–intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic‐Echocardiographic Heart of England Screening (E‐ECHOES) Study (2011) (4)
- A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. (2004) (4)
- Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China (2022) (4)
- Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty? (2010) (4)
- Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation (2021) (4)
- Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management. (2020) (4)
- Clinical risk factors for retinal artery occlusions: a nationwide case–control study (2022) (4)
- Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD. (2007) (4)
- Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors? (2015) (4)
- Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project (2012) (4)
- Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988) (2022) (4)
- Renal impairment and stroke risk assessment in patients with atrial fibrillation (2013) (4)
- Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation. (2020) (3)
- Influence of renal function on anticoagulation control in patients with non‐valvular atrial fibrillation taking vitamin K antagonists (2017) (3)
- Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation (2022) (3)
- Highlights and hot topics from 2011 in Thrombosis and Haemostasis (2012) (3)
- Hormone Replacement Therapy and Cardiovascular Risk (1995) (3)
- Is Chlamydia pneumoniae Infection Associated with Acute Cardiac Ischaemic Syndromes (1996) (3)
- 'Rise of the machines': the next frontier in individualized medicine. (2021) (3)
- Atrial fibrillation (recent onset). (2005) (3)
- Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis (2021) (3)
- Palpitations in the Cancer Patient (2021) (3)
- The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (2021) (3)
- Thrombosis and Haemostasis 2019 Editor's Choice Papers (2020) (3)
- Comparison of Risk Stratification Schemes for Stroke in Atrial Fibrillation (2009) (3)
- Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents. (2012) (3)
- Do Clinicians Prescribe Hormone Replacement Therapy (HRT) for Hypertensive Post-Menopausal Women? (1994) (3)
- Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification. (2016) (3)
- Prevention of Thromboembolism in Atrial Fibrillation Patients (2010) (3)
- Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review (2021) (3)
- Stroke and recurrent haemorrhage associated with antithrombotic treatment following gastrointestinal bleeding in patients with atrial fibrillation: A Danish nationwide cohort study (2015) (3)
- Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands (2018) (3)
- Percutaneous balloon valvuloplasty of stenosed mitral bioprosthesis. (1997) (3)
- Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis". (2017) (3)
- Use of the HAS-BLED bleeding score in real-life settings. (2014) (3)
- CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. (2015) (3)
- Genetic Polymorphisms and Thromoembolic Risk in Atrial Fibrillation (2004) (3)
- The quest for circulating endothelial cell standardization: The peril of platelets (2007) (3)
- Looking Back on 2020, Looking Forward to 2021 (2021) (3)
- Gender and the response to blood pressure-lowering treatment. (2008) (3)
- High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal (2012) (3)
- Monocyte-platelet cross-talk in peripheral artery disease-how much does the pathogenesis of atherosclerosis depend on anatomical location? (2019) (3)
- Fibrin monomers improves stroke risk stratification in chronic anticoagulated non-valvular atrial fibrillation patients (2013) (3)
- Thrombosis and Haemostasis Wishes You a Happy New Year Ahead! (2018) (3)
- Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link? (2010) (3)
- Antihypertensive agents and left ventricular hypertrophy with ‘usual’ care in the population setting (1999) (3)
- Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT2R2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol (2021) (3)
- Peripheral arterial disease in patients with atrial fibrillation: The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. (2020) (3)
- Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation (2019) (3)
- Cardioversion of atrial fibrillation or flutter: a 'stunning' problem. (2001) (3)
- Stroke prevention in atrial fibrillation: the case for ximelagatran (2005) (3)
- Renin‐angiotensin‐aldosterone system blockade in atrial fibrillation and left atrial remodelling (2009) (3)
- Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis (2021) (3)
- Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA (2019) (3)
- Anticoagulation in patients with atrial fibrillation. No consensus among doctors. (1993) (3)
- Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation (2017) (3)
- A review of risk factors for retinal vein occlusions (2022) (3)
- Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial (2020) (3)
- ABC of Atrial Fibrillation: DIFFERENTIAL DIAGNOSIS OF ATRIAL FIBRILLATION (1995) (3)
- Premature Cardiac Aging in South Asian Compared to Afro‐Caribbean Subjects in a Community‐Based Screening Study (2016) (3)
- Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. (2021) (3)
- South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients. (2007) (3)
- ABC of heart failure: Management: diuretics, ACE inhibitors, and nitrates (2000) (3)
- Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis (2019) (3)
- Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation. (2021) (3)
- Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (2021) (3)
- Thrombosis and Haemostasis: Volume 100 and going strong …. (2008) (3)
- Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. (2015) (3)
- Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding (2011) (3)
- Renin–angiotensin blockade in atrial fibrillation: where are we now? (2017) (3)
- Regression of LVH or improved prognosis (or both): what is the question? (1998) (3)
- 5768Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc (2017) (3)
- Monday, 27 August 2012 (2012) (3)
- Angiotensin Receptor Blockers and Tumorigenesis: Something To Be (or Not To Be) Concerned About? (2012) (3)
- Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure. (2013) (3)
- An independent verdict: does infection with Helicobacter pylori cause ischaemic heart disease? (2000) (3)
- Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke. (2019) (3)
- Blood pressure changes in acute stroke — The West Birmingham stroke project (1996) (3)
- Left Atrial Appendage Morphology Impacts Thrombus Formation Risks in Multi-Physics Atrial Models (2021) (3)
- Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants. (2015) (3)
- COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE (2018) (3)
- 297 Left ventricular systolic dysfunction in rheumatoid disease: an unrecognised burden? (2005) (3)
- Monday, 27 August 2012 (2012) (3)
- Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation (2022) (3)
- Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm. (2018) (3)
- Bleeding risk during oral anticoagulation therapy for atrial fibrillation. (2013) (3)
- Hypertension and renal failure. (2002) (3)
- Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation (2020) (3)
- Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. (2017) (3)
- New Anticoagulants for the Prevention of Deep Venous Thrombosis (2012) (3)
- Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry (2022) (3)
- Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities? (2015) (3)
- Are calcium antagonists safe in hypertension? (1996) (3)
- Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly (2012) (3)
- Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry. (2022) (3)
- Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices (2021) (3)
- Management of hypertension in relation to acute coronary syndromes and revascularisation. (2007) (3)
- Translating regulatory advice into practice: Use of dronedarone and older anti-arrhythmics in AF management (2012) (3)
- Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry (2020) (3)
- Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke (2022) (3)
- P1256Resumption of anticoagulant treatment in patients with atrial fibrillation following gastrointestinal bleeding: a nationwide cohort study (2019) (3)
- Antidiabetic drugs use and new-onset atrial fibrillation in patients with diabetes mellitus (2021) (3)
- Hormone replacement therapy and cardiovascular risk (1995) (3)
- Thrombosis and Haemostasis 2018 Editor's Choice Papers (2018) (3)
- O14 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor (sFlt-1) levels in coronary artery disease and peripheral artery disease (1999) (3)
- Soluble P-selectin is influenced by cancer chemotherapy (2001) (3)
- Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis. (2019) (3)
- The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review (2021) (3)
- Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades (2019) (3)
- The year in cardiology: arrhythmias and pacing. (2020) (3)
- Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association (2019) (3)
- Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation (2022) (3)
- Restart TICrH Trial Design: an adaptive randomized trial of time intervals to restart direct oral anticoagulants after traumatic intracranial hemorrhage. (2021) (3)
- The atrial fibrillation epidemic: a validated diagnosis, or not? (2014) (3)
- Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (2017) (3)
- Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study (2021) (3)
- Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson. (2007) (3)
- Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study. (2020) (3)
- Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage (2020) (3)
- The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management. (2019) (3)
- Soluble adhesion molecules and coronary heart disease. Authors' reply (2002) (3)
- Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia. (2003) (3)
- Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation (2022) (3)
- Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials (2022) (3)
- Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation (2022) (3)
- Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke (2022) (3)
- Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke? (2016) (3)
- The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection (2020) (3)
- Heart Survey Patients With Atrial Fibrillation : The Euro Assess 1-Year Risk of Major Bleeding in A Novel User-Friendly Score (HAS-BLED) To (2010) (3)
- Poisoning with anti-hypertensive drugs: alpha-adrenoceptor antagonists. (1995) (3)
- A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation. (2020) (3)
- Diuretic therapy for hypertension: a cancer risk? (1999) (3)
- Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 studies (2022) (3)
- Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry (2021) (3)
- Congenital absence of the deep inferior epigastric system: a case report (2018) (3)
- Systemic and intracardiac vascular endothelial growth factor and angiopoietin‐1 and ‐2 levels in coronary artery disease: Effects of angioplasty (2007) (3)
- Frontiers in Cardiovascular Drug Discovery (2012) (3)
- Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis (2022) (3)
- Similarities and differences in systemic risk factors for retinal artery occlusion and stroke: A nationwide case-control study. (2022) (3)
- Screening participants’ attitudes to the introduction of artificial intelligence in breast screening (2021) (3)
- The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity. (2008) (3)
- GLORIA-AF Investigators: Antithrombotic treatment patterns in 10,871 patients with newly diagnosed non-valvular atrial fibrillation: the GLORIA-AF Registry Program, Phase II (2015) (3)
- Antithrombotic Management and Type of Stent in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention (2013) (3)
- Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy (2005) (3)
- Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy (2020) (3)
- Cardiac biomarkers: myths, facts and future horizons (2007) (3)
- Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement (2011) (3)
- Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end? (2014) (3)
- Renal Parenchymal Hypertension, Post-Transplant Hypertension, Renovascular Hypertension (2005) (3)
- Stroke prevention in atrial fibrillation--things can only get better. (2007) (3)
- Lack of relationship between left ventricular mass and serum cholesterol in hypertensives. (1998) (3)
- Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction (2010) (3)
- The search for new anticoagulants: dabigatran etexilate (2008) (3)
- Birth Weight and the Risk of Cardiovascular Outcomes: A Report From the Large Population-Based UK Biobank Cohort Study (2022) (3)
- Soluble adhesion molecules and coronary heart disease (2002) (3)
- Exploring the influence of rural residence on uptake of organized cancer screening - A systematic review of international literature. (2021) (3)
- Left internal mammary graft stenosis and restenosis following angioplasty and stenting (2001) (3)
- Managing uncertainty: Physicians' decision-making for stroke prevention for patients with atrial fibrillation and intracerebral haemorrhage. (2022) (3)
- Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review (2021) (3)
- Teaching Anatomy Using Multimedia (2000) (3)
- P1720Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction (2017) (3)
- Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study (2021) (3)
- DIASTOLIC DYSFUNCTION IN HYPERTENSIVES AS ASSESSED BY TISSUE DOPPLER; RELATION TO MATRIX METALLOPROTEINASES (2004) (3)
- Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program (2021) (3)
- Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease (2002) (3)
- Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality. (2021) (3)
- C-reactive protein and lone atrial fibrillation: potential confounders. (2006) (3)
- Misuse of calcium antagonists after myocardial infarction (1992) (3)
- Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA2DS2-VASc score. (2014) (3)
- Warfarin for stroke prevention in atrial fibrillation: time to switch? (2013) (3)
- Management of atrial fibrillation: easy as ABC. (2019) (3)
- Atrial fibrillation during sepsis: a determinant of long-term outcomes? (2014) (3)
- O215 Results of the 1st Phase of the International GLORIA-AF Registry Program: Regional Treatment Differences Before the Era of Novel Anticoagulants (2014) (3)
- E003: Are plasma markers of platelet, endothelial and hemostatic function related to conventional measures of cardiovascular risk in hypertensives? (2000) (3)
- Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation (2019) (3)
- Direct oral anticoagulant reversal: how, when and issues faced (2017) (3)
- Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation (2018) (3)
- Can we treat hypertensive menopausal women with hormone replacement therapy? (1997) (3)
- Goodbye Mercury? Blood Pressure Measurement and Its Future (2005) (3)
- Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project (2018) (3)
- Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). (2018) (3)
- Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis. (2022) (3)
- Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial. (2017) (3)
- CD4+ T cell surface alpha enolase is lower in older adults (2015) (3)
- The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients (2021) (3)
- Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter? (2021) (3)
- Long-term cardiac monitoring after embolic stroke of undetermined source. Search longer - look harder. (2022) (3)
- Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS (2021) (3)
- Atrial fibrillation and stroke: more concepts and controversies. (2001) (3)
- Non-VKA Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients with Atrial Fibrillation: a Meta-analysis of Randomized Controlled Trials. (2015) (3)
- Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure (2017) (3)
- Low Risk of Dementia in Patients With Newly Diagnosed Atrial Fibrillation and a Clustering of Healthy Lifestyle Behaviors: A Nationwide Population‐Based Cohort Study (2022) (3)
- Atrial fibrillation and stroke prevention (2006) (3)
- Clinical and basic science articles from Thrombosis and Haemostasis (2011) (3)
- PCV144 Stroke Prevention in Patients with Atrial Fibrillation: Inappropriate Anticoagulation and Poor INR Control (2011) (3)
- MYOCARDIAL INFARCTION COMPLICATING HORMONE REPLACEMENT THERAPY IN A YOUNG WOMAN WITH NORMAL CORONARY ARTERIES (2000) (3)
- Do Depression and Anxiety Predict Recurrent Coronary Events Twelve Months after Myocardial Infarction (2001) (3)
- Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke (2021) (3)
- Relationship Between Diabetes Mellitus and Atrial Fibrillation Prevalence in the Polish Population. A Report From the Non-Invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) Prospective Cross-Sectional Observational Study (2021) (3)
- Clinical utility and prognostic implications of the 4S‐AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry (2022) (3)
- HYPERTENSION : (1) EPIDEMIOLOGY AND RISKS (1999) (3)
- Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis (2012) (3)
- University of Birmingham A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s (SAFE) (2004) (3)
- How to REVISIT the increasing “real world” evidence for stroke prevention in non-valvular atrial fibrillation? (2016) (3)
- New antiarrhythmic agents for atrial fibrillation. (2007) (3)
- Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation (2022) (3)
- Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated (2020) (3)
- Switching from a vitamin K antagonist to a NOAC. (2015) (3)
- Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect. (2005) (3)
- Heart rate variability changes following catheter ablation for atrial fibrillation. (2020) (3)
- Renal Cell Carcinoma and Malignant Phase Hypertension (2001) (3)
- Recent progress in antithrombotic therapy for atrial fibrillation. (2011) (3)
- Risk of Atrial Fibrillation in Young Adults With Isolated Diastolic, Isolated Systolic, and Systolic-Diastolic Hypertension (2021) (3)
- Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project. (2021) (3)
- Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis. (2020) (3)
- Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better? (2006) (2)
- Aortovascular medicine: what is it? (2021) (2)
- Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds. (2008) (2)
- Comparing TEE‐ vs Non–TEE‐guided cardioversion of atrial fibrillation: The ENSURE‐AF trial (2020) (2)
- Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation. (2018) (2)
- Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis (2021) (2)
- Cardioversion and remodelling in atrial fibrillation: Insights beyond the prothrombotic state. (2008) (2)
- Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not? (2013) (2)
- Platelet reactivity in prolonged stress disorders—A link with cardiovascular disease? (2011) (2)
- Atrial fibrillation and thrombosis: the missing molecular links. (2013) (2)
- Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes (2006) (2)
- Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF (2020) (2)
- The prevalence of left ventricular systolic dysfunction and AF in 5354 South Asian and African Caribbean subjects: results from the Ethnic-Echocardiographic Heart of England (E-ECHOES) study (2010) (2)
- Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease: Is Stroke Prevention Worth the Risk? (2016) (2)
- Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations. (2019) (2)
- Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm. (2005) (2)
- Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (2017) (2)
- Platelets in Thrombotic and Non-thrombotic Disorders: Platelet involvement in venous thrombosis and pulmonary embolism (2002) (2)
- Prothrombotic factors and edothelial dysfunction in left ventricular hypertrophy: Implications for thrombogenesis and atherogenesis (1996) (2)
- WITHDRAWN: Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. (2016) (2)
- Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients? (2016) (2)
- irculating Endothelial Cells in Cardiovascular Disease (2006) (2)
- Variability of response to antiplatelet therapy: what should we do next? (2009) (2)
- To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation (2016) (2)
- Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the ‘real world’ (2017) (2)
- How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation (2021) (2)
- A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention (2019) (2)
- Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: Screening versus routine practice in detection cluster randomised controlled trial (2007) (2)
- VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY (2019) (2)
- Erratum: Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (2017) (2)
- EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS (2019) (2)
- Risk of Arrhythmia and Sudden Death (2002) (2)
- Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction? (2006) (2)
- Vernakalant hydrochloride to treat atrial fibrillation (2014) (2)
- Further pathophysiological insights into age related macular degeneration (2001) (2)
- Raised levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the plasma of patients with ischaemic heart disease and hyperlipidaemia. (1998) (2)
- Management of Atrial Fibrillation (2006) (2)
- Outcome of femoral-popliteal bypass procedures in different ethnic groups in England: A retrospective analysis of Hospital Episode Statistics. (2021) (2)
- Stroke prevention in atrial fibrillation in heart failure. (2013) (2)
- Risk Stratification for Thromboprophylaxis in Atrial Fibrillation (2001) (2)
- Mortality in congestive heart failure complicated by atrial fibrillation. (2004) (2)
- Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension. (2004) (2)
- Angiotensin-II-receptor inhibitors in pregnancy (2001) (2)
- Evidence of inadequate investigation and treatment of patients with heart failure. (1994) (2)
- Renal Artery Embolism: A Rare Cause of Renal Colic (1991) (2)
- Handbook of Oral Anticoagulation (2011) (2)
- From the CHA2DS2-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial. (2020) (2)
- Embolic Stroke of Undetermined Source: The Need for an Integrated and Holistic Approach to Care (2020) (2)
- 'Lone' atrial fibrillation: no longer lone or even alone. (2014) (2)
- Spontaneous conversion in patients with non‐valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE‐AF) trial (2019) (2)
- Cardiovascular disease prevention: Risk factor modification at the heart of the matter (2021) (2)
- Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - a nationwide register-based cohort study: Thromboembolism and bleeding in liver disease. (2022) (2)
- Ethnic disparities in malignant hypertension: further observations. (2007) (2)
- Ximelagatran: the future in anticoagulation practice? (2004) (2)
- Symptom management strategies: rhythm versus rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF Survey (2020) (2)
- Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves. (2009) (2)
- Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. (2016) (2)
- Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail? (2013) (2)
- Dronedarone (Multaq ® ) for the treatment of atrial fibrillation (2011) (2)
- Circulating endothelial progenitor cells. (2005) (2)
- USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE) (2012) (2)
- Single right coronary artery with congenital absence of left coronary system (2018) (2)
- Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study (2021) (2)
- 1145-119 Tissue inhibitor of matrix metalloproteinase-1 is a marker of left ventricular diastolic dysfunction in diabetic heart disease (2004) (2)
- Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation (2014) (2)
- Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment? (2009) (2)
- Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism (2019) (2)
- In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events (2021) (2)
- Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses. (2006) (2)
- Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation. (2012) (2)
- Antithrombotic therapy: standard therapy in essential hypertension? (2006) (2)
- Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: the Catanzaro atrial fibrillation project. (2014) (2)
- ECGs are valuable in hospital as well as general practice (1996) (2)
- Recent scientific documents from the European Heart Rhythm Association (EHRA). (2015) (2)
- Measurement of Diastolic Blood Pressure in Obstetrical Research (1996) (2)
- Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand (2020) (2)
- Anticoagulation variability: is it the physician, patient or hospital? (2009) (2)
- Dabigatran etexilate for venous thromboembolism: a safety evaluation (2014) (2)
- Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials. (2017) (2)
- Diurnal variation and cardiovascular disease. (2001) (2)
- Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA. (1999) (2)
- Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants (2017) (2)
- Hyperhomocysteinaemia: a cardiovascular risk factor needing a large intervention trial? (1997) (2)
- Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project (2013) (2)
- The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project (2011) (2)
- E001: Malignant phase hypertension is associated with endothelial dysfunction, platelet activation and elevated fibrinogen (2000) (2)
- The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function? (2008) (2)
- Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation (2012) (2)
- Endothelial progenitor cells: from pathophysiology to clinical practice (2007) (2)
- Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction (2)
- Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial. (2021) (2)
- Letters to the Editor Atrial Fibrillation and Stroke: More Concepts and Controversies (2001) (2)
- A case of resistant hypertension in a 69-year-old man (2002) (2)
- Strategies to improve oral anticoagulation management. (2011) (2)
- Infective endocarditis causing ulnar mycotic aneurysm and compartment syndrome (2012) (2)
- P3180The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial (2018) (2)
- Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men - The Nishimura Health Survey. (2021) (2)
- Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial. (2022) (2)
- Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat". (2011) (2)
- The Liverpool Centre for Cardiovascular Science. (2019) (2)
- New Oral Anticoagulants (2014) (2)
- Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) registry (2021) (2)
- Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil (2009) (2)
- Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation (2021) (2)
- The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort (2022) (2)
- Impaired fasting glycaemia vs. impaired glucose tolerance: two sides of the same coin with implications for cardiovascular risk (2004) (2)
- Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. (2016) (2)
- Optimisation of atrial fibrillation care - management strategies and quality measures. (2020) (2)
- Cardiovascular Health and Atrial Fibrillation or Flutter: A Cross-Sectional Study from ELSA-Brasil. (2022) (2)
- Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort (2021) (2)
- Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation. (2019) (2)
- Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study (2022) (2)
- Risk assessment and management of atrial fibrillation patients with left atrial thrombus (2018) (2)
- Habitual fish oil supplementation and the risk of incident atrial fibrillation: Findings from a large prospective longitudinal cohort study. (2022) (2)
- Systemic thromboembolism in atrial fibrillation. (2001) (2)
- Blood pressure targets in atrial fibrillation. (2020) (2)
- Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review (2019) (2)
- Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice. (2020) (2)
- The Prognosis of Baseline Mitral Regurgitation in Patients with Transcatheter Aortic Valve Implantation (2021) (2)
- Periprocedural and Long‐Term Anticoagulation (2011) (2)
- Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry (2022) (2)
- Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry (2022) (2)
- Safety and efficacy of direct oral anticoagulants (DOAC) in patients with anaemia and atrial fibrillation: an observational nation-wide Danish cohort study. (2021) (2)
- Modern management of atrial fibrillation. (2007) (2)
- Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP‐AF General Long‐Term Registry (2020) (2)
- Atrial Fibrillation and Percutaneous Coronary Intervention (2017) (2)
- Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program (2022) (2)
- Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment (2021) (2)
- Atrial fibrillation: Stroke prevention in atrial fibrillation: can we do better? (2016) (2)
- Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL? (2007) (2)
- Development and Validation of 3‐Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models (2022) (2)
- SLEEP DURATION MAY NOT HAVE ANY EFFECT ON THE RISK OF STROKE: INSIGHTS FROM MENDELIAN RANDOMIZATION AND PROSPECTIVE COHORT STUDIES (2020) (2)
- Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data (2020) (2)
- Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention. (2013) (2)
- Thrombosis and Haemostasis 2022 Editors' Choice Papers (2022) (2)
- Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in (2012) (2)
- Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention (2022) (2)
- Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes. (1998) (2)
- Atrial fibrillation, the prothrombotic state, inflammation, and gender. (2005) (2)
- Angiopoietins and preeclampsia: new perspectives in the quest for markers. (2009) (2)
- Comparison of the HAS‐BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct‐acting oral anticoagulants (2021) (2)
- Oral anti‐coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study (2022) (2)
- Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial (2020) (2)
- Comparing the 'new' R2CHADS2 with the 'old' CHA2DS2-VASc scores for predicting thromboembolism in patients undergoing atrial fibrillation ablation: new does not mean better. (2014) (2)
- Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients (2021) (2)
- Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry (2022) (2)
- Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT (2020) (2)
- Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults (2022) (2)
- Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. Labeling. (2017) (2)
- Blood pressure changes in acute haemorrhagic stroke. (2005) (2)
- Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot (2021) (2)
- Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints. (2013) (2)
- Social determinants of health and cardiovascular outcomes in patients with heart failure (2022) (2)
- Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options. (2022) (2)
- New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers. (2007) (2)
- Abstract TP294: Effect of Educational Level on Atrial Fibrillation Patients’ Knowledge and Perceptions About Oral Anticoagulation Therapy: Results From an International Study (2017) (2)
- Interpretation of IST and CAST stroke trials (1997) (2)
- Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation (2009) (2)
- Salt-loading and nitric oxide inhibition after the menopause. (2003) (2)
- Soluble adhesion molecule P-selectin, von Willebrand factor and fibrinogen in acute stroke: Evidence for early endothelial and haemorheological dysfunction — the West Birmingham stroke project (1996) (2)
- Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies (2021) (2)
- THE CHA2DS2-VASC SCORE IDENTIFIES AF PATIENTS WITH A CHADS2 SCORE OF 0 OR 1 TREATED WITH ANTIPLATELET THERAPY WHO ARE UNLIKELY TO BENEFIT FROM ORAL ANTICOAGULANT THERAPY (2012) (2)
- Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation (2022) (2)
- Revisiting ‘intensive’ blood glucose control: A causal directed acyclic graph‐guided systematic review of randomized controlled trials (2022) (2)
- Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies. (2022) (2)
- Takayasu's pulseless disease (2000) (2)
- Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data (2021) (2)
- Risk Factors for Acute Myocardial Infarction Amongst Asians from England and Trinidad (1994) (2)
- New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation (2010) (2)
- Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey (2020) (2)
- Intracerebral haemorrhage, atrial fibrillation, and anticoagulation (2015) (2)
- DOAC discontinuation among patients with atrial fibrillation according to gender and cohabitation status; A Nationwide Cohort Study. (2021) (2)
- Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study (2021) (2)
- A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry (2022) (2)
- A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial. (2022) (2)
- Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study. (2015) (2)
- Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation. (2021) (2)
- From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants. (2016) (2)
- Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study. (2000) (2)
- Atrial fibrillation in general practice. (1999) (2)
- Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials (2022) (2)
- Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry (2020) (2)
- Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry (2022) (2)
- Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation (2019) (2)
- Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage (2020) (2)
- Arrhythmias and cognitive function. (2018) (2)
- The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations. (2008) (2)
- Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply. (2022) (2)
- Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia. (2016) (2)
- Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban (2021) (2)
- Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case report (2020) (2)
- THE LEFT ATRIUM IN HYPERTENSION: A SYMBOL OF MORTALITY AND MORBIDITY? (2003) (2)
- STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support (2022) (2)
- Acute, periprocedural and longterm antithrombotic therapy in older adults. (2022) (2)
- Regression of Left Ventricular Hypertrophy and Improved Prognosis Some HOPE Now. . .or Hype? (2001) (2)
- Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea (2022) (2)
- Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study (2021) (2)
- Novel biomarker‐based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality (2018) (2)
- How do we get better at identifying patients with atrial fibrillation who are at ‘truly low risk’ or ‘truly high risk’ of stroke? (2010) (2)
- Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial (2022) (2)
- Drug Interactions Affecting Antiarrhythmic Drug Use (2022) (2)
- Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role. (2003) (2)
- A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis! (2020) (2)
- The role of aspirin in carcinogenesis (2002) (2)
- Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom (2022) (2)
- Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case–control study (2022) (2)
- Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry (2022) (2)
- Assigning diagnosis codes using medication history (2022) (2)
- The Importance and Future of Population Screening for Atrial Fibrillation. (2018) (2)
- Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists (2022) (2)
- Hypertension and atrial fibrillation: Closing a virtuous circle (2021) (2)
- Validity of D-dimer tests for pulmonary embolism: better to diagnose or exclude? (2003) (2)
- Soluble fms-like tyrosine kinase-1 – a novel marker for atherosclerotic progression? –. (2010) (2)
- An update on atrial fibrillation: focus on stroke risk reduction strategies. (2015) (2)
- Warfarin is associated with a net clinical benefit in patients with atrial fibrillation and chronic kidney disease: a nationwide study (2014) (2)
- Motif Based Feature Vectors: Towards a Homogeneous Data Representation for Cardiovascular Diseases Classification (2021) (2)
- Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study (2022) (2)
- Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention (2020) (2)
- Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation (2017) (2)
- Left ventricular hypertrophy and sudden death. (1999) (2)
- Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide (2015) (2)
- Stroke prevention. (2002) (2)
- Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects (2020) (2)
- Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice (2007) (2)
- Platelets and hypertension: the pressure is on the clot (1997) (2)
- Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry (2019) (2)
- Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes (2014) (2)
- Stroke Prevention in Atrial Fibrillation (2017) (2)
- Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis (2022) (2)
- The Patient Pathway Review for Atrial Fibrillation (2022) (2)
- Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry (2021) (2)
- Losartan and the meaning of LIFE (2002) (2)
- Beta-blockers in hypertension: to reappraise or to call a halt? (1998) (2)
- Associations between obesity parameters and the risk of incident atrial fibrillation and ischaemic stroke in the different age groups (2022) (2)
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. (2018) (2)
- Haemorheological factors in hypertension (2000) (2)
- Consumer-Led Screening for Atrial Fibrillation (2022) (2)
- The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study (2020) (2)
- Stroke Prevention in Atrial Fibrillation. (2021) (2)
- Sudden infant death syndrome among Asians in Britain (1994) (2)
- Urinary sodium excretion and blood pressure in chronic psychiatric in-patients (1999) (2)
- Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? (2003) (2)
- Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. (2022) (2)
- Reply to letter to the editor: Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention (2014) (2)
- Permanent atrial fibrillation and heart rate control (2000) (2)
- Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible? (2011) (2)
- Management of atrial fibrillation in specific patient populations. (2016) (2)
- The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy (2001) (2)
- ‘Reverse dipping’ on ambulatory blood pressure monitoring (1997) (2)
- ABC of Atrial Fibrillation: INVESTIGATION AND NON-DRUG MANAGEMENT OF ATRIAL FIBRILLATION (1995) (2)
- Lipoprotein (a): more than just a bystander in the pathophysiology of hypertension? (1998) (2)
- Ethnic Differences in Public Health Awareness, Health Perceptions and Physical Exercise in Birmingham, England (1994) (2)
- Questionable levels of evidence in new atrial fibrillation guidelines (2013) (2)
- 1669Increased rate of previous stroke in asymptomatic/minimally symptomatic versus symptomatic patients with newly detected atrial fibrillation in western Europe - results from the GLORIA-AF registry (2017) (2)
- UNSTABLE ANGINA FOLLOWING ACUTE MI IN A PATIENT WITH BILATERAL CORONARY ARTERY FISTULAE: AN UNUSUAL PRESENTATION OF CORONARY STEAL? (2001) (2)
- P2911Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey (2018) (2)
- ANOMALOUS ORIGIN OF THE LEFT CORONARY ARTERY (1998) (2)
- Safety and efficacy of anticoagulation for secondary stroke prevention in atrial fibrillation patients: The AMADEUS trial (2010) (2)
- DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI (2018) (2)
- No Effect of Clopidogrel Activity or Cessation on Vascular Function or Markers of Inflammation (2012) (2)
- Chapter 17 – Matrix Metalloproteinases and the Extracellular Matrix (2007) (2)
- Introducing Our New Offspring Journal … TH Open (2017) (1)
- 931 Platelet Activation in Non-Variceal Acute Upper Gastrointestinal Bleeding (2013) (1)
- TCT CONNECT-58 Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial (2020) (1)
- Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus (2009) (1)
- Quality of care and risk of incident atrial fibrillation in patients with newly-diagnosed heart failure: A nationwide cohort study. (2021) (1)
- Stroke prevention in atrial fibrillation: antiplatelet therapy revisited. (2007) (1)
- Elevated Chlamydia Pneumoniae Antibody Titres are Associated with Acute Stroke Syndromes: the West Birmingham Stroke Project (1996) (1)
- P1195Current and future incidence and prevalence of atrial fibrillation in korea (2018) (1)
- Non-steroidal anti-inflammatory drugs and incident atrial fibrillation. (2015) (1)
- W01.82 Circulating neutrophil matrix metalloproteinase-9 is elevated in stable coronary artery disease and ischaemic cardiomyopathy (2004) (1)
- 6152A novel model for prediction of ischemic stroke in patients without atrial fibrillation (2018) (1)
- PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (2017) (1)
- High Stroke Risk of Patients Aged ≥65 Years with Screen-Detected Atrial Fibrillation: Collaboration and Meta-Analysis of 15 Screening Studies (2018) (1)
- Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics (2022) (1)
- The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept (2006) (1)
- Stroke prevention. (2008) (1)
- EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE (2018) (1)
- Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all? (2014) (1)
- 088 Is there any improvement in 3D and 2D echocardiography determined left atrial volume following continuous positive airway pressure treatment in patients with obstructive sleep apnoea? (2010) (1)
- P1177Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry (2018) (1)
- Is there an association between hypertension and the development of coronary collateral flow? (2005) (1)
- Left ventricular hypertrophy in the population. (1999) (1)
- Should we make the risk stratification process more complex in patients with atrial fibrillation? (2021) (1)
- P-482: Incidence of maligant phase hypertension in a multiethnic population: The West Birmingham malignant hypertension register (2003) (1)
- ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PREGNANCY: AN INCREASING PROBLEM (2010) (1)
- Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic‐Echocardiographic Heart of England Screening Study (E‐ECHOES) (2017) (1)
- Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension? (2018) (1)
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort (2018) (1)
- Therapeutic vs prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies. (2022) (1)
- Atrial fibrillation and heart failure: a bad combination. (2014) (1)
- Physical fitness and the relationship between hypertension and markers of atherothrombosis. (2007) (1)
- A study of thrombogenesis in atrial fibrillation and left ventricular dysfunction (1994) (1)
- Post-stenting antithrombotic drug therapy in patients with atrial fibrillation. (2007) (1)
- RELATIONSHIP OF SOLUBLE CD40 LIGAND TO VASCULAR ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETINS AND TISSUE FACTOR IN ATRIAL FIBRILLATION: A LINK BETWEEN PLATELET ACTIVATION, ANGIOGENESIS AND THROMBOSIS? (2008) (1)
- Chronic Atrial Fibrillation (2012) (1)
- YM-337. Yamanouchi. (2001) (1)
- Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes (2019) (1)
- Effects of introducing ultra-low dose wartarin and aspirin on fibrin D-dimer and beta-thromboglobulin as markers of intravascular thrombogenesis and platelet activation in chronic atrial fibrillation (1996) (1)
- Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’ (2020) (1)
- Abstract 12985: Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study (2014) (1)
- Oral anticoagulants for stroke prevention in atrial (2015) (1)
- PWE-162 Seasonal and diurnal variation in the presentation and severity of acute upper gastrointestinal bleeding (2012) (1)
- Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus (2018) (1)
- Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF (2021) (1)
- Anti-platelet therapy: Is it all over in peripheral artery disease? (2010) (1)
- AORTIC COARCTATION AND TWIN PREGNANCY (2011) (1)
- Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales. (2022) (1)
- COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY (2018) (1)
- RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL (2018) (1)
- PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY (2017) (1)
- Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation: A Nationwide, Population-Based Cohort Study (2021) (1)
- Abstract 12001: AFCAS, a Prospective Multicenter Registry of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting: Comparison of Chads2- with Cha2ds2-vasc Score (2011) (1)
- How Would i Manage a 40–Year-Old Bank Executive with a Blood Pressure of 145/85? (2000) (1)
- Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation--Reply. (2015) (1)
- Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study (2020) (1)
- Oxidised LDL-lipids alter redox ratio, lipid raft formation and increase amyloid beta production by SHSY-5Y cells (2013) (1)
- P5333Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis) (2018) (1)
- The vitamin K antagonists and their limitations (2010) (1)
- Atrial fibrillation (chronic). (2011) (1)
- INTERPRETATION OF IST AND CAST STROKE TRIALS. AUTHORS' REPLY (1997) (1)
- Stress-induced ST-segment elevation on Q leads after myocardial infarction (2000) (1)
- P1181Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (2018) (1)
- Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0–1: A Korean Multi-Center Cohort (2022) (1)
- Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach (2022) (1)
- Abstract 14: Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke (2015) (1)
- JNC-VI: a view from the United Kingdom (1998) (1)
- Use of non‐vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice? (2016) (1)
- Percutaneous coronary intervention in anticoagulated patients and balancing the risk of stroke and bleeding: to interrupt or not to interrupt? (2010) (1)
- Fundal changes in malignant hypertension (1997) (1)
- EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). (2023) (1)
- Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". (2016) (1)
- Dietary prevention of carcinogenesis in smokers (2002) (1)
- Current Issues in Cardiology: Management Strategies (1998) (1)
- Dual versus single chamber ventricular pacemakers in sick sinus syndrome and atrioventricular block (2001) (1)
- A Time to Stop and Think Before the Shock. (2019) (1)
- National service framework for coronary heart disease. Many operators and facilities will not meet standards set out in framework. (2000) (1)
- End-Stage renal disease and 30-day mortality for adults with and without COVID-19 (2020) (1)
- Non—Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism: Where are we Now? (2014) (1)
- Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS–TIMI 51, TRACER and PALLAS (2012) (1)
- Anticoagulants in Heart Disease Position Paper Syndromes: ESC Working Group on ThrombosisTask Force on New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary (2012) (1)
- CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM (2016) (1)
- Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction. (2021) (1)
- Trends in antithrombotic management in patients with atrial fibrillation: a report from Polish participants in the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry. (2020) (1)
- d-Dimer elevation and adverse outcomes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2015) (1)
- Lipid lowering and the assessment of endothelial function. (2002) (1)
- BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT (2018) (1)
- C0386 A meta-synthesis of qualitative studies exploring patients' and healthcare professionals views of atrial fibrillation and oral anticoagulant therapy (2012) (1)
- Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients (2023) (1)
- Bridging the Gap Between Artificial Intelligence Research and Clinical Practice in Cardiovascular Science: What the Clinician Needs to Know (2022) (1)
- Pulse pressure and carotid atherosclerosis: an important link revisited? (2006) (1)
- Left ventricular hypertrophy and its regression: the prothrombic state in hypertension may be involved in its pathophysiology and altered by therapy. (1999) (1)
- Migration Related Differences in Blood Iron Availability Among Resident Compared With Migrant South Asians are Related to Indices of Atherogenesis (2008) (1)
- Current management of atrial fibrillation in older people (2007) (1)
- PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY (2017) (1)
- Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals (2022) (1)
- P15 Increased levels of soluble P selectin, a marker of platelet activation, in solid and haematological cancer (1999) (1)
- Hypertension and sleep health: a multidimensional puzzle. (2021) (1)
- Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine‐learning algorithms (2022) (1)
- Comprar Lip & Hall Comprehensive Hypertension | Gregory Lip | 9780323039611 | Mosby (2007) (1)
- P6620Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry (2018) (1)
- Current approaches to the management of atrial fibrillation (2010) (1)
- Compliance and the treatment of hypertension: where are we now? (2007) (1)
- Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation (2022) (1)
- Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry (2022) (1)
- IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL (2018) (1)
- Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation (2016) (1)
- HRT in a general practice population: further observations on the ‘healthy cohort’ effect (2002) (1)
- Digoxin: a drug whose time has gone? (2001) (1)
- Abstract 1578: Comparison of Risk Stratification Schemes for Stroke in Atrial Fibrillation (2009) (1)
- Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failu (2015) (1)
- Serum urate is related to baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension (1999) (1)
- P4565Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy (2017) (1)
- Sialography – A technique worth revisiting: Normalanatomy, anatomical variants and duct pathology. (2014) (1)
- Intravenous amiodarone in treatment of recent-onset atrial fibrillation. (1996) (1)
- Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants (2023) (1)
- Female gender and atrial fibrillation: An association with worse prognosis and outcomes. (2015) (1)
- Artificial intelligence to detect abnormal heart rhythm from scanned electrocardiogram tracings (2022) (1)
- Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with antiphospholipid syndrome: a nationwide cohort study (2020) (1)
- Malignant phase hypertension does not vary by season (1995) (1)
- Not all thromboembolism comes from the left atrial appendage in atrial fibrillation (2015) (1)
- Aspirin for prevention of stroke in atrial fibrillation. (2006) (1)
- Reduced stroke risk without increased bleeding risk in patients with atrial fibrillation and complicated liver cirrhosis treated with oral anticoagulation (2020) (1)
- INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY (2017) (1)
- Research update for articles published in EJCI in 2008 (2010) (1)
- Blood pressure monitoring in atrial fibrillation using electronic devices. (2001) (1)
- 3057Relation of atrial remodeling to circulating biomarkers of myocardial fibrosis and apoptotic microparticles in patients with atrial fibrillation and heart failure with preserved ejection fraction (2019) (1)
- How safe is the antiarrhythmic drug therapy in atrial fibrillation? (2009) (1)
- What Cannot Be Missed: Important Publications on Electrophysiology in 2019 (2020) (1)
- Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS Trial (2021) (1)
- 83 Autonomic and vascular function characteristics in patients with atrial high rate episodes (2021) (1)
- Abstract 13828: Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin (2016) (1)
- Alcohol and Atrial Fibrillation (2023) (1)
- Anticoagulation for stroke prevention: high effectiveness, more cost benefit? (2006) (1)
- A Happy New Year from a 60-Year-Old Journal ‘Thrombosis and Haemostasis’! (2018) (1)
- Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex. (2021) (1)
- Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project (2021) (1)
- Atrial fibrillation (acute onset). (2011) (1)
- A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF) (2021) (1)
- Peripheral artery disease: appreciating the asymptomatic – yet lethal – epidemic (2010) (1)
- Acute coronary syndromes: Oral factor Xa inhibitors in acute coronary syndromes (2009) (1)
- 43 US Emergency Department Prescription of Oral Anticoagulants After Atrial Fibrillation Diagnosis (2016) (1)
- Effects of balloon mitral valvuloplasty on systemic and regional left atrial levels of prothrombin fragment 1+2 in mitral stenosis. (2001) (1)
- Targeting patients with atrial fibrillation and improving their anticoagulation management (2001) (1)
- Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation (2015) (1)
- Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study. (2022) (1)
- Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study. (2019) (1)
- Changing the scope of preventative and therapeutic approaches in atherothrombosis (2010) (1)
- ‘You cannot be serious!’ Compliance and antihypertensive regimens (2002) (1)
- Antiplatelet and anticoagulant therapy in patients with advanced heart failure. (2005) (1)
- Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry (2020) (1)
- Stroke risk assessment in atrial fibrillation (2012) (1)
- PLATELET FUNCTION IN CORONARY ARTERY DISEASE: DEFINING RESPONSE TO ANTIPLATELETS (2008) (1)
- Outcomes of digoxin vs. beta-blocker in AF: report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (1)
- Is it the post‐challenge hyperglycaemic spike or arterial stiffness we should be screening for? (2007) (1)
- Diabetes mellitus and atrial fibrillation—Untying the Gordian Knot (2021) (1)
- Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis? (2012) (1)
- Sequential changes in indices of angiogenesis endothelial damage/dysfunction and thrombogenesis in acute coronary syndromes (2003) (1)
- Time trends in cardiovascular drug treatment and cardiovascular events in patients with acute heart failure (2010) (1)
- ATRIAL HIGH RATE EPISODES AND ATRIAL FIBRILLATION BURDEN: ASSOCIATION WITH LEFT ATRIAL/VENTRICULAR FUNCTION AND REMODELING (2011) (1)
- Is Chlamydia Pneumoniaeinfection associated with acute cardiac ischaemic syndromes (1996) (1)
- Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis (2021) (1)
- 684 Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2021) (1)
- Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions. (2014) (1)
- Relative skeletal muscle mass and incident hypertension: associations, caveats, and future perspectives. (2020) (1)
- Endothelial damage and adhesion molecules ICAM, VCAM and E-selectin in acute stroke (1996) (1)
- Response. (2019) (1)
- Cardioversion of Atrial Fibrillation: How Important is a Long Arrhythmia Duration? (1994) (1)
- Haemorheological and Endothelial Markers in Patients with Chronic Heart Failure in Sinus Rhythm: Relationship with Severity of Left Ventricular Dysfunction (2000) (1)
- Prevalence of anti-nuclear autoantibodies (ANA) in the general Polish population - analysis of the influence of sex and age on the variability of ANA. (2021) (1)
- Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis (2010) (1)
- The year in cardiology: arrhythmias and pacing The year in cardiology 2019 (2020) (1)
- Atrial fibrillation and stroke in patients admitted to a city centre hospital serving a multiethnic community. (2000) (1)
- N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Commentary (2007) (1)
- Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study (2010) (1)
- 10 STEPS before you refer for : Atrial fibrillation (2008) (1)
- C0131 Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis (2012) (1)
- Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation (2021) (1)
- The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed. (2006) (1)
- Coronary heart disease and atrial fibrillation (1996) (1)
- Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care (2022) (1)
- Can venous thromboembolism navigate the prevention of cardiovascular complications? (2015) (1)
- Machine learning predicts cardiovascular events in patients with diabetes: The Silesia Diabetes-Heart Project. (2023) (1)
- The Potential Role of Edoxaban in Stroke Prevention Guidelines. (2014) (1)
- Editors’ Choice papers in Thrombosis and Haemostasis (2013) (1)
- Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease (2022) (1)
- Comparison of Dabigatran Plus a P2Y12 Inhibitor with Warfarin-Based Triple Therapy across Body Mass Index in RE-DUAL PCI. (2020) (1)
- LIFE: losartan versus atenolol (2003) (1)
- Ongoing trials involving angiotensin-converting enzyme inhibitors (2002) (1)
- Heparin-Induced Thrombocytopenia: Response (2009) (1)
- Risk of ischemic stroke in patients with atrial fibrillation and concomitant hyperthyroidism: a nationwide cohort study (2021) (1)
- Fondaparinux in atrial fibrillation – old dog, new tricks? (2015) (1)
- Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). (2022) (1)
- Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation (2022) (1)
- Risk for a major bleed was higher for women than men receiving warfarin in patients with atrial fibrillation (2001) (1)
- The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment (2018) (1)
- Haemostasis and Thrombosis: Focus on Atrial Fibrillation (2014) (1)
- Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism? (2008) (1)
- Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity (2022) (1)
- AZD6140 and bleeding: towards safer antiplatelet therapy? (2009) (1)
- 26 Digoxin – Friend or Foe? A Comprehensive Review of Digoxin use and Mortality (2015) (1)
- Alterations in atrial electrogram amplitude as steady sinus rhythm transitions to paroxysmal atrial fibrillation during continuous monitoring in patients with implantable cardiac devices: Insights from the IMPACT study (2021) (1)
- Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and (2010) (1)
- Monocytes: Possible mediators of benefits and harms from physical activity? (2011) (1)
- Abstract 14839: Transesophageal Echocardiography-Guided Strategy vs Conventional Anticoagulation for Cardioversion of Atrial Fibrillation: An Analysis of Thromboembolic and Bleeding Events From the ENSURE-AF Study (2018) (1)
- Diagnosis and Clinical Assessment (2005) (1)
- The impact of different glycaemic index carbohydrate staple foods on south asian diabetic and cardiovascular indices of health: A RCT (2015) (1)
- Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (2018) (1)
- Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis (2022) (1)
- In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs (2019) (1)
- Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers. (2020) (1)
- Silent cerebral embolism after catheter ablation of atrial fibrillation (2012) (1)
- Avoiding Stroke: A Continuous Monitoring Challenge (2020) (1)
- Coronary artery calcium score and its association with stroke: A systematic review and meta‐analysis (2022) (1)
- Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation (2014) (1)
- PWE-161 Platelet activation in acute upper gastrointestinal bleeding (2012) (1)
- Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study (2021) (1)
- Aspirin--a drug whose time has gone? (2010) (1)
- Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis (2022) (1)
- Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction (2019) (1)
- Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. (2019) (1)
- Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation (2022) (1)
- Short axis inferior vena cava measures are more sensitive than long‐axis measures in defining acute volume loading in normal human volunteers. (2008) (1)
- Neurovascular Coupling is Blunted in Atrial Fibrillation (2019) (1)
- Atrial fibrillation …. more than simply being irregularly irregular (2014) (1)
- Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding (2016) (1)
- Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study". (2019) (1)
- Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage". (2016) (1)
- URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY (2014) (1)
- Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias. (2006) (1)
- 144 Does Home-Based, Slow Deep Breathing Training Reduce Central Sympathetic Outflow and Enhance Baroreflex Sensivitiy in Primary Hypertension? (2015) (1)
- Relationship between Endothelial Damage, Angiogenesis and Cardiovascular Risk Factors in Healthy Controls and Hypertensive Patients (2001) (1)
- PERSISTENT ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH MALIGNANT HYPERTENSION (2011) (1)
- Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines (2009) (1)
- Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper (2021) (1)
- P3590Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy (2017) (1)
- Editors’ Choice 2015 papers in Thrombosis and Haemostasis (2016) (1)
- Reply: ankle-brachial index in patients with nonvalvular atrial fibrillation. (2014) (1)
- Sex differences in atrial fibrillation (2020) (1)
- Further insights into the prothrombotic state in mitral stenosis and atrial flutter. (2004) (1)
- Stroke prevention. (2005) (1)
- Figure 1.1, [The coagulation cascade]. (2016) (1)
- Integrated care for atrial fibrillation management: The role of the pharmacist. (2022) (1)
- Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry (2020) (1)
- Hormone replacement therapy. Attitudes of women should be considered. (1994) (1)
- Utilising biomarkers in atrial fibrillation: the pros and cons. (2021) (1)
- Cardiovascular considerations in management of patients with Turner syndrome. (2021) (1)
- Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location (2022) (1)
- The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease (2014) (1)
- Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation. (2020) (1)
- How early is early enough to prevent stroke in atrial fibrillation? (2012) (1)
- Wytyczne dotyczace stymulacji serca i resynchronizacji. (2007) (1)
- Abstract 15542: Impact of Treatment with Apixaban and Aspirin in Patients with Atrial Fibrillation in Relation to the CHADS2 and CHA2DS2-VASc Scores: the AVERROES Study (2011) (1)
- Adherence to the 4S-AF Scheme in the Balkan region: insights from the BALKAN-AF survey. (2022) (1)
- Cumulative Alcohol Consumption Burden and the Risk of Stroke in Young Adults (2022) (1)
- Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis (2022) (1)
- Poisoning with antihypertensive drugs: diuretics and potassium supplements. (1995) (1)
- Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease? (2021) (1)
- Documenting Sex and Sex Differences in Animal Studies (2020) (1)
- Stroke prevention with direct oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk. (2021) (1)
- 136-28: Contemporary patterns of rhythm control in patients with non-valvular atrial fibrillation in the Balkan Region: Insight from the BALKAN-AF Survey (2016) (1)
- Localisation of Vascular Endothelial Growth Factor (VEGF) A, B, C and Their Receptors in Human Atherosclerotic Ateries (2001) (1)
- P4799When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry (2018) (1)
- Pushing the envelope too far? (2004) (1)
- The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis (2022) (1)
- Abnormal Levels of Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR1) and Vegf in Diabetics (2000) (1)
- Relationship between frailty and all-cause mortality in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme AF general long-term registry (2020) (1)
- PMO-202 Use of the Blatchford score to identify low-risk upper gastrointestinal bleeds (2012) (1)
- Modelling Virchow's Triad to Improve Stroke Risk Assessment in Atrial Fibrillation Patients (2022) (1)
- Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients? (2013) (1)
- A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension (2020) (1)
- Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable? (2012) (1)
- RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN CHOLESTEROL, LIPID LOWERING AGENTS AND THE RISK OF STROKE: A META-ANALYSIS OF OBSERVATIONAL STUDIES AND RANDOMIZED CONTROLLED TRIALS (2020) (1)
- P4569Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial (2017) (1)
- Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more. (2020) (1)
- measurementof hypertension: Blood pressure (2006) (1)
- Pre-admission and In-Hospital Statin Use is Associated With Reduced Short Term Mortality in Infective Endocarditis. (2022) (1)
- P1919Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation (2018) (1)
- P2898Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study (2018) (1)
- Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future (2018) (1)
- Common Questions in Anticoagulation Management in Atrial Fibrillation. (2014) (1)
- 36 Monocyte Subpopulations Counts and Associations with Global Longitudinal Strain in St-Elevation Myocardial Infarction Patients with Normal Ejection Fraction (2014) (1)
- Evidence guided antiplatelet treatment: time to move from bench to bedside. (2009) (1)
- Protective effect of proton‐pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta‐analysis (2022) (1)
- Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry (2022) (1)
- 367Prediction of very late arrhythmia recurrence after catheter ablation in patients with atrial fibrillation using APPLE and MB-LATER scores: the Leipzig AF ablation registry (2018) (1)
- Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study (2022) (1)
- Acute atrial fibrillation. (2002) (1)
- Review: combining 2 classes of blood pressure–lowering drugs has an approximately additive effect on systolic blood pressure (2009) (1)
- Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study (2021) (1)
- Family History of Atrial Fibrillation and Risk of Cardiovascular Events (2020) (1)
- Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision Analyses (2016) (1)
- Predictors of Outcome in Acute Stroke Patients: Are They Reliable and Potentially Useful? (2017) (1)
- Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications. (2021) (1)
- Addressing the Challenge of Data Heterogeneity Using a Homogeneous Feature Vector Representation: A Study Using Time Series and Cardiovascular Disease Classification (2021) (1)
- Current anticoagulation therapy--a GP guide. (2004) (1)
- Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study (2017) (1)
- P4748HASBLED score, frailty index or comorbidity index for bleeding risk assessment in patients with atrial fibrillation? (2019) (1)
- Should Audits Consider the Care Pathway Model? A New Approach to Benchmarking Real-World Activities (2022) (1)
- Efficacy of mobile health-technology integrated care based on the ‘Atrial fibrillation Better Care’ (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial (2023) (1)
- Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’ (2021) (1)
- Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF? (2019) (1)
- Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants (2021) (1)
- INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions (2021) (1)
- Plasma thrombomodulin in atherosclerosis and its risk factors. (1997) (1)
- Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
- The Birmingham and Black Country cohort of Venous Thromboembolism (BBC-VTE) registry: Rationale, design and preliminary results. (2022) (1)
- P3845Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study (2018) (1)
- Screening for Atrial Fibrillation: Improving Efficiency of Manual Review of Handheld Electrocardiograms † (2020) (1)
- Telemedical Monitoring Based on Implantable Devices—the Evolution Beyond the CardioMEMS™ Technology (2022) (1)
- What are the costs of atrial fibrillation? (2011) (1)
- Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients (2021) (1)
- Atrial Fibrillation and End-Stage COPD: A Close Association Revisited. (2019) (1)
- INCIDENCE, CHARACTERISTIC AND RISK FACTORS OF CEREBRAL THROMBOEMBOLIC COMPLICATIONS FOLLOWING HIGH-FREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION: EXPERIENCE OF 3,360 PROCEDURES (2013) (1)
- Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention) (2013) (1)
- P849Relationship between time in therapeutic range and study-level factors in patients treated with vitamin k antagonists: a systematic review and meta-regression (2017) (1)
- Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration (2022) (1)
- PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN (2014) (1)
- Temporal trends of catheter ablation for patients with atrial fibrillation: A Korean nationwide population‐based study (2020) (1)
- Disparities in atrial fibrillation: a call for holistic care (2021) (1)
- GW26-e2300 Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry (2015) (1)
- Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study (2022) (1)
- ‘Patient choice’ concept in AF ESC Guidelines: is the clinician giving up? Reply (2013) (1)
- A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project (2013) (1)
- Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry (2022) (1)
- Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients. (2009) (1)
- Inconsistent Methodology as a Barrier to Meaningful Research Outputs From Studies of Atrial Fibrillation After Cardiac Surgery. (2021) (1)
- A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation. (2016) (1)
- P281Baseline characteristics of patients with atrial fibrillation with and without comorbid heart failure: the GLORIA-AF registry (2017) (1)
- Intracranial haemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: what does 'real world' registry data tell us (2014) (1)
- Anticoagulants for Atrial Fibrillation (2017) (1)
- Net clinical benefit of combination anticoagulant and antiplatelet therapy versus anticoagulation alone in atrial fibrillation patients: Results from the amadeus trial (2010) (1)
- The management of hypertension in type II diabetes mellitus (2006) (1)
- Rheumatoid arthritis and autonomic function (1132.10) (2014) (1)
- Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways (2020) (1)
- Tamoxifen for breast-cancer prevention (2003) (1)
- Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke (2023) (1)
- Risk Stratification in Atrial Fibrillation (2019) (1)
- Edoxaban in Asian Patients With Atrial Fibrillation (2018) (1)
- PLASMA MATRIX METALLOPROTEINASE (MMP)-9 AND TISSUE INHIBITOR OF MMPS (TIMP)-1 IN HYPERTENSION: A META-ANALYSIS: 4B.03 (2011) (1)
- Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. (2022) (1)
- An initial energy of 360 J for elective cardioversion was more effective than 100 or 200 J in persistent atrial fibrillation (2001) (1)
- Early rhythm-control therapy in patients with atrial fibrillation: a nationwide cohort study (2021) (1)
- Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study (2022) (1)
- Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation. (2022) (1)
- Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. (2019) (1)
- Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress (2022) (1)
- 'Association of platelet function in hypertensive patients with left ventricular hypertrophy'. (1999) (1)
- Assessment of endothelial function: implications for hypertension and cardiovascular disorders (2009) (1)
- Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!). (2003) (1)
- Ximelagatran in the clinic: practical management of patients. (2005) (1)
- Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection (2023) (1)
- Thromboembolism in heart failure (2002) (1)
- Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV–Heart Project (2021) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry (2022) (1)
- Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet? (2022) (1)
- Non-selective beta-blockers decrease thrombotic events in patients with heart failure (2009) (1)
- Efficacy and Safety of Anticoagulants in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: A Systematic Review and Multilevel Meta-Analysis (2022) (1)
- Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey. (2021) (1)
- Fusion of Higher Order Spectra and Texture Extraction Methods for Automated Stroke Severity Classification with MRI Images (2021) (1)
- Gender related clinical predictors of adverse events after catheter ablation of atrial fibrillation (2013) (1)
- E002: Platelet and haemorheological markers in high risk hypertensives are improved by tighter blood pressure control (2000) (1)
- Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation. (2023) (1)
- Atrial fibrillation and stroke (2022) (1)
- Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation. (2015) (1)
- P2887Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry (2018) (1)
- External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - a nationwide registry-based study. (2022) (1)
- Chemotherapy-Induced Arrhythmias (2021) (1)
- Common causes of atrial fibrillation (2000) (1)
- Stroke risk stratification in hypertrophic cardiomyopathy. (2020) (1)
- Stroke risk stratification in patients with heart failure and sinus rhythm. (2022) (1)
- Can we IMPROVE bleeding risk assessment for acutely ill, hospitalized medical patients? (2011) (1)
- IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS (2018) (1)
- Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults 60 years of age (2017) (1)
- Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. (2021) (1)
- Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do? (2013) (1)
- W04.140 Plasma VEGF and angiopoietins in diabetes: Relationship with endothelial damage/dysfunction and atherosclerosis and effect of multifactorial intervention (2004) (1)
- Reply: To PMID 22575324. (2013) (1)
- Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All? (2021) (1)
- Bene fi t of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease (1)
- Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: A Danish nationwide cohort study. (2022) (1)
- Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients (2022) (1)
- Oxidative Stress and Endothelial Damage in Malignant Phase Hypertension (2001) (1)
- To the Editor- Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification? (2019) (1)
- Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects. (2022) (1)
- Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study (2021) (1)
- Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation. (2008) (1)
- Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm (2013) (1)
- Screening for atrial fibrillation in subjects aged 65 using a long-term continuous ECG telemonitoring vest: the NOninvasive Monitoring for early detection of atrial fibrillation (NOMED-AF) study (2020) (1)
- Right atrial function in hypertension (2001) (1)
- Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program (2022) (1)
- Patients ’ and health professionals ’ views and experiences of atrial fibrillation and oral-anticoagulant therapy : a meta-synthesis (2016) (1)
- Lipid Lowering Therapy Reduces Plasma Vascular Endothelial Growth Factor (VEGF) in Hypercholesterolaemia (2000) (1)
- Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and/or undergoing a percutaneous coronary intervention. (2020) (1)
- Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? (2022) (1)
- Coronary risk factors, endothelial function, and atherosclerosis: A review: To the editor (1997) (1)
- Hormone replacement therapy with conjugated estrogens and high blood pressure: response to Dr. Jespersen. (1997) (1)
- CHA2DS2-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation? (2018) (1)
- Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation (2015) (1)
- Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management. (2022) (1)
- Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex. (2019) (1)
- Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis (2022) (1)
- Abstract 19565: SAMeTT2R2 Scores Predict Stroke Risk After Initiation of Vitamin K Antagonist Therapy for Atrial Fibrillation: a Real-world Practice Study (2014) (1)
- Respiratory modulation of muscle sympathetic nerve activity in patients with hypertension (2010) (1)
- Abstract 14898: Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin Among Patients With Non-Valvular Atrial Fibrillation and Diabetes: ARISTOPHANES Diabetes Subgroup Analysis (2018) (1)
- P6112Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial (2017) (1)
- A Rollercoaster Plunge into 2022. (2022) (1)
- OC-024 Prolonged Platelet Activation in Patients with Acute Upper Gastrointestinal Bleeding (2013) (1)
- Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis (2022) (1)
- Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion (2020) (1)
- Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? (2021) (1)
- BLEEDING WITH ASPIRIN AND APIXABAN IN PATIENTS UNSUITABLE FOR VITAMIN K ANTAGONIST THERAPY: THE AVERROES STUDY (2012) (1)
- Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk ― The Fushimi AF Registry ― (2021) (1)
- Universitet Integrating new approaches to atrial fibrillation management the 6 th AFNET / EHRA Consensus Conference (2018) (1)
- Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout (2022) (1)
- 115 Atrial high rate episodes and atrial fibrillation burden: do they have similar association with cardiac remodelling? (2011) (1)
- Fast straining CT in assesment of difficult abdominal wall herniae. (2010) (1)
- Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan (2022) (1)
- Left atrial thrombin generation and prothrombin fragment 1+2. (2000) (1)
- Editorial: combination therapy for systemic hypertension (15 September 1995). (1996) (1)
- RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY (2017) (1)
- Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2022) (1)
- 1142-186 Elevated levels of circulating tissue inhibitor of metalloproteinase-1 correlate with impaired diastolic relaxation in hypertension: Implications for diastolic heart failure (2004) (1)
- Is atrial fibrillation another manifestation of organ damage in diabetes? (2017) (1)
- Anticoagulant treatment is effective in atrial fibrillation (2013) (1)
- Is depression a risk factor for coronary heart disease? Authors' reply (2004) (1)
- Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the ESC-EHRA EORP AF general long-term registry. (2022) (1)
- W03-P-002 Circulating endothelial cells, Von Willebrand factor and flow mediated dilatation as indices of endothelial damage/dysfunction in patients with acute (2005) (1)
- Antithrombotic therapy for non-rheumatic atrial fibrillation. (1996) (1)
- Effects of multimorbidity on incident COVID‐19 events and its interplay with COVID‐19 event status on subsequent incident myocardial infarction (MI) (2022) (1)
- Abstract 15612: The Impact of Smoking on Thromboembolism and Mortality in Patients with Atrial Fibrillation: The Diet, Cancer and Health Study (2012) (0)
- Association of Atherogenic Low Density Lipoprotein (Ldl) Subfractions with Carotid Atherosclerosis (1998) (0)
- Atrial fibrillation (acute). (2003) (0)
- Atrial fibrillation in the presence of chronic kidney disease: To ablation or not to ablate (2021) (0)
- Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol (2020) (0)
- Haemoglobin disorders and low HDL cholesterol in South Asians – Are they connected? (2010) (0)
- Plasma metalloproteinase-9 in age-related macular degeneration (2009) (0)
- Faculty Opinions recommendation of Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. (2016) (0)
- Chapter 19 Guidelines on the pharmacological management of hypertension (2009) (0)
- Duration of diabetes mellitus and thromboembolic events in atrial fibrillation (2015) (0)
- EVALUATION OF SYMPTOMS REPORTED BY PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION USING ELECTRONIC MEDICAL RECORDS (2021) (0)
- Atrial Fibrillation: Non Surgical Management (2010) (0)
- Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis? (2008) (0)
- Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist (2022) (0)
- The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke (2022) (0)
- Renal impairment and prognosis of patients with AF undergoing PCI - The AFCAS trial (2013) (0)
- Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage (2021) (0)
- Dabigatran for stroke prevention: an effective alternative to warfarin (2012) (0)
- 1378: Generalised obesity but not centripedal obesity is associated with increased perceived breathlessness on treadmill exercise testing (2006) (0)
- 219Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score (2018) (0)
- Single-lead VDD pacing: a literature review on short-term and long-term performance (2023) (0)
- 1460Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK (2022) (0)
- Predictors of left ventricular thrombus after acute myocardial infarction: a systematic review and meta-analysis (2023) (0)
- P1886Validation of the MB-LATER score prediction ability for recurrent atrial fibrillation after electrical cardioversion (2019) (0)
- Haemorheological and Cardiovascular Risk Factors in Retinal Vascular Occlusion (1996) (0)
- Adjusted Dose Vitamin-K Antagonist , Comparing Efficacy and Safety With Unadjusted (2008) (0)
- Carpentier-Edwards pericardial bioprosthesis at the mitral site: twelve year results (1998) (0)
- G001: Malignant phase hypertension is associated with abnormalities of low density lipoprotein subfraction profiles (2000) (0)
- ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation (2022) (0)
- Mini-review QJM Digoxin revisited (1998) (0)
- Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248] (2011) (0)
- ABC of heart failure: Aetiology (2000) (0)
- In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies (2021) (0)
- Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study (2015) (0)
- Atrial fibrillation prevalence and incidence varies by population definition: Association with co-morbidity profiles and multimorbidity in a large United States adult cohort (2020) (0)
- Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm (2015) (0)
- Elevation of pulse pressure in middle age is associated with the risk of dementia: data from a population-based cohort (2020) (0)
- infective endocarditis A randomized trial of aspirin on the risk of embolic events in patients with (2012) (0)
- Review: Direct thrombin inhibitors are similar to LMWH and vitamin K antagonists for preventing VTE after hip or knee replacement (2010) (0)
- P3862A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics (2018) (0)
- The unifying role of matrix metalloproteinases in atheroma and vascular stroke. (2004) (0)
- Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities” (2009) (0)
- P-579: Nondipping status and high pulse pressure: relationship to endothelial damage/dysfunction (2004) (0)
- Atrial fibrillation 10 STEPS Before you refer for (2008) (0)
- Awareness and treatment of atrial fibrillation in older adults: the present and the future. (2013) (0)
- A comparison of plasma and vitreous levels of angiogenic factors [Vascular Endothelial Growth Factor, soluble VEGF receptor, Angiopoietin 1 & 2, and angiopoietin receptor TIE 2] in proliferative diabetic retinopathy (2004) (0)
- 95 Is outpatient based acute heart failure treatment cost-effective? An analysis based on a pilot prospective trial (2020) (0)
- P5137NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study (2018) (0)
- Matrix metalloproteinase-12 levels in hypertension: relationship to left ventricular mass, diastolic dysfunction and antihypertensive therapy (1999) (0)
- EFFECT OF BLOOD PRESSURE OPTIMISATION ON ENDOTHELIAL FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AND HYPERTENSION (2021) (0)
- Atrial Fibrillation in the Elderly (2017) (0)
- P3509Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients.The FANTASIIA Registry (2018) (0)
- Antiplatelet therapy and atrial fibrillation: some caution needed (2017) (0)
- Atrial fibrillation: Rate control and digoxin. (2007) (0)
- of matrix metalloproteinase Inhibitor of Metalloproteinase - 1 in the development of new onset of atrial fibrillation after coronary artery bypass graft (0)
- Treatment of Ventricular Arrhythmias (2003) (0)
- Left ventricular mass and diastolic function in patients with coronary artery disease with and without hypertension: relationship to endothelial damage/dysfunction (2004) (0)
- Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out? (2021) (0)
- Vascular endothelial growth factor, soluble receptor Flt-1 and von willebrand factor in coronary artery disease: relationship to disease severity (2001) (0)
- 408Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study (2019) (0)
- P4816Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice (2018) (0)
- Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: an ARISTOPHANES analysis (2021) (0)
- Post myocardial infarction and atrial fibrillation : Thromboprophylaxis and risk stratification using the CHA 2 DS 2-VASc score (2014) (0)
- Abstract 19941: Clinical and Demographic Characteristics According to Dosage Among New Initiators and/or Switchers From Warfarin Non-valvular Atrial Fibrillation Patients on Apixaban, Dabigatran and Rivaroxaban (2015) (0)
- C0129 Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature (2012) (0)
- P3474Relationship between international normalized ratio variability, quality of anticoagulation control and outcomes in patients with atrial fibrillation: an AFFIRM post-hoc analysis (2019) (0)
- Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. (2021) (0)
- Multivariable prediction models for atrial fibrillation after cardiac surgery: a systematic review protocol (2023) (0)
- Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial". (2019) (0)
- Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation". (2020) (0)
- Alcohol intake and prognosis of atrial fi brillation (2013) (0)
- A 69-year-old man with atrial fibrillation, previous duodenal ulcer and peripheral arterial disease (1998) (0)
- Hydrocortisone acutely reduces cardiovagal baroreflex sensitivity and heart rate variability (2015) (0)
- P005: Pregnancy in hypertensive women: Differences among ethnic Groups (1998) (0)
- Atrial Fibrillation Diagnosed following Stroke: Dealing with a New Clinical Entity or Just a Matter of Definition? (2021) (0)
- Dronedarone: NICE enough? (2010) (0)
- University of Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation (2015) (0)
- P1900Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score (2018) (0)
- Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk (2021) (0)
- 1360Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients? (2018) (0)
- The comorbidity network in older adults with atrial fibrillation: a Danish nationwide cohort study (2022) (0)
- Which is the ideal plasma marker of endothelial damage/dysfunction in atrial fibrillation? A comparison of von Willebrand factor, E-selectin and soluble thrombomodulin (2003) (0)
- The American College of Chest Physician score to assess therisk of bleeding during anticoagulation in patients with venous thromboembolism (2018) (0)
- Alcohol and the heart. (2001) (0)
- Managing cardiac arrhythmias. Part I. General principles of investigation and management. (2000) (0)
- A Survey of Acute Admissions with Atrial Fibrilation in a Multiracial Hospital Population (1995) (0)
- Abstract 10716: Vitamin D Deficiency and Cardiovascular Disease Amongst Minority Ethnic Groups in the UK: A Cross Sectional Study (2012) (0)
- Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply. (2020) (0)
- Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the AF-GEN-UK registry (2022) (0)
- Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. (2023) (0)
- Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient. (2023) (0)
- Authors' reply (1996) (0)
- Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review (2021) (0)
- Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: the Danish Stroke Registry (2021) (0)
- Clinical Features Associated with ‘Normal Range’ Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus (2022) (0)
- Announcement / Book Reviews (2003) (0)
- Hypertension latelet Indexes in Relation to Target rgan Damage in High-Risk Hypertensive Patients Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial ( ASCOT ) unil (2016) (0)
- Reply: The Case of Dynamic CHA2DS2-VASc Score: Beyond Risk Prediction. (2018) (0)
- Effects of Carvedilol, a Vasodilatory Beta-Blocker, on Microalbuminuria in Heart Failure (2001) (0)
- P3348Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): a retrospective cohort study (2019) (0)
- Abstract 13114: Predictive Value of the Has-Bled Score in Patients with Atrial Fibrillation and Chronic Kidney Disease Using Vitamin K-Antagonists (2012) (0)
- Lipoprotein (a) and thrombogenesis in left ventricular dysfunction. (2001) (0)
- Hypertension as a contributor to ethnic differences in prevalence of Peripheral Vascular Disease (2002) (0)
- Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. (2022) (0)
- P1003Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial (2018) (0)
- Heart Disease Prevention and the Differences in Dietary Fat Amongst Whites, Blacks and Asians in England (1994) (0)
- Increased bleeding risk without thromboembolic protection with antiplatelet treatment on top of oral anticoagulation in heart failure patients with atrial fibrillation and co-existing vascular disease (2013) (0)
- H001: Does blood pressure influence the hypercoagulable state in atrial fibrillation? (1999) (0)
- 982-114 Are Hypertensive Women Being Denied Hormone Replacement Therapy? (1995) (0)
- In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets (2020) (0)
- P1885CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function (2018) (0)
- Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening. (2020) (0)
- Incidence, type and prediction of death in anticoagulated patients with atrial fibrillation: a post-hoc analysis from the SPORTIF trials (2020) (0)
- Author and Subject Index (2005) (0)
- University of Birmingham Asymptomatic versus symptomatic atrial fibrillation (2015) (0)
- Role of multiple- and single-pregnancy complications with incident cardiovascular diseases: a nationwide data linkage study in Wales (2022) (0)
- P4800Estimated effect of NOACs compared to Vitamin K Antagonists in real-world atrial fibrillation patients: Data from FANTASIA Registry (2019) (0)
- PCV107 PREFERENCE AND WILLINGNESS-TO-PAY FOR NOVEL ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – PRELIMINARY RESULTS FROM A TWO-CENTRE SURVEY IN CHINA (2019) (0)
- Matrix metalloproteinases in atrial fibrillation. Authors' reply (2004) (0)
- Postępowanie z migotaniem przedsionków w szczególnych populacjach pacjentów. Przegląd współczesnego stanu wiedzy (2016) (0)
- Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135] (2008) (0)
- Stroke Prevention (1995) (0)
- Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry (2021) (0)
- Prediction of mortality and mode of death by clinical risk score systems in 2.6 million patients with atrial fibrillation: a nationwide analysis (2020) (0)
- Electrocardiographic evidence of atrial cardiomyopathy in mitral stenosis: a retrospective analysis in a Chinese cohort (2018) (0)
- Do cardiologists and non-cardiologists vary in their management of patients with atrial fibrillation? (1996) (0)
- Early atrial fibrillation rhythm control after stroke (2023) (0)
- A nationwide cohort study on the impact of gestational diabetes on future cardiovascular events (2022) (0)
- 3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis (2017) (0)
- Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement. (2019) (0)
- MS56 APOLIPOPROTEINS IN THE DISCRIMINATION OF ATHEROSCLEROTIC BURDEN AND CARDIAC FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE (2010) (0)
- Stroke risk factors and risk stratification in atrial fibrillation (2018) (0)
- Potential Embolic Sources in Embolic Stroke of Undetermined Source in Patients with Patent Foramen Ovale: Look Harder. (2023) (0)
- Diurnal Variation in Stroke Onset in Atrial Fibrillation (2001) (0)
- Faculty Opinions recommendation of Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS₂ score. (2011) (0)
- P2902Association of circulating apoptotic (annexin V+) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction (2018) (0)
- University of Birmingham Patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment: (2018) (0)
- Oral Anticoagulant Therapy after Major Bleeding in Atrial Fibrillation : A Systematic Review and Meta-Analysis (2018) (0)
- 0173: Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke? (2015) (0)
- Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015 (2016) (0)
- The Athlete’s Heart and Machine Learning: A Review of Current Implementations and Gaps for Future Research (2022) (0)
- P3588Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis (2017) (0)
- Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient. (2022) (0)
- Longitudinal changes in CHA2DS2-VASc and HAS-BLED scores are superior to baseline score values for predicting ischemic stroke and major bleeding in atrial fibrillation patients (2022) (0)
- Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke (2023) (0)
- Non-pharmacological strategies for atrial fibrillation (2000) (0)
- P2899Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification (2018) (0)
- Cerebrovascular Reactivity in Atrial Fibrillation (2017) (0)
- 86 Impaired left ventricular function in malignant phase hypertension (2003) (0)
- The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review (2023) (0)
- Angiogenesis Factors in Diabetic Retinopathy: Effects of laser photocoagulation and renin– angiotensin system blockade. (2004) (0)
- Pushing the envelope too far? Authors' replies (2004) (0)
- The Renin–Angiotensin–Aldosterone System (2005) (0)
- Scanned ECG Arrhythmia Classification Using a Pre-trained Convolutional Neural Network as a Feature Extractor (2022) (0)
- What do the RELY , AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation ? (2017) (0)
- A Study of the Placebo Effect and white Coat Effect in Isolated Systolic Hypertension (1996) (0)
- OR-6: Effects of treatment on endothelial function, angiogenesis and thrombogenesis in hypertension (2002) (0)
- Etiology, Physiology and Pathophysiology (2005) (0)
- Abstract 15529: Aspirin and Renal Insufficiency Progression in Patients With Atrial Fibrillation and Chronic Kidney Disease (2015) (0)
- Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample (2023) (0)
- P5505The efficacy and safety of the use of drug-eluting stents vs bare metal stents stratifying by antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting: a systematic review (2018) (0)
- P4794Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis (2019) (0)
- Risk of Ischaemic Stroke in Patients with Atrial Fibrillation and Concomitant Hyperthyroidism: A Nationwide Cohort Study (2021) (0)
- Response to Magnesium and Vascular Dysfunction in Malignant Hypertension (2011) (0)
- The Reply. (2022) (0)
- Drug Induced Hypertension (2005) (0)
- 18Effect of warfarin and rivaroxaban on clot structure (2014) (0)
- Psychological influence of the media on patients commencing oral anticoagulation in atrial fibrillation:a qualitative analysis (2013) (0)
- External validation of the biomarker based ABCD score in atrial fibrillation patients with a non gender CHA2DS2 VASc score 0 to 1, A Korean multicenter retrospective cohort (2022) (0)
- Cardiac resynchronization halves death from heart failure (2003) (0)
- Factors associated with prescription of oral anticoagulation for atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018 (2022) (0)
- Investigation of Atrial Fibrillation (2000) (0)
- Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)] (2004) (0)
- Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL‐AF Registry (2023) (0)
- Zero-burden atrial fibrillation: does stroke risk diminish the longer a person is free from atrial fibrillation? (2022) (0)
- Abstract 15998: Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases (2017) (0)
- 536Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin (2014) (0)
- Original articles Do Indo-Asians have smaller coronary arteries? (1999) (0)
- Relationship of aging and incident comorbidities to stroke risk in 594,169 Patients with atrial fibrillation: a nationwide analysis (2020) (0)
- Abstract 14904: Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Very Elderly Patients With Non-Valvular Atrial Fibrillation: An Observational Study (2018) (0)
- Impact of mental health conditions on anticoagulation prescription in people with atrial fibrillation (2021) (0)
- University of Birmingham Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation (2015) (0)
- Heightened risks of cardiovascular disease in South Asian populations: causes and consequences (2023) (0)
- P4758Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study (2019) (0)
- Improving survival post myocardial infarction – does this translate to an increasing incidence of atrial fibrillation? (2018) (0)
- Health Care Cost In Patients Undergoing Electrical Cardioversion: An analysis from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ensure-af) study (2017) (0)
- University of Birmingham Assessment of atrial fibrosis for the rhythm control of atrial fibrillation (2016) (0)
- Mean glucose concentrations are increased, and cardiovascular risk factors are common in children and young people with secondary adrenal insufficiency (GRACE2) (2022) (0)
- Chapter 8 Pulmonary vascular diseases (2011) (0)
- MODERATED POSTERS SESSION: ATRIAL FIBRILLATION A 10-year prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project (2013) (0)
- University of Birmingham Secondary versus primary stroke prevention in atrial fibrillation (2017) (0)
- Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation (2023) (0)
- Effects of intensive cardiovascular risk factor management on endothelial function and angiogenesis in ‘high risk’ hypertensive patients (2002) (0)
- 13) Genetic variant of CD36 gene is not associated with Cardiovascular risk factors in South Asians (2012) (0)
- Effects of amlodipine-based therapy on platelet morphology, beta-thromboglobulin and soluble and platelet P-selectin in essential hypertension (2004) (0)
- The ideal environment for the development of postcardiac surgery atrial fibrillation: evidence for endothelial activation and poor cell-cell interaction (2022) (0)
- Monocyte subset counts associations with left ventricular systolic function post ST elevation myocardial infarction (2013) (0)
- Thromboembolic risk in non-anticoagulated atrial fibrillation patients with valvular heart disease and low CHA2DS2-VASc scores: are these patients truly low risk of stroke? (2020) (0)
- Supplementary material : Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation (2017) (0)
- Hypertension, diuretics and breast cancer risk. Commentary (2006) (0)
- Faculty Opinions recommendation of Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation. (2016) (0)
- Cardiovascular medications and long‐term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (EMMA) (2022) (0)
- History of atrial fibrillation (2000) (0)
- 10 A simple method to improve the reliability of echocardiography in patients with atrial fibrillation (2019) (0)
- Angiogenesis and endothelial damage in acute myocardial infarction: an acute or chronic process? (2001) (0)
- P2913Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation (2018) (0)
- Non-Vitamin K Oral Anticoagulants ( NOACs ) for stroke prevention in Asian patients with atrial fibrillation : Time for a reappraisal (2014) (0)
- Abstract 10703: Does CHADS2 Score Predict Atrial Arrhythmias? (2012) (0)
- Statins in women: Is primary prevention beneficial? (2005) (0)
- Increased levels of plasma glycoprotein V in peripheral and coronary artery disease (2001) (0)
- Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms (2022) (0)
- Abstract 12578: Stroke Prophylaxis After US Emergency Department Diagnosis and Discharge of Patients With Atrial Fibrillation and Flutter (2019) (0)
- Antihypertensive Treatment Trials: Quality of Life (2005) (0)
- A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure (2022) (0)
- Preface [Hot Topic: Antihypertensive Drugs (Executive Editor : Gregory Y.H. Lip)]. (2003) (0)
- ’ Choice in the 60 th Anniversary Year of Thrombosis and Haemostasis : Past , Present and Future (2017) (0)
- What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for Ventricular Tachycardia and Sudden Cardiac Death. (2022) (0)
- Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study (2023) (0)
- Triple or dual antithrombotic therapy post‐percutaneous coronary intervention: Which one is better? (2019) (0)
- Faculty Opinions recommendation of Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current. (2016) (0)
- Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia. (2023) (0)
- P3759Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry (2019) (0)
- Relationship Between Occult AF Detected on Long-Term Monitoring How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring (2016) (0)
- Atrial Fibrillation in Practice (2002) (0)
- Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (2014) (0)
- P3472Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study (2019) (0)
- Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis. (2022) (0)
- Average Effects of New Oral Anticoagulants Versus Warfarin. (2014) (0)
- Stroke prevention in atrial fibrillation: changing concepts (2015) (0)
- Discussion: Contemporary guidelines on implantable cardioverter defibrillator (ICD) therapy do not specifically address recommendations for secondary prevention after life-threatening ventricular arrhythmias due to vasospasm. The arrhythmic risk of coronary vasospasm (2020) (0)
- Regular exercise after a diagnosis of atrial fibrillation and lower risks of cardiovascular disease: a nationwide population-based study (2020) (0)
- Hypertension does not significantly alter abnormalities of haemorheology, endothelial dysfunction and thrombogenesis in acute stroke: the West birmingham stroke project. (1999) (0)
- Long-term Management Considerations for Retinal Artery Occlusion and Cardiovascular and Cerebrovascular Mortality. (2023) (0)
- Stroke Prevention in Atrial Fibrillation (2022) (0)
- Cancer and ethnic minorities. (2002) (0)
- Continuation or discontinuation of oral anticoagulants after an increase in HAS-BLED scores and the risks of clinical outcomes in patients with atrial fibrillation. a nationwide cohort study (2020) (0)
- Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men. (1998) (0)
- Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes? (2011) (0)
- Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease (2019) (0)
- Antithrombotic therapy in chronic liver disease: to clot or not to clot (2021) (0)
- P3850Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores (2018) (0)
- C0378: The Predictive Value of the SAME-TT2R2 Score for Anticoagulation Control and Adverse Outcomes in Anticoagulated Patients with Atrial Fibrillation (2014) (0)
- Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fi brillation : a prospective multicentre cohort study (2015) (0)
- ORIGINAL ARTICLE Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis (2022) (0)
- Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation ( CS‐SPAF ) (2023) (0)
- Relationship of particular matter and temperature on the risk of adverse events in atrial fibrillation patients (2020) (0)
- P670Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function (2018) (0)
- Alterations of Thrombogenesis, Endothelial Damage and Platelet Function following Percutaneous Peripheral Artery Angiography and Angioplasty (2002) (0)
- What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes (2015) (0)
- New use for an old drug: Metformin and atrial fibrillation (2022) (0)
- Author response for "Metabolically Healthy Obesity and Cardiovascular Events. A Nationwide Cohort Study" (2021) (0)
- Modified lipids from LDL in the blood during mid-life increase blood brain barrier permeability (2013) (0)
- Abstract 11219: Risk of Major Bleeding in Different Indications for New Oral Anticoagulants: Insights From a Meta- Analysis of Approved Dosages From 48 Randomized Trials (2013) (0)
- Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function (2016) (0)
- Editor´s choice articles 2008–2009 (2010) (0)
- ANTICOAGULATION USE VARIES BY REGION IN PATIENTS WITH RECENT DIAGNOSIS OF ATRIAL FIBRILLATION: GLORIA-AF PHASE III DATA (2021) (0)
- Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial (2021) (0)
- Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol (2022) (0)
- Modification of coagulation and fibrinolysis factors (2017) (0)
- Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial (2022) (0)
- Letter to the Editor (1998) (0)
- Impact of body mass index on outcomes in European patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term registry (AFGen LT) (2020) (0)
- Incidence of atrial fibrillation in cancer patients according to cancer type (2020) (0)
- Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and Mendelian randomization analysis (2022) (0)
- Rate control in atrial fibrillation (2017) (0)
- Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study (2015) (0)
- Aalborg Universitet Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation nationwide cohort study (2015) (0)
- Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? (2022) (0)
- National trends of use of oral anticoagulants and severities of stroke among patients with atrial fibrillation (2020) (0)
- Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry (2022) (0)
- An unlikely Wells rule score (1) plus a negative d-dimer result excluded DVT in noncancer patients (2014) (0)
- Rate control and digoxin (2007) (0)
- USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY (2019) (0)
- Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation? (2020) (0)
- Abnormal Platelet and Endothelial Function in Hypertensives with Target Organ Damage (2000) (0)
- Trisomy X (2020) (0)
- Antazoline: the Lazarus of antiarrhythmic drugs? (2022) (0)
- Management strategies for atrial fibrillation (2000) (0)
- Faculty Opinions recommendation of Idarucizumab for dabigatran reversal. (2016) (0)
- 126 Safety and effectiveness of acute heart failure care as outpatient (safe): a meta-analysis of studies comparing outpatient based management with standard inpatient care (2022) (0)
- Associations between serum triglycerides and abdominal aortic calcification in a cross-sectional study from the United States of America (2021) (0)
- Stroke prevention. (2004) (0)
- Paroxysmal atrial fibrillation (2001) (0)
- Retinal and Peripheral Micro-vascular Reactivity in Patients Suffering From Coronary Artery Disease (2009) (0)
- Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial (2018) (0)
- Influence of age on respiratory modulation of muscle sympathetic nerve activity and blood pressure in humans (2013) (0)
- Rheumatoid Arthritis and Arterial Baroreflex Function (2013) (0)
- University of Birmingham The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality (2021) (0)
- Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: Impact of atrial fibrillation. (2022) (0)
- Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis (2021) (0)
- An audience with... Gregory Lip. Interview by Asher Mullard. (2012) (0)
- Salivary cortisol and cortisone in healthy children and young people (2022) (0)
- Cryoablation as Initial Therapy for Atrial Fibrillation. (2021) (0)
- 45 Rivaroxaban vs. dabigatran or warfarin in real-world observational studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis (2017) (0)
- P4789Comparisons of direct oral anticoagulants and warfarin in patients with atrial fibrillation and liver cirrhosis (2019) (0)
- Salivary adrenal biomarkers differ depending on age and sex in healthy children: preliminary data (2022) (0)
- Determining the use of smart watches to detect irregular heart rhythms for people following a stroke (2022) (0)
- Haematocrit and urine volume response to acute intravenous saline and oral water loading in normal volunteers (2008) (0)
- Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches (2018) (0)
- P3784Impact of progressively impaired renal function on major adverse outcomes in European patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry (2019) (0)
- Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
- Crizanlizumab (2021) (0)
- P2568Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study (2018) (0)
- Response to Letter by De Silva et al (2009) (0)
- P-90: Soluble P-selectin, a marker of platelet activation, is related to plasma homocyst(e)ine in ‘high risk’ hypertensives (2001) (0)
- Community screening for atrial fibrillation in the era of smart devices. (2019) (0)
- Editors’ Choice papers in Thrombosis and Haemostasis (2015) (0)
- Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation (2021) (0)
- P3789Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction (2019) (0)
- Atrial fibrillation Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis (2016) (0)
- Reply (2001) (0)
- What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK? (2020) (0)
- Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry (2021) (0)
- Assessing endothelial function in patients with atrial fibrillation and hypertension using flow mediated dilatation: does atrial fibrillation add anything? (2020) (0)
- HORMONE REPLACEMENT THERAPY AND AF IN POSTMENOPAUSAL WOMEN: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE (NIS) DATABASE AND (2022) (0)
- Heart Disease in Pregnancy (1997) (0)
- Prior aspirin therapy and cardiovascular implantable electronic device infections. (2013) (0)
- Safety and effectiveness of dabigatran in patients with atrial fibrillation with and without prior stroke: Data from the gloria-af registry program (2018) (0)
- Ambulatory blood pressure monitoring in patients with single chamber ventricular pacemakers (VVI pacing mode) (1996) (0)
- Response to: The Cause of the Arteriolar Injury in Malignant Hypertension. (2017) (0)
- Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study (2023) (0)
- AP19-00781 Abstract View (2019) (0)
- Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines (2006) (0)
- Review Article Fibrinolytic function and atrial fibrillation (2003) (0)
- A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy (2009) (0)
- Hypertension to heart failure: new developmental strategies do not cross a clinical and therapeutic divide. (2003) (0)
- Soluble adhesion molecule P-selectin and beta-thromboglobulin as markers of platelet activation in hypertension (1998) (0)
- How to choose the best NOAC for patients with atrial fibrillation (2015) (0)
- Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project (2022) (0)
- The Atrial fibrillation Better Care (ABC) pathway is associated to a lower incidence of cardiac complications in patients with atrial fibrillation: a report from the ATHERO-AF study (2020) (0)
- Clinical Risk of Stroke in Atrial Fibrillation is Unrelated to Platelet Activation (2002) (0)
- Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients? (2018) (0)
- Long-term risk of cardiovascular implantable electronic device re-interventions following external cardioversion of atrial fibrillation and flutter - a nationwide cohort study. (2023) (0)
- University of Birmingham Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation (2014) (0)
- Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications. (2018) (0)
- P-605: Endothelial damage/dysfunction is not related to pulse pressure in patients with coronary artery disease (2003) (0)
- Implications of new-onset atrial fibrillation for in-hospital and long-term prognosis in patients with acute myocardial infarction: the CBD Bank study (2020) (0)
- 430 Measuring blood pressure in children and adolescents: 20 years of change (2022) (0)
- Thrombogenesis, angiogenesis, and endothelial function in hypertension (2002) (0)
- P2243The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial (2018) (0)
- Clinical Implications of the Stroke Prevention in Atrial Fibrillation III Trial: A Clinician's Perspective (1998) (0)
- Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial (2022) (0)
- The Patient-physician Relationship: Experiences of Atrial Fibrillation and Anticoagulation Therapy (2014) (0)
- University of Birmingham Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? (2015) (0)
- Anticoagulation control in atrial fibrillation patients with chronic kidney disease receiving warfarin for stroke prevention: The west Birmingham AF project (2021) (0)
- Chapter 89 – Antithrombotic Therapy in Hypertension (2007) (0)
- Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: Observations from a large diversified multimorbid cohort (2022) (0)
- PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (2016) (0)
- Diagnosis, Clinical Assessment and Sequelae of Hypertension (2005) (0)
- University of Birmingham Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (2014) (0)
- Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer (2021) (0)
- Effectiveness and safety of novel oral anticoagulants among patients with nonvalvular atrial fibrillation and diabetes: A pooled claims database analysis (2018) (0)
- University of Groningen Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey) Erkuner, (2018) (0)
- Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease - The Silesia Diabetes-Heart Project. (2023) (0)
- The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: The Liverpool AF-Falls Project. A systematic review and meta-analysis (2022) (0)
- Increased platelet adhesion in metastatic cancer (2003) (0)
- Initiation of Warfarin is associated with Decreased Mortality in Patients with Infective Endocarditis: A Population-Based Cohort Study (2023) (0)
- RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS (2007) (0)
- Lifestyle Modifications and Value of Nondrug Therapy (2005) (0)
- The Year in Hypertension 2002 (2003) (0)
- Abstract 16732: Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients (2014) (0)
- P1026Risk factors for the occurrence of stroke after atrial fibrillation ablation (2019) (0)
- Future directions in antiplatelet therapy: efficacy versus safety (2009) (0)
- Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system (2022) (0)
- Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke (2023) (0)
- Aspirin, clopidogrel or both in atrial fibrillation patients on oral anticoagulation following an acute coronary event (2013) (0)
- Fast Fourier Transform of Retinal Blood Vessel Structure as a Methodology for Detection of Structural Change in Smokers and Individuals With Coronary Artery Disease (2010) (0)
- P2905Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry (2018) (0)
- Stroke-heart syndrome: sex-specific incidence, risk factors, and major adverse cardiovascular events in 486,515 patients with incident ischaemic stroke (2022) (0)
- SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM (2016) (0)
- Chapter 10 Peripheral vascular diseases (2011) (0)
- Features of Clinical Complexity in European Patients with Atrial Fibrillation: A Report from a European Observational Prospective AF Registry. (2023) (0)
- Relationship between Low-Density Lipoprotein Cholesterol, Lipid Lowering Agents and the Risk of Stroke: A meta-analysis of Observational studies (n=355,591) and Randomized Controlled Trials (2022) (0)
- Abstract 20207: Lower Risk in Young Patients Aged < 50 With Atrial Fibrillation and Low CHA2DS2-VASc Risk Score (2017) (0)
- Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis (2022) (0)
- The Impact of Smoking on Thromboembolism and Mortality in Patients with Atrial Fibrillation: The Diet, Cancer and Health Study (2012) (0)
- Endothelin binding and calcium signalling in hypertension. (2002) (0)
- Increased arterial stiffness amongst healthy South Asians in the United Kingdom in the absence of raised blood pressure (2007) (0)
- P2567Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study (2018) (0)
- Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage? (2011) (0)
- Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
- MYOCARDIAL BRIDGING (2000) (0)
- Faculty Opinions recommendation of A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran. (2016) (0)
- University of Birmingham Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation (2017) (0)
- Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation (2018) (0)
- Thromboembolic risk dynamics, integrated care management and outcomes in patients with atrial fibrillation: a proof-of-concept analysis from the SPORTIF trials (2022) (0)
- P4768Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study (2019) (0)
- CONGENITAL HEART DISEASE Quality of life in adults with congenital heart disease (2002) (0)
- Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making. (2022) (0)
- 5743Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry (2017) (0)
- Antithrombotic therapy: what the dental surgeon has to know (2010) (0)
- Hypertensive Heart Disease or Acute Coronary Syndrome? (2000) (0)
- When should we start thromboprophylaxis (2016) (0)
- Cardioversion and the endothelium in atrial fibrillation. (2006) (0)
- Cardioversion of atrial fibrillation (1996) (0)
- P-383: Increased left ventricular mass index and pulse pressure are related to echocardiographic indices of left ventricular diastolic dysfunction (2003) (0)
- P2896Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF (2018) (0)
- Bleeding and thrombotic events in patients with atrial fibrillation and cancer: a systematic review and meta-regression analysis (2022) (0)
- Associations of exercise-based cardiac rehabilitation with all-cause mortality among patients with atrial fibrillation (2021) (0)
- University A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s (SAFE) (2004) (0)
- Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies. (2021) (0)
- P4783Treatment persistence of patients with atrial fibrillation on VKA or NOAC: Data from GLORIA-AF Phase III 1-year interim analysis (2019) (0)
- 92 High heart rate predicts cardiac fibrosis in patients with atrial fibrillation and preserved left ventricular function (2018) (0)
- Calcium antagonists in diabetic hypertension (2001) (0)
- P5140Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program (2018) (0)
- Risk factors for silent and symptomatic atrial fibrillation in an elderly population screening programme:a report from the noninvasive monitoring for early detection of atrial fibrillation (NOMED-AF) (2020) (0)
- Thromboembolic events and major bleeding with warfarin, non-vitamin K antagonist oral anticoagulants or antiplatelets following mitral valve repair: A systematic review and meta-analysis (2022) (0)
- Treatment ofatrial fibrillation inadistrict general hospital (1994) (0)
- Reply (2019) (0)
- University of Birmingham Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: (2017) (0)
- The Eye and Hypertension (2005) (0)
- Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy – A Multicenter Study (2017) (0)
- Chapter 2 Clinical presentations (2011) (0)
- Association between serum potassium levels and short-term mortality in out-of-hospital cardiac arrest survivors (2022) (0)
- Anthropometric discriminators of the risk of high blood pressure amongst public schoolchildren in Gujarat, India (2012) (0)
- P662Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials (2019) (0)
- P1196Increasing trends in hospital-care burden of atrial fibrillation in korea, 2006 through 2015: implications for healthcare planning (2018) (0)
- Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19 (2022) (0)
- 157 CD14++CD16+CCR2+ monocytes are increased in diffuse coronary artery disease (2015) (0)
- Time saving, simple and reproducible method to quantify left ventricular function in patients with atrial fibrillation (2020) (0)
- 512 ETHNIC DIFFERENCES IN CIRCULATING MARKERS OF ANGIOGENESIS AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND PERIPHERAL ARTERIAL DISEASE (2011) (0)
- 1199Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients (2018) (0)
- Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393–1401 (2021) (0)
- P835Prognosis in patients with atrial fibrillation and sinus node disease in a community based cohort study (2017) (0)
- Risk of atrial fibrillation in young adults aged 20 to 39 years with isolated diastolic, isolated systolic, and systolic-diastolic hypertension: a nationwide population-based study (2021) (0)
- GENDERED SOCIAL DETERMINANTS OF HEALTH AND RISK OF MAJOR ADVERSE OUTCOMES IN ATRIAL FIBRILLATION (2023) (0)
- WO16-OR-6 SECULAR TRENDS IN THE CARDIOVASCULAR RISK PROFILE AND MORTALITY OF STROKE ADMISSIONS IN AN INNER CITY MULTI ETHNIC POPULATION (2007) (0)
- Impact of mental disease on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study (2022) (0)
- Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation (2019) (0)
- Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter. (2019) (0)
- Potential drug interactions in heart disease. (1992) (0)
- Effects of Treatment with ACE Inhibitors and Beta-Blockers on Haemorheological and Endothelial Markers in Chronic Heart Failure (2000) (0)
- INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (2017) (0)
- a repository of Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation . (2018) (0)
- The effectiveness of atrial fibrillation identification using non-invasive long-term ECG monitoring system (NOMED AF TECH). (2023) (0)
- Comprar Problem Solving In Cardiology | Lim | 9781846920462 | Clinical Pub. (2010) (0)
- Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study (2021) (0)
- P3597Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials (2017) (0)
- EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS (2019) (0)
- Aalborg Universitet Management of atrial fibrillation in specific patient populations a state of the art review (2016) (0)
- Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies. (2018) (0)
- Chapter 5 Ischaemic heart disease (2011) (0)
- P-95: Does pulse pressure influence the hypercoagulable state in nonvalvular atrial fibrillation? (2001) (0)
- New oral anticoagulants: the evidence base and role in patients undergoing percutaneous coronary intervention (2018) (0)
- Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry. (2023) (0)
- Cardioversion of Atrial Fibrillation Reduces Intravascular Fibrin Turnover and Thrombogenesis (1994) (0)
- Symptom status, clinical subtypes and prognosis in Middle East patients with atrial fibrillation: a report from the Gulf-SAFE registry (2020) (0)
- University of Birmingham Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks (2017) (0)
- P5829Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events (2017) (0)
- Renal adiponectin as a biomarker of kidney disease in stable anticoagulated atrial fibrillation patients (2013) (0)
- 28Left atrial voltage predicts AF recurrence after ablation, irrespective of the rhythm during mapping, while circulating biomarkers of fibrosis do not. (2017) (0)
- P5 COMMON CAROTID INTIMA MEDIA THICKNESS IS INDEPENDENTLY ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE IN UK 1ST GENERATION ASIAN AND BLACK MIGRANTS (2010) (0)
- APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage. (2022) (0)
- Performance of the C2HEST score to predict sustained atrial high-rate episodes in patients implanted with cardiac implantable electronic device (2021) (0)
- Spironolactone versus placebo for patients experiencing heart failure with preserved ejection fraction: The IMPRESS-AF randomized controlled trial (2020) (0)
- Cancer and atrial fibrillation. Author's reply. (2019) (0)
- Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis (2022) (0)
- The Relation of Epicardial Adipose Tissue and Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project (2021) (0)
- Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women (2022) (0)
- Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation". (2020) (0)
- Lead editorial – Atrial fibrillation and stroke risk (2012) (0)
- Relation of the CHA(2)DS(2)-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study) (0)
- The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients. (2023) (0)
- The Year in Hypertension 2003 (2003) (0)
- Impacts of off-label dosing noacs on clinical outcomes in very elderly patients with atrial fibrillation (2021) (0)
- Hormone replacement use and cardiovascular function and structure in postmenopausal women (2005) (0)
- What Cannot Be Missed: Important Publications on Electrophysiology in 2021 (2022) (0)
- A 10-year prospective study of estimated glomerular filtration rate and outcomes with oral anticoagulation in patients with atrial fibrillation (2013) (0)
- P1717Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2017) (0)
- Acute dental infections and cardiac arrhythmias: a systematic literature review and case report (2020) (0)
- Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2 (2020) (0)
- 3052Non-vitamin K antagonist oral anticoagulants are safe and effective alternatives to warfarin across subgroups by renal function: results from Danish registries (2019) (0)
- PO16-468 ETHNIC DIFFERENCES IN RATES OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH HYPERTENSION ARE EXPLAINED BY AN EXCESS OF DIABETES (2007) (0)
- Meta-analysis finds exercise training is safe in people with heart failure and left ventricular dysfunction. (2004) (0)
- Management and Treatment in General and in Special Populations (2005) (0)
- Direct Thrombin Inhibitors (2016) (0)
- Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study (2022) (0)
- 5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (2017) (0)
- Dronedarone (Multaqa®) for the treatment of atrial fibrillation (2011) (0)
- Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review) (2022) (0)
- Abstract 12011: Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry (2016) (0)
- Hemodynamics, Circulation, and the Vascular Tree in Hypertension (2005) (0)
- Matrix metalloproteinases in atrial fibrillation. (2004) (0)
- Relationship of vitamin D deficiency to cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: The Silesia Diabetes-Heart Project. (2023) (0)
- Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure?: Alpha-Adrenergic Receptor Antagonists Revisited. (2018) (0)
- 98Screening for atrial fibrillation in primary care using the alivecor device: AF incidence, feasibility and patient acceptability (2018) (0)
- Monocyte Subsets and Their Relevance to Cardiovascular Diseases Series (2009) (0)
- Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study (2022) (0)
- The diagnostic role of cardiac troponin I beyond acute myocardial infarction (2023) (0)
- Atrial Fibrillation and Oral Health (2021) (0)
- Guidelines on the pharmacological management of hypertension (2015) (0)
- Letters (1999) (0)
- P3618Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey (2017) (0)
- Changes at the Journal of Human Hypertension (1997) (0)
- POSITIVE EFFECT OF A LOW DOSE COMBINATION OF PERINDOPRIL/INDAPAMIDE ON THE D-DIMERS AND THE ENDOTHELIAL FACTORS IN HYPERTENSIVE PATIENTS: P2.340 (2004) (0)
- Education programme to help improve patient's knowledge and understanding of atrial fibrillation and warfarin control in Thailand (2020) (0)
- Beta-trace protein and prognosis in anticoagulated patients with atrial fibrillation (2013) (0)
- Macrolide antibiotics do not reduce mortality or adverse clinical events in coronary heart disease (2003) (0)
- onocyte Diversity in yocardial Infarction * (0)
- 1208 FEASIBILITY OF A PHARMACIST-LED INTERVENTION FOR ATRIAL FIBRILLATION IN LONG-TERM CARE: THE PIVOTALL STUDY (2023) (0)
- Disparities in atrial fibrillation management: Is race to blame? (2021) (0)
- Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database (2022) (0)
- Prediction of long-term net clinical outcomes using the TIMI-AF score : Comparison with CHA 2 DS 2-VASc and HAS-BLED Cover title : Prediction of net clinical outcomes by the TIMI-AF (2017) (0)
- Hypertension, Platelets, and the Endothelium (2003) (0)
- Atrial fibrillation (chronic). (2015) (0)
- Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation (1969) (0)
- Effect of perindopril/indapamide versus atenolol on angiogenesis and endothelial function in essential hypertension (2004) (0)
- ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE? (2015) (0)
- Re: Measurement of defect angle in superior semicircular canal dehiscence. A reply (2010) (0)
- Aalborg Universitet Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion (2018) (0)
- W03-P-003 Circulating endothelial cells in acute ischaemic stroke (2005) (0)
- CIRCULATING ADIPONECTIN REFLECTS SEVERITY OF CORONARY ATHEROSCLEROSIS, BUT NOT - CARDIAC FUNCTION ABNORMALITIES (2008) (0)
- A025: Placebo lowers blood pressure in isolated systolic hypertension but not systolic/diastolic hypertension (2000) (0)
- Impact on outcomes in Europe: a cluster analysis from the ESC-EHRA EORP AF general long-term registry (2021) (0)
- P-494: Ethnic differences in the prevalence of left ventricular hypertrophy among hypertensives vary with electrocardiographic criteria (2001) (0)
- Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review (2021) (0)
- Lipid lowering therapy and coronary heart disease risk assessment in general practice (2001) (0)
- 102 Ethnic differences in endothelial function in chronic heart failure (2011) (0)
- Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database (2022) (0)
- Chapter 9 Pericardial diseases (2011) (0)
- P-647: Endothelial damage and angiogenesis in high-risk hypertesive patient: Relation to risk factors (2001) (0)
- P968Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study (2018) (0)
- Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation (2017) (0)
- P665Incidence and predictors of intracerebral haemorrhage recurrence in patients with and without atrial fibrillation: a cohort study (2019) (0)
- Looking through the PRISM: New Insights for Young Patients with Atrial Fibrillation and Stroke (2011) (0)
- Heterotopic heart transplantation. (2005) (0)
- Chapter 7 Valvular heart diseases (2011) (0)
- Long-Term Followup following Surgical Correction of Tetralogy of Fallot (1997) (0)
- Clinical outcomes related to fasting plasma glucose variability, history of diabetes mellitus and antidiabetic regimens in patients with atrial fibrillation: a subgroup analysis from the SPORTIF trial (2020) (0)
- Multi-Morbidity, Anti-Thrombotic Treatment, and Mortality Among the Elderly Non-Valvular Atrial Fibrillation Patients: Results from the KERALA-AF Registry Study (2022) (0)
- S-10-5: OPTIMAL BLOOD PRESSURE AND CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH ATRIAL FIBRILLATION (2023) (0)
- Relationship Between Stroke Relative Risk and Change in Systolic Blood Pressure: The Misuse of Meta-Regression (2004) (0)
- Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch? (2020) (0)
- 1009Body mass index variability and long-term risk of new-onset atrial fibrillation in the general population: a korean nationwide cohort study (2018) (0)
- CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY (2014) (0)
- Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke (2022) (0)
- The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study (2022) (0)
- The Birmingham Hypertension Square, the St George's Star and Imploding Diamond and the Melbourne Aide Memoire (1999) (0)
- P6074Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry (2018) (0)
- Aalborg Universitet Decision-Making in Clinical Practice (2016) (0)
- Impact of cumulative burden of body mass index and waist circumference on risk of atrial fibrillation: an analysis of 3,700,000 participants who underwent 4-year consecutive annual health examination (2021) (0)
- Author's reply (1996) (0)
- Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation. (2012) (0)
- Raised arterial blood pressure exacerbates diastolic dysfunction in diabetes mellitus independent of atherosclerosis (2004) (0)
- Anticoagulant selection in relation to the SAMe-TT 2 R 2 score in patients with atrial fi brillation: The GLORIA-AF registry Hellenic Journal of Cardiology (2021) (0)
- Effects of Cardiovascular Drug use in Early Stage Pregnancy (1995) (0)
- ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES (2018) (0)
- Fibromuscular dysplasia (1997) (0)
- EDITORIAL ALCOHOL AND HYPERTENSION: AN OLD RELATIONSHIP REVISITED (2006) (0)
- Cardiovascular events in metabolically healthy obese. A nationwide cohort study (2021) (0)
- P34 The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial (2018) (0)
- Common clinical indications for anticoagulation (2010) (0)
- Association between thromboembolic and bleeding risk with adverse outcomes in contemporary European atrial fibrillation patients: final analysis from the ESC-EHRA EORP AF general long-term registry (2021) (0)
- Design and baseline characteristics of a hypertension intervention program in a South African village: patient awareness and understanding of their disease process are important. (1996) (0)
- Health economic consequences of resuming anticoagulation after intracranial hemorrhage in patients with atrial fibrillation (2016) (0)
- Principles of Individualized Hypertension Management (2005) (0)
- All-cause mortality and cardiovascular death in 52091 patients with hypertrophic cardiomyopathy. A nationwide cohort study (2021) (0)
- Lone atrial fibrillation (2000) (0)
- Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer? (2014) (0)
- Short Runs of Atrial Arrhythmia and Stroke Risk: A European-Wide Online Survey among Stroke Physicians and Cardiologists (2016) (0)
- Abstract 14762: Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (2016) (0)
- Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk (2008) (0)
- P4017Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation (2017) (0)
- Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study (2023) (0)
- Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population (2022) (0)
- S130 Continuous positive airway pressure (CPAP) compliance in obstructive sleep apnoea/obesity hypoventilation syndrome patients: can we use digital data to identify predictors of compliance? (2021) (0)
- The Management of Anticoagulants in Patients With Atrial Fibrillation and History of Falls or Risk of Falls: The Liverpool Af-falls Project. Protocol for a Systematic Review and Meta-analysis (2021) (0)
- The effect of home-based versus hospital-based cardiac rehabilitation on 24-hour ambulatory blood pressure and lipid profile in patients with coronary heart disease: the birmingham rehabilitation uptake maximisation study (BRUM) (2004) (0)
- 64Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation (2019) (0)
- University of Birmingham Risk of major bleeding in different indications for new oral anticoagulants (2014) (0)
- Vascular Endothelial Growth Factor (VEGF) and Soluble Flt-1 (SFLT-1) in Patients with Atherosclerotic Vascular Disease (2000) (0)
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: The dose subgroup analysis of the ARISTOPHANES study (2019) (0)
- Abstract 18967: Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients (2014) (0)
- 123CMRI-assessed left ventricular extra-cellular volume fraction, not left atrial late gadolinium uptake, is related to higher left atrial pressure and increased type 1 collagen telopeptide levels in pre-ablation AF patients (2017) (0)
- Authors’ reply to Beales (2016) (0)
- Correction to: Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (2018) (0)
- PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease (2013) (0)
- Oral Anticoagulant Management in Sub-Saharian African Patients with Mechanical Heart Valves: Observations on Quality of Anticoagulation and Thrombotic Risk (2022) (0)
- Prognostic impact of renal function trajectories and temporal variability amongst anticoagulated atrial fibrillation patients: a subgroup analysis of the SPORTIF III and V trials (2020) (0)
- Risk factors for mortality in acute myocardial infarction (2002) (0)
- 81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis (2017) (0)
- A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
- University Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population (2003) (0)
- The Effect of Intensified Blood Pressure Treatment on Endothelial Function and Vascular Endothelial Growth Factor. An Index of Angiogenesis in High-Risk Hypertensives (2001) (0)
- Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation (2021) (0)
- Markers of the prothrombotic state are not increased with severity of atherosclerotic disease (2002) (0)
- PRECEDENT AND INCIDENT ATRIAL FIBRILLATION ARE ASSOCIATED WITH INCREASED MORTALITY IN PULMONARY EMBOLISM: FINDINGS FROM A MULTINATIONAL COHORT STUDY (2020) (0)
- Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
- Commonly used anticoagulant and antiplatelet drugs: aspirin, heparin and warfari (2005) (0)
- P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (2018) (0)
- Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 (2023) (0)
- Abstract 15462: Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial (2017) (0)
- High bodyweight variability and increased risk of atrial fibrillation in patients with type 2 diabetes mellitus (2020) (0)
- Subclinical thyroid dysfunction and incident atrial fibrillation - a systematic review and meta-analysis (2021) (0)
- Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study (2023) (0)
- Atrial pacing was better than ventricular pacing for the sick-sinus syndrome (1998) (0)
- IDIOPATHIC DEEP VEIN THROMBOSIS AND THE DURATION OF LOW-INTENSITY WARFARIN. (2017) (0)
- Review: Combining 2 classes of blood pressurelowering drugs has an approximately additive effect on systolic blood pressure (2009) (0)
- Atrial fibrillation and surgery (2000) (0)
- Eventos clínicos en pacientes con fibrilación auricular y un control de anticoagulación apropiado (2019) (0)
- Predicting silent atrial fibrillation in the elderly – NOMED-AF study (2021) (0)
- Free and Vascular Endothelial Growth Factor (VEGF) Complexed Soluble Receptor FLT-1 in Patients with Cardiovascular Disease (2001) (0)
- Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (2022) (0)
- Impaired endothelial function may underlies increased arterial stiffness in South Asian stroke survivors compared to European Caucasians counterparts in the United Kingdom (2008) (0)
- Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response (2020) (0)
- Anticoagulation uptake in emergency department patients with atrial fibrillation. (2003) (0)
- Ethnic differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and peripheral arterial disease (2011) (0)
- Acute atrial fibrillation. (2002) (0)
- Face to face with basic and clinical research in Thrombosis and Haemostasis (2008) (0)
- Letter to the Editor (1995) (0)
- Expression of Angiopoietin and Tie 2 in Human Atherosclerotic Arteries: A Possible Contribution to Atherogenesis (2001) (0)
- University of Birmingham Premature cardiac ageing in South Asian compared to Afro-Caribbean subjects in a community based screening study (2016) (0)
- Percutaneous Balloon Valvuloplasty for Congenital Pulmonary Stenosis in Adults (1997) (0)
- Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors (2022) (0)
- P-253: Lack of an independent effect of blood pressure on the hypercoagulable state in 1338 patients with atrial fibrillation (2002) (0)
- Increased venous and intra-atrial appendicular blood plasma levels of tissue factor-exposing extracellular vesicles in atrial fibrillation patients (2018) (0)
- P4769Optimal rivaroxaban dose in Asian patients with atrial fibrillation and normal or mildly impaired renal function (2019) (0)
- Blood pressure control and prevention of stroke (2006) (0)
- Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men (2021) (0)
- 208Effect of hypertension duration and systolic blood pressure on dementia in patients with atrial fibrillation (2019) (0)
- Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. (2022) (0)
- Physical activity score differences amongst Indo-Asian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England (2000) (0)
- Machine learning prediction of mortality in venous thromboembolism patients: the Birmingham Black Country Venous Thromboembolism (BBC-VTE) cohort (2021) (0)
- Epidemiology of Hypertension (2005) (0)
- Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (2021) (0)
- Changes in antithrombotic treatment in patients with abdominal aortic aneurysmal disease and incident atrial fibrillation: a population-based case-crossover analyses (2021) (0)
- Identifying at-risk subjects for sustained atrial high-rate episodes using the C2HEST score: the West Birmingham AF project (2020) (0)
- P-384: Carotid and brachial intima-media thickness are related to echocardiographic left ventricular mass index in patients with coronary artery disease with and without hypertension (2003) (0)
- Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights (2022) (0)
- Detection, Treatment, and Control of Hypertension in the General Population (2005) (0)
- Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets (2015) (0)
- Casebook: dyspnoea. (2003) (0)
- Increasing age as a major determinant of major adverse outcomes in patients with atrial fibrillation: the EURObservational research programme in atrial fibrillation general long-term registry (2020) (0)
- History, Definitions and Epidemiology (2005) (0)
- 2258Peripheral arterial disease in a cohort of atrial fibrillation patients. The Atrial Fibrillation Follow Up Investigation Of Rhythm Management (AFFIRM) study (2017) (0)
- Prevalence and impact of frailty in patients with atrial fibrillation: a systematic review and meta-analysis (2021) (0)
- STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY (2016) (0)
- Increased Plasma Fibrinogen and Fibrin D-Dimer Levels in Patients with Left Ventricular Aneurysms: A Mechanism for Thromboembolism? (1993) (0)
- Percutaneous Coronary Intervention in the Patient on Oral Anticoagulation (2014) (0)
- 328 IMPACT OF INTEGRATED CARE WITH ABC PATHWAY IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: DATA FROM MORE THAN 11000 PATIENTS ENROLLED IN A EUROPEAN REGISTRY (2022) (0)
- P5342The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry (2017) (0)
- Defining a hypertensive crisis (1999) (0)
- Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial. (2022) (0)
- EVALUATION OF EFFECTIVENESS AND SAFETY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS WHO SWITCHED FROM WARFARIN TO DIRECT ORAL ANTICOAGULANTS FROM MULTIPLE HEALTH CARE CLAIMS DATABASES (2023) (0)
- The Change in Endothelial Damage and Vascular Endothelial Growth Factor An Index of Angiogenesis, following Intensified Blood Pressure Treatment in High-Risk Hypertensives (2001) (0)
- Effect of cardiorenal syndrome and its different subtypes on incidence of atrial fibrillation in a nationwide analysis (2022) (0)
- Beta-blockers in heart failure patients with atrial fibrillation: Insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (2016) (0)
- Aalborg Universitet Time to therapeutic range ( TtTR ) , anticoagulation control , and cardiovascular events in vitamin K antagonists – naive patients with atrial fibrillation (2018) (0)
- P2298High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI (2018) (0)
- Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence. (2009) (0)
- Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation (2018) (0)
- Clinical features, presenting symptoms and complications of atrial fibrillation (2000) (0)
- Inflammaging: mechanisms and role in the cardiac and vasculature (2023) (0)
- OC11_04 Antithrombotic Therapy in Relation to Symptoms in Patients With Atrial Fibrillation: Observations From The Gloria-AF Registry Program (2016) (0)
- P2753Anticoagulation control and all-cause death in patients with operated valvular heart disease with and without atrial fibrillation receiving vitamin K antagonists (2019) (0)
- Chapter 4 Hypertension (2011) (0)
- THE IMPACT OF ATRIAL FIBRILLATION ON OUTCOMES OF PERIPHERAL ARTERIAL DISEASE: ANALYSIS OF ROUTINELY COLLECTED PRIMARY CARE DATA. (2021) (0)
- Von Willebrand Factor as Marker of Vascular Function in South African Women : The POWIRS Study. Commentary (2008) (0)
- Persistent atrial fibrillation and cardioversion (2000) (0)
- P5656Heart failure clinical phenotypes and outcomes in patients with atrial fibrillation: an analysis from the eurobservational research programme in atrial fibrillation long-term general registry (2019) (0)
- Stroke Prevention in Atrial Fibrillation (2022) (0)
- P2552Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis (2019) (0)
- The Association of Cardiovascular Risk Factors and Disease in People With HIV in the UK: A Retrospective Matched Cohort Study (2021) (0)
- Response. (2019) (0)
- Statins to Prevent Pacing-Induced Cardiomyopathy: Evidence from the Bench applied to Clinical Studies. (2022) (0)
- Changes in Magnesium and Zinc Concentrations following Thrombolysis in Acute Myocardial Infarction (1994) (0)
- Atrial fibrillation detection in ambulatory patients using a smart ring powered by deep learning analysis of continuous photoplethysmography monitoring (2022) (0)
- Chapter 147 – Atrial Fibrillation (2018) (0)
- Pharmacotherapy for atrial fibrillation: is rhythm control achievable? (2006) (0)
- Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer? (2006) (0)
- Abstract WP83: The Challenges Of Stroke Prevention Following Intracerebral Haemorrhage; A Qualitative Study Exploring Physicians’ Decision Making. (2022) (0)
- Poster Session 3 (2012) (0)
- Abstract 20670: Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation (2017) (0)
- Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk. (2022) (0)
- Airborne Occupational Exposure and ABO Phenotype: An Example of Gene–Environment Interaction in Ischaemic Heart Disease? (2002) (0)
- Case book: palpitations. (2001) (0)
- HYPERTENSION. (4) RECENT ADVANCES IN HYPERTENSION (1999) (0)
- Silent cerebral lesions in patients with non-valvular atrial fibrillation and structurally normal hearts (2013) (0)
- Chapter 3 Cardiac arrhythmias (2011) (0)
- Age, aerobic fitness and cerebral vascular reactivity to carbon dioxide (2015) (0)
- Effects of Discontinuing Hormone Replacement Therapy on Blood Pressure in Menopausal Women with Uncontrolled Hypertension (1995) (0)
- Supplementary Material for White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction (2016) (0)
- P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease (2019) (0)
- University Relation of the CHA2DS2-VASc score to risk of thrombotic and embolic stroke in community-dwelling individuals without atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study) (2018) (0)
- Reply (2020) (0)
- PO-640-07 SEVERITY OF METABOLIC SYNDROME AND INCIDENT END-STAGE RENAL DISEASE AMONG PATIENTS WITH AF (2022) (0)
- New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin? (2011) (0)
- Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease. (2019) (0)
- C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism (2014) (0)
- A New Era of Oral Anticoagulation in Atrial Fibrillation: Implications in Clinical Practice (2013) (0)
- Nondipping pattern of nocturnal blood pressure in patients with coronary heart disease is associated with abnormal diastolic left ventricular filling and higher ambulatory pulse pressure (2004) (0)
- Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation (2022) (0)
- P65 ARTERIAL STIFFNESS IN PAROXYSMAL ATRIAL FIBRILLATION: RELATIONSHIP WITH MICRO- AND MACROVASCULAR ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASE (2010) (0)
- Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF (2014) (0)
- Failed reperfusion with thrombolysis--the effect of a local environment? (2006) (0)
- Reply to Jolobe (2017) (0)
- GLYCEMIC STATUS UNDERLIES THE INCREASED ARTERIAL STIFFNESS AND IMPAIRED ENDOTHELIAL FUNCTION IN SOUTH ASIAN STROKE SURVIVORS IN THE UNITED KINGDOM (2008) (0)
- Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: A dose subgroup analysis of the ARISTOPHANES Study (2019) (0)
- EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: De fi nition, characterisation, and clinical implication $ , $$ Journal of Arrhythmia (2016) (0)
- Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios (2017) (0)
- Temporal changes in quality of life amongst European atrial fibrillation patients: relationship to all-cause mortality. A report from the ESC-EHRA EORP-AF General Long-Term Registry (2020) (0)
- Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators (2018) (0)
- The “obesity paradox” in patients with atrial fibrillation: Insights from the Gulf SAFE registry (2020) (0)
- 77 Preventing stroke in patients with atrial fibrillation and intracerebral haemorrhage: a qualitative study of physicians’ decision-making (2022) (0)
- Increased 5-year risk of stroke, atrial fibrillation, acute coronary syndrome and heart failure in out-of-hospital cardiac arrest survivors relative to population controls: a nationwide register-based (2020) (0)
- University of Birmingham Incident heart failure in patients with rheumatoid arthritis (2018) (0)
- Management of Hypertension in Cardiometabolic Syndrome and Diabetes with Associated Nephropathy (2005) (0)
- SERUM SOLUBLE FAS AND SOLUBLE FAS LIGAND IN HYPERTENSION IN PREGNANCY (2010) (0)
- Faculty Opinions recommendation of Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. (2008) (0)
- P2297How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation? (2018) (0)
- Depression, Anxiety, Knowledge, Beliefs About Medication and Quality of Life Among Newly Anticoagulated Atrial Fibrillation Patients (2019) (0)
- HYPERTENSION. (3) MANAGEMENT OF THE HYPERTENSIVE PATIENT (1999) (0)
- Physical activity in relation to endothelial dysfunction and angiogenesis in hypertension (2002) (0)
- Editors choice: recent highlights from the journal of human hypertension (2010) (0)
- University of Birmingham Uptake of evidence-based statin therapy among atrial fibrillation patients in China (2016) (0)
- Abstract W P189: Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores (2015) (0)
- Response to Savino and Halperin (2016) (0)
- From diabetes to metabolic syndrome: a viewpoint on an evolving concept. (2007) (0)
- Commentary: do angiotensin II receptor antagonists regress left ventricular hypertrophy? (1996) (0)
- Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study (2022) (0)
- Vascular Aging Indices in The Discrimination of Premature Coronary Artery Disease In South Asians (2010) (0)
- Number needed to treat for net effect of anticoagulation in atrial fibrillation (2021) (0)
- IMPACT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON RISK OF SERIOUS BLEEDING AND THROMBOEMBOLISM IN ATRIAL FIBRILLATION – A NATIONWIDE COHORT STUDY (2013) (0)
- University of Birmingham Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: (2018) (0)
- RelationshipbetweenMediterraneandietandtime in therapeutic range in atrial fibrillation patients taking vitamin K antagonists (2015) (0)
- Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial. (1997) (0)
- Review new concepts in pharmacotherapy for peripheral arterial disease (2021) (0)
- O050 Prior history of falls and risk of cardiovascular outcomes in atrial fibrillation:The Loire Valley Atrial Fibrillation Project (2014) (0)
- Antithrombotic therapy in atrial fibrillation (2000) (0)
- A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol. (2021) (0)
- Comprar Handbook Of Oral Anticoagulation | Shantsila, E. | 9781908517586 | Springer (2013) (0)
- Glucose regulation and cardiovascular health in children and young people (CYP) with primary adrenal insufficiency: preliminary data (GRACE study) (2021) (0)
- Abstract 13225: Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation? (2016) (0)
- (22) Changes IN CD36 expression and lipid metabolism in response to an oral glucose challenge in south Asians (2012) (0)
- Prediction of atrial fibrillation and sudden cardiac death in type 2 diabetic patients on insulin: a territory-wide observational cohort study (2021) (0)
- Faculty of 1000 evaluation for Reversal of anticoagulants: an overview of current developments. (2016) (0)
- Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis (2015) (0)
- Comparison of bleeding risk scores in patients with atrial fibrillation and cancer (2021) (0)
- Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system? (2006) (0)
- Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review (2022) (0)
- Management of atrial fibrillation – Authors' reply (2007) (0)
- Oral Contraceptive Pills, Hormonal Replacement Therapy, Pre-Eclampsia, and Hypertension (2005) (0)
- Amlodipine reduces platelet derived vegf and angiopoietin-1 in hypertension (2004) (0)
- Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?". (2016) (0)
- Left ventricular systolic dysfunction in rheumatoid disease. Authors' reply (2006) (0)
- Is endothelial function and vascular endothelial growth factor, an index of angiogenesis, affected by intensified blood pressure treatment in high-risk hypertensives? (2001) (0)
- Continuous infusion versus bolus injection of loop diuretics for congestive heart failure (2021) (0)
- P-260: Impact of blood pressure on coronary artery disease severity, endothelial damage and angiogenesis (2002) (0)
- Difficult hypertension management issues: hypertension and ethnicity (2010) (0)
- University of Birmingham Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation (2016) (0)
- Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals (1170.4) (2014) (0)
- Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS (2021) (0)
- 96 Safety and effectiveness of outpatient based acute heart failure care: a randomised controlled feasibility trial (2020) (0)
- 199 Autonomic function in resistant and malignant hypertension (2021) (0)
- P5350Atrial fibrillation prediction using P wave signal-averaged ECG in patients with embolic stroke of undetermined source (2019) (0)
- Cardiomyopathy in practice. (2002) (0)
- In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling (2020) (0)
- 80Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry (2017) (0)
- W03-P-001 Increased circulating endothelial cells in acute congestive heart failure: Comparison (2005) (0)
- Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated? (1999) (0)
- Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study (2022) (0)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention AF-PCI (2018) (0)
- ́ s choice articles 2008 – 2009 (2017) (0)
- Regular Article Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease: Relationship to ethnicity and disease severity (2003) (0)
- P1892Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study (2018) (0)
- Is Diastolic Dysfunction a Risk Factor for Thrombo-Embolic Risk in Cardiac Impairment? (1994) (0)
- Acute Q wave myocardial infarction (2016) (0)
- Regular reassessment of bleeding risk using the HAS-BLED score reduces bleeding outcomes in a prospective cohort: a report from the mAFA II clinical trial extension (2020) (0)
- Thromboembolic events and major bleeding in frail patients with incident atrial fibrillation: a nationwide cohort study (2020) (0)
- Author Correction: Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (2021) (0)
- Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis". (2016) (0)
- A Survey of Atrial Fibrillation Amongst Acute Medical Admissions to a District General Hospital (1994) (0)
- Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)] (2006) (0)
- A validation of the 4S-AF scheme in Spanish and French patients from the EORP-AF Long-Term General Registry (2021) (0)
- Short-TermApixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion (2020) (0)
- Device‐guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered? (1132.7) (2014) (0)
- P4241Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different strategy needed in case of acute coronary syndrome? (2018) (0)
- 'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply. (2013) (0)
- Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm: a nationwide cohort study (2015) (0)
- P341Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme (2019) (0)
- Abstract 18190: Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial (2017) (0)
- Patients With Atrial Fibrillation Prospective Primary Prevention Cohort of Bleeding and Stroke Risk in a Real-world (2011) (0)
- Role of cardiorespiratory fitness in cancer development: time for an update. (2020) (0)
- 210Predictors of thromboembolism in patients with atrial fibrillation and valvular heart disease according to the EHRA classification: beyond mitral stenosis and mechanical prosthetic heart valves (2019) (0)
- Chapter 11 Cardiac consultations and emergencies (2011) (0)
- ANGIOGENIN, A MARKER OF ANGIOGENESIS INCREASES WITH CORONARY HEART DISEASE SEVERITY (2008) (0)
- The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set (2018) (0)
- Comparison of the CHADS2 and CHA2DS2VASc prediction rules for stroke in patients with atrial fibrillation. The Danish diet, cancer and health cohort study (2011) (0)
- Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease (2022) (0)
- Abstract 12800: Increased Carotid Intima-Media Thickness and Presence of Carotid Plaque are Associated With Increased Stroke Incidence in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study (2014) (0)
- Faculty of 1000 evaluation for Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice. (2016) (0)
- Circulating endothelial microparticles (EMP) modifications as predictive biomarkers of resistance to chemotherapy for breast cancer (BC). (2013) (0)
- 'Accounting for nearly 10% of all deaths, stroke mortality rates are second only to coronary heart disease (13%) and cancer (12%).' (2006) (0)
- Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody. (2012) (0)
- Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study (2021) (0)
- Reversible anterior ischaemic optic neuropathy in accelerated hypertension. (1999) (0)
- Antithrombotics for left-ventricular impairment (1998) (0)
- Smoking status in relation to blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: the Birmingham Factory Screening Project (2003) (0)
- An interview with Professor Gregory Lip (2020) (0)
- A Survey of Risk Factors and Health Perceptions in Patients following Acute Myocardial Infarction (1995) (0)
- Editors’ Choice papers in Thrombosis and Haemostasis (2014) (0)
- Questionable levels of evidence in new atrial fibrillation guidelines? Reply. (2013) (0)
- Hormone replacement therapy is not a risk for venous thrombosis. (1995) (0)
- Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry , on behalf of the EORP-AF General Pilot Registry Investigators † (2016) (0)
- Helicobacter pylori and myocardial infarction: one final push for the truth? (2001) (0)
- Abstract 13207: The First Prognostic Model for Stroke and Death in Patients With Systolic Heart Failure (2013) (0)
- Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation (2022) (0)
- 152 Does outpatient based IV diuretic treatment for acute heart failure give patients hope? (2021) (0)
- Corrigendum to "Dabigatran in clinical practice: Contemporary overview of the evidence" [Int. J. Cardiol. 220 (2016) 417-428]. (2016) (0)
- Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage". (2020) (0)
- Rhythm control agents and adverse events in patients with atrial fibrillation (2010) (0)
- Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation". (2013) (0)
- Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fi brillation: a prospective multicentre cohort study (2015) (0)
- Regular exercise is associated with a lower risk of developing dementia in patients with a new diagnosis of atrial fibrillation: a nationwide population-based study (2020) (0)
- P4782Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation (2019) (0)
- Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated? C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE (2016) (0)
- CARDIOVASCULAR GENOMIC MEDICINE Circulating Endothelial Cells in Cardiovascular Disease (2006) (0)
- Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity? (2019) (0)
- Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways. (2022) (0)
- Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension? (1997) (0)
- Prescribing in heart disease. (1992) (0)
- University of Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation (2017) (0)
- Alcohol intake and prognosis of incident atrial fibrillation patients (2013) (0)
- Abstract 14729: Changes in Renal Function After Radiofrequency Catheter Ablation of Atrial Fibrillation Are Associated With CHA2DSs-Vasc Score: The Leipzig Heart Center AF Ablation Registry (2013) (0)
- P-412RELATIONSHIP OF VON WILLEBRAND FACTOR, AN INDEX FOR ENDOTHELIAL DAMAGE, AND VASCULAR ENDOTHELIAL GROWTH FACTOR, AN INDEX OF ANGIOGENESIS TO CARDIOVASCULAR AND CEREBROVASCULAR RISK SCORES BASED ON THE FRAMINGHAM EQUATION ADRENOMEDULLIN (AM) AND ENDOTHELIN (ET) IN CULTURED RAT CARDIOMYOCYTES (2001) (0)
- 073_16963-C5 The Association of Cardiopulmonary Comorbidities With Early In-Hospital Outcome Post Out-of-Hospital Cardiac Arrest (2017) (0)
- Usefulness of the 2 MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation (2017) (0)
- Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding (2020) (0)
- Recombinant CRP induces increased release of ICAM and thrombomodulin, but not vWF or E selectin, from HUVECs (2001) (0)
- Advances in therapy for atrial fibrillation (2010) (0)
- Comprar Infant and Young Child Feeding | Gareth Beevers | 9781405187213 | Wiley (2009) (0)
- White coat hypertension and carotid atheroscierosis: is there a relationship? (1998) (0)
- Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review (2002) (0)
- Oral antiplatelet and anticoagulant drugs in secondary stroke prevention in Polish patients – Results of lipidogram and lipidogen study (2019) (0)
- The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism (2016) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Cardiac rehabilitation is associated with lower 1-year all-cause mortality in primary pulmonary hypertension (2021) (0)
- P4793Comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in the elderly Asian patients with atrial fibrillation (2019) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in patients with pacemakers and implantable cardioverter defibrillators (ICDs) (2022) (0)
- Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in âreal-worldâ clinical practice (2017) (0)
- P4770Antithrombotic challenge in the clinical dilemma of high-risk patients with atrial fibrillation: one-year result from ChiOTEAF Registry (2019) (0)
- Prioritising electrocardiograms for manual review to improve the efficiency of atrial fibrillation screening (2022) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban (2022) (0)
- What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? (2012) (0)
- P1870Predicting mortality and mode of death by clinical score systems for patients with atrial fibrillation (2019) (0)
- 235Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study (2018) (0)
- Comments on the Spanish Society of Cardiology Critical Review of the ESC 2010 Clinical Practice Guidelines on Atrial Fibrillation (2012) (0)
- Using the C2HEST Score for Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Report From the Western Denmark Heart Registry, the Danish National Patient Registry, and the Danish National Prescription Registry. (2022) (0)
- Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation (2010) (0)
- Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. (2022) (0)
- Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate (2013) (0)
- P6589The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project (2018) (0)
- P3598Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project (2017) (0)
- Nationwide trends and projections of peripheral arterial disease among Danish adults (2022) (0)
- P6365Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study (2017) (0)
- Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study (2016) (0)
- Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General (2022) (0)
- P4793Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project (2018) (0)
- An Audit of Cardioversion of Atrial Fibrillation in a District General Hospital (1995) (0)
- P5143The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study (2018) (0)
- Response to letter from Du et al. regarding article ‘Sodium‐glucose cotransporter‐2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?’ (2022) (0)
- CARDIOVERSION OF ATRIAL FIBRILLATION. AUTHOR'S REPLY (1996) (0)
- P6231Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry (2018) (0)
- P3603Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis (2017) (0)
- Atrial fibrillation (acute). (2004) (0)
- Platelet Aggregation in Atrial Fibrillation (2001) (0)
- Quality of Life in Grown up Congenital Heart Disease (2001) (0)
- Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists (2015) (0)
- P6515Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction (2018) (0)
- P1187Relation of renal function to thromboprophylaxis in non-valvular atrial fibrillation: Insights from the international BALKAN-AF Survey (2018) (0)
- Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years? (2022) (0)
- Effect of Placebo Treatment on Blood Pressure in Systolic Hypertension and Systolic/Diastolic Hypertension (2000) (0)
- 99Validation of the modified microlife blood pressure monitor in patients with paroxysmal atrial fibrillation (2018) (0)
- Predictors of changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2019) (0)
- Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010 (2022) (0)
- Soluble P-Selectin and Endothelial Dysfunction in Hypertension: Implications for Atherogenesis (1995) (0)
- Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis (2023) (0)
- The Effect of Blood Pressure on Plasma Levels of von Willebrand factor and Soluble P-Selectin in Patients with Atrial Fibrillation (2002) (0)
- Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation (2009) (0)
- Thromboembolic and bleeding risk stratification according to the EHRA valvular heart disease classification in patients with atrial fibrillation (2019) (0)
- Tissuemed porcine bioprosthesis at the aortic position: five year clinical experience (1998) (0)
- Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality. (2015) (0)
- Abstract 19512: Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation (2017) (0)
- Contents Vol. 33 (2003) (0)
- P2904Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population (2018) (0)
- Positive effect of a low dose combination of perindopril/ indapamide on the d-dimers and the endothelial factors in hypertensive patients (2004) (0)
- The year in cardiology: arrhythmias and pacing (2020) (0)
- 242 EXPRESSION OF RECEPTORS TO INTERLEUKIN 6 AND ADHESION MOLECULES ON CIRCULATING MONOCYTE SUBSETS IN MYOCARDIAL INFARCTION (2013) (0)
- MANAGEMENT OF ANTICOAGULATION DURING ELECTIVE INTERVENTIONAL PROCEDURES : BURNING DOWN THE BRIDGE ? (2015) (0)
- P934Adverse Outcomes in Very Elderly Patients with Atrial Fibrillation: an analysis from the SPORTIF Trials (2018) (0)
- and cardiovascular risk in immigrant Asians Insulin resistance, high prevalence of diabetes, (2017) (0)
- Is thrombogenesis related to residual platelet function in ischaemic heart disease? (2008) (0)
- Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population‐Based Cohort Study (2022) (0)
- Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score (2023) (0)
- Ethnic Differences in Blood Pressure in England: An Analysis of the Birmingham Factory Screen and Intersalt Epidemiological Studies (2001) (0)
- ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES (2014) (0)
- Abnormalities of Endothelial Function and Thrombogenesis in Malignant Phase Hypertension (2001) (0)
- Severe Hypertension and Bilateral Papilloedema Only: A Possible New Syndrome of Malignant Phase Hypertension (1995) (0)
- Severe Heart Failure (2011) (0)
- External validation of the simple NULL-PLEASE clinical score in predicting outcomes in men and women with out-of-hospital cardiac arrest (2022) (0)
- GW29-e1538 Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program (2018) (0)
- Basic investigations and initial assessment (2000) (0)
- Association of obesity with incident atrial fibrillation in Korea and the United Kingdom (2023) (0)
- Increased risk of incident atrial fibrillation in young adults with mental disorders: a nationwide population-based study. (2022) (0)
- 17-03: Effect of Age on Atrial Fibrillation Patient's Knowledge and Perceptions about Oral Anticoagulation Therapy: Results from an International Survey (2016) (0)
- Is angiotensin receptor blockade antithrombotic? (2003) (0)
- Contents Vol. 33 (2003) (0)
- Adrenaline in allergic emergencies. (1992) (0)
- Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women". (2018) (0)
- Abnormal prothrombotic factors and endothelial dysfunction in isolated systolic hypertension: implications for thrombogenesis and atherogenesis (1999) (0)
- Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study (2022) (0)
- Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies’ Guidelines (2016) (0)
- Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (2021) (0)
- Low Density Lipoprotein Particle Size Profile and Oestrogen-Only Hormone Replacement Therapy Evidence for an Adverse Effect on Atherogenesis? (1996) (0)
- Soluble P-Selectin, Coagulation and Lipid Changes with Hormone Replacement Therapy: Implications for Atherosclerosis Prevention (1995) (0)
- How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction? (2005) (0)
- Screening for Atrial Fibrillation by Village Doctors in Rural Areas of China: The Jiangsu Province Rural Community AF Project (2022) (0)
- Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level. (2023) (0)
- Social determinants of health and recurrence of atrial fibrillation after catheter ablation. A Danish nationwide cohort study. (2022) (0)
- Malignant Hypertension in a District General Hospital a Survey of 21 Years Experience (1994) (0)
- Atrial Fibrillation and Heart Failure Syndromes (2010) (0)
- Does Return of Left Atrial Function after Cardioversion of Patients with Atrial Fibrillation (AF) Improve Haemostatic Markers? (Non-MRS Member) (2000) (0)
- Management strategies (2020) (0)
- P-481: Survival and prognosis of maligant phase hypertension in a multiethnic population: The West Birmingham malignant hypertension register (2003) (0)
- Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study (2022) (0)
- Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs (2021) (0)
- Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. (2021) (0)
- P2.18 NON INVASIVE MEASUREMENT OF ENDOTHELIAL DYSFUNCTION BY DIGITAL VOLUME PULSE ANALYSIS TECHNIQUE: APPLICATION & UTILITY IN CLINICAL PRACTICE (2008) (0)
- P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs) (2017) (0)
- Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2022) (0)
- Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report (2023) (0)
- Salt Intake and Blood Pressure in Chronic Psychiatric Inpatients (1995) (0)
- Obstructive sleep apnoea and atrial fibrillation: a key omission in guidelines. (2022) (0)
- OACs in Complex Settings: Cardioversion, CAD, and PCI (2015) (0)
- Associations between pregnancy complications and incident cardiovascular disease: a nationwide data linkage study in Wales (2022) (0)
- Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis (2023) (0)
- Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors. (2023) (0)
- 501 Comparing the sensitivity of non‐invasive markers of volume response to intravenous furosemide in patients with acute pulmonary oedema (2007) (0)
- The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway. (2023) (0)
- Sodium‐glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation? (2022) (0)
- Heart failure and cardiovascular outcomes in european patients with atrial fibrillation (2022) (0)
- O13 The effect of acute smoking on platelet aggregometry and alpha granule degranulation (1999) (0)
- Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions (2022) (0)
- Monocytes are increased in pregnancy after gestational hypertensive disease (2022) (0)
- ACE INHIBITORS AND ANGIOEDEMA. AUTHORS' REPLY (1999) (0)
- Does Endothelial Dysfunction Contribute to Thrombogenesis in Patients with Chronic Atrial Fibrillation (1994) (0)
- COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (2019) (0)
- Foreword (2013) (0)
- Anticoagulation versus placebo for heart failure in sinus rhythm. (2021) (0)
- Accelerated/Malignant Hypertension (2018) (0)
- Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018 (2022) (0)
- Thrombosis and Haemostasis 2022 Editors' Choice Papers. (2023) (0)
- MEETING THE CHALLENGES IN ATRIAL FIBRILLATION MANAGEMENT: THE ROLE OF NEW ANTICOAGULANTS (2014) (0)
- Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level (2022) (0)
- 612 EVOLUTION OF ATRIAL FIBRILLATION PATTERNS AND IMPACT ON ALL-CAUSE MORTALITY IN A CONTEMPORARY COHORT OF EUROPEAN PATIENTS WITH ATRIAL FIBRILLATION (2022) (0)
- Clinical implications and importance (2000) (0)
- The Reply. (2021) (0)
- P1882Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (2018) (0)
- Comprar Handbook of Oral Anticoagulation | Gregory Lip | 9781858734521 | Springer (2010) (0)
- 600 Short-term statin therapy improves power spectral heart rate variability indices in unselected chronic heart failure patients (2005) (0)
- P-137: Echocardiographic changes in patients with malignant phase hypertension (2003) (0)
- Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. (2022) (0)
- C-Reactive Protein and Electron Beam Computed Tomography: A Perfect Match? (2001) (0)
- The Impact of Coronary Heart Disease and Hypertension on Hormone Replacement Therapy Use in General Practice (2001) (0)
- Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation (2022) (0)
- Characterisation of Access Site Versus Non-Access Site Bleeding After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation (2018) (0)
- Atherosclerotic Renal Artery Stenosis – Do We Really Know What To Do? (2007) (0)
- P5139Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- Functional characteristics of monocytes subsets in the acute and healing phases of ST Elevation Myocardial Infarction and their predictive role for major adverse cardiac events (2012) (0)
- Abstract 19679: Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients? (2015) (0)
- P-412: Relationship of von Willebrand factor, an index for endothelial damage, and vascular endothelial growth factor, an index of angiogenesis to cardiovascular and cerebrovascular risk scores based on the framingham equation (2001) (0)
- P3625Monocyte counts predict major bleeding events in patients with atrial fibrillation (2017) (0)
- Should Heart Failure Be Treated with Antithrombotic Drugs? (2002) (0)
- Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker? (2007) (0)
- Increased Plasma Fibrinogen Levels in Patients with Atrial Fibrillation: A Rheological Mechanism for Thromboembolic Risk? (1993) (0)
- Predictive value of the HAS-BLED score in patients with atrial fibrillation and chronic kidney disease using vitamin K-antagonists (2013) (0)
- 1 CD 4 + T cell surface alpha enolase is lower in older adults Running title : T cell surface CD 4 + α-enolase in ageing (2015) (0)
- Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study (2021) (0)
- P846Length of hospital stay to long-term mortality in patients with atrial fibrillation: evidence from the AFFIRM trial (2017) (0)
- Atrial Septal Aneurysm (2000) (0)
- Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
- Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect. (2010) (0)
- Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants (2022) (0)
- Atrial Fibrillation ManagementContents (2013) (0)
- Abstract 14900: Non-Vitamin K Antagonist Oral Anticoagulants Associated With Lower Stroke Rates Compared to Warfarin Among Very Elderly Patients With Non-Valvular Atrial Fibrillation: An ARISTOPHANES Subgroup Analysis (2018) (0)
- EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (2019) (0)
- Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation. (2023) (0)
- W08-P-001 Relationship between diabetes mellitus, BMI, coronary heart disease risk and the metabolic syndrome (2005) (0)
- Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study (2022) (0)
- 146 Is there an association between thrombogenesis markers and atrial fibrillation burden in pacemaker population? (2011) (0)
- P4600Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry (2017) (0)
- Bacterial Count on Surgeons Bare and Gloved Fingertips in Cardiac Surgery (1998) (0)
- BS20 Comparison of various anticoagulants on clot structure in atrial fibrillation (2019) (0)
- Revisiting the Dynamic Risks of Incident Atrial Fibrillation: Does the Use of Nonsteroidal Anti-Inflammatory Drugs Contribute to Risk? (2019) (0)
- Heparin-Induced Thrombocytopenia. Authors' reply (2009) (0)
- Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study (2022) (0)
- Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study (2023) (0)
- P869Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification (2018) (0)
- Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply. (2020) (0)
- Should we reintroduce previous venous thromboembolism into decision-making for anticoagulation in atrial fibrillation? Insights from a nationwide cohort. (2020) (0)
- 10 ATR IAL FIBRILLATION STEPS Before you refer for (2011) (0)
- POLYPHARMACY IN A GLOBAL COHORT OF PATIENTS TAKING ANTICOAGULANTS FOR ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY (2021) (0)
- Development and validation of prediction models for incident atrial fibrillation in heart failure (2023) (0)
- Chapter 61 – Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions (2007) (0)
- Impact of Pleural Effusion on Clinical Outcomes in Patients with Pulmonary Embolism: Insights from the National Inpatient Sample. (2023) (0)
- Hypertension and the prothrombotic state [1] (multiple letters) (2003) (0)
- Association of renal dysfunction and stroke risk stratification scores with rhythm outcomes in patients after catheter ablation of atrial fibrillation (2013) (0)
- 115 Unique characteristics of CD14++CD16+ monocytes in patients with acute heart failure and implications for clinical outcome (2012) (0)
- Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data (2022) (0)
- Outcome of Femoral Angioplasty/Stenting Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics and Review of Literature (2022) (0)
- 781-2 Survival in Patients with Malignant Phase Hypertension (1995) (0)
- Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial. (2023) (0)
- Clinical features (2020) (0)
- P-374: Circulating tissue inhibitor of metalloproteinase-1 elevation correlates with impaired diastolic relaxation in patients with hypertension (2004) (0)
- 623 Distributions of B-type natriuretic peptide levels are similar amongst patients with systolic heart failure of White European, South Asian, or African Caribbean origin (2005) (0)
- An invasive strategy reduced the combined rate of death and myocardial infarction in unstable coronary artery disease (2000) (0)
- Do the National Institute of Clinical Excellence guidelines apply to ‘real world’ use of Abciximab in percutaneous coronary intervention in a teaching hospital setting? (2006) (0)
- Clustering of healthy lifestyle behaviors is associated with a lower incidence of adverse events in patients with newly diagnosed atrial fibrillation: a nationwide cohort study (2021) (0)
- Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease: A Focus on Diabetes Mellitus as a High-Risk Patient Group. (2020) (0)
- Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry (2020) (0)
- Managing cardiac arrhythmias. Part II. Management strategies for specific cardiac arrhythmias. (2000) (0)
- Assessing the Performance of the HAS-BLED Score: Response (2011) (0)
- SHORT-TERM OUTCOMES OF PILOT STUDY ON TELE-HEALTH GUIDED OUTPATIENT MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE (2023) (0)
- GW26-e2302 Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials (2015) (0)
- Title Cost-effectiveness of apixaban versus warfarin in Chinese patients with non-valvular atrial fibrillation : a real-life and modelling analysis (2016) (0)
- High pulse pressure but not mean arterial blood pressure is associated with abnormal thrombogenesis and endothelial damage/dysfunction in patients with coronary heart disease with and without hypertension (2004) (0)
- Oral anticoagulation in atrial fibrillation, the patients and physicians experiences of the consultation: a qualitative study (2012) (0)
- Adverse reactions of drugs used to treat arrhythmia (2000) (0)
- Oxidative Stress and Endothelial Damage in Chronic Heart Failure: Effects of Carvedilol and Bisoprolol (2001) (0)
- What Cannot Be Missed: Important Publications on Electrophysiology in 2020 (2021) (0)
- P-479: Obesity, blood pressure and all-cause mortality in an epidemiological study of blood pressure in a multiethnic community: The Birmingham Factory Screening Project (2003) (0)
- Letter to the Editor Biomarkers in Atrial Fibrillation: Further Observations on Biologic Plausibility, Cause and Effect (2005) (0)
- Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study. (2023) (0)
- Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases (2022) (0)
- Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status (2023) (0)
- Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)". (2014) (0)
- Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation ( ChiOTEAF ) registry (2023) (0)
- P-474: Ethnic differences in blood pressure levels and hypertension status in England (2001) (0)
- Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation (2020) (0)
- Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists (2023) (0)
- Acute Management of Atrial Fibrillation: Response (2009) (0)
- Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol (2022) (0)
- Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy—A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database (2023) (0)
- 626 APOA5 -1131 T>C POLYMORPHISM IS A DETERMINANT OF TRIGLYCERIDE LEVELS IN THE SOUTH ASIAN POPULATION (2011) (0)
- Apolipoprotein C3 gene variants are not related to isolated low HDL cholesterol in South Asians: The Ethnic-Echocardiographic Heart of England Screening study (E-ECHOES) (2011) (0)
- USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF (2022) (0)
- The HAS-BLED Score and Renal Failure: Response (2011) (0)
- In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death (2023) (0)
- Psychosocial consequences of venous thromboembolism in youth: Results from a mixed methods study (2015) (0)
- Managing high-risk atrial fibrillation patients with multiple comorbidities (2023) (0)
- P1380Gender differences in the progression of atrial fibrillation in low-risk paroxysmal AF patients with hypertension: the role of left ventricular hypertrophy (2017) (0)
- Clinical factors and imaging leading to risk of incident atrial fibrillation. (2019) (0)
- Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI (2023) (0)
- Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank (2023) (0)
- P4614Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation (2017) (0)
- P378Influence of reimbursement of non-vitamin K antagonist oral anticoagulants on overall prescription rates of oral anticoagulation: A nationwide study using the Korean National Health Insurance Data (2018) (0)
- Functional characteristics of monocytes subsets in the acute and healing phases of ST elevation myocardial infarction and their effect on ejection fraction (2012) (0)
- Incidence of atrial fibrillation in patients with diabetes mellitus: effect of sex, age and type of diabetes in a nationwide analysis (2021) (0)
- CHA2DS2‐VASc impact on risk following percutaneous coronary intervention in atrial fibrillation (2021) (0)
- P3608Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation (2017) (0)
- ANTITHROMBOTIC TREATMENT PATTERN IN NEWLY DIAGNOSED ATRIAL FIBRILLATION PATIENTS AND 2-YEAR FOLLOW-UP RESULTS FOR DABIGATRAN-TREATED PATIENTS IN THE AFRICA/MIDDLE EASTERN REGION: PHASE II RESULTS FROM THE GLORIA-AF REGISTRY PROGRAM (2020) (0)
- Faculty Opinions recommendation of Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation. (2016) (0)
- Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry (2023) (0)
- P6367Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study (2017) (0)
- Essential pharmacology of antithrombotic agents (2014) (0)
- Abstract 17771: The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data (2017) (0)
- Association between early rhythm control and the risk of dementia in patients with atrial fibrillation and prior history of stroke: a nationwide population-based study (2022) (0)
- Drug management (2020) (0)
- P4779High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban (2019) (0)
- MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar 1 intracerebral haemorrhage 2 (2022) (0)
- 2162Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation (2018) (0)
- Atrial Fibrillation in Patients with Chronic Kidney Disease. (2021) (0)
- Lipids and atrial fibrillation: New insights into a paradox (2022) (0)
- The Net Clinical Bene fi t of Rivaroxaban for Patients With Acute Coronary Syndrome (2018) (0)
- Mental health prognosis of young venous thromboembolism patients: a nationwide cohort study on psychotropic drug purchases (2015) (0)
- Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain. (2021) (0)
- Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor (2018) (0)
- Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke". (2016) (0)
- P3610Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients (2017) (0)
- 4366Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol (2018) (0)
- ABNORMAL FIBRIN CLOT STRUCTURE IN ATRIAL FIBRILLATION (2014) (0)
- Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study (2021) (0)
- A Haemo-Rheological Perspective of Mitral Regurgitation and Aortic Stenoosis (1994) (0)
- Reply to ‘Digoxin and beta‐blockers in patients with heart failure’. Letter regarding the article ‘Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure’ (2022) (0)
- Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. (2023) (0)
- AAI cardiac pacing as an alternative to CPAP in a patient with sleep apnea syndrome: case report (2011) (0)
- Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study (2022) (0)
- Factor XIa Inhibition - A Novel Alternative Antithrombotic Strategy for High-risk ACS Patients? (2022) (0)
- W03-O-001 Increased numbers of circulating endothelial cells predict adverse cardiovascular events following an acute coronary syndrome (2005) (0)
- Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients (2022) (0)
- Aspirin reduces platelet vascular endothelial growth factor and angiopoietin-1 (2004) (0)
- Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study (2021) (0)
- Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease (2019) (0)
- WITHDRAWN: Erratum to “Angiogenin, a marker of angiogenesis increases with coronary heart disease severity” [Atheroscler. Suppl. 9(1) (2008) 247–248] (2008) (0)
- Abstract 15070: Idiopathic Atrial Fibrillation: Does Age Matter? (2010) (0)
- CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension (2019) (0)
- Investigations (2020) (0)
- Predicting silent cerebral microischemia in patients with non-valvular atrial fibrillation and structurally normal hearts: the CHADS2, CHA2DS2-VASc and -R scores (2013) (0)
- PP.29.27: FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD mA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY (2015) (0)
- Use of historical remote monitoring data to determine predictors of CPAP non-compliance in patients with OSA. (2023) (0)
- Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation (2020) (0)
- Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants (2021) (0)
- Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer (2022) (0)
- Exposure dependent effects on coagulation assays by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. Results from two phase II studies (2009) (0)
- Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy (2022) (0)
- P6240Long term cardiovascular risk prediction in Real-World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry (2018) (0)
- An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis (2023) (0)
- Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long‐term warfarin therapy (2022) (0)
- Pathophysiology and electrophysiology (2020) (0)
- P5759Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation (2018) (0)
- Faculty Opinions recommendation of Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. (2016) (0)
- Decrease in fibrin D-dimer levels correlates to pharmacogenetic exposure of the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation (2009) (0)
- GW26-e2303 Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project (2015) (0)
- Medication Non-adherence Patterns and Profiles for Patients with Incident Myocardial Infarction: Observations from a Large Multi-morbid US Population. (2023) (0)
- Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias. (2023) (0)
- The reply. (2014) (0)
- Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation. Authors' reply (2010) (0)
- P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (2018) (0)
- Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention (2022) (0)
- Prevalence of atrial fibrillation in Polish population ≥65 old. Report of cross-sectional NOMED-AF study. (2022) (0)
- Epidemiology of supraventricular tachycardias (2018) (0)
- mHealth based patient-centered self-management reduces the burden and episodes of atrial fibrillation (2022) (0)
- Abstract 11180: Contemporary Evidence on Risk Stratification of Anticoagulated Non-Valvular Atrial Fibrillation Patients Grouped by Cha 2 D 2 -vasc Score Levels (2021) (0)
- Association between body mass index and the risk of atrial fibrillation and ischemic stroke according to age: a nationwide population-based cohort study (2021) (0)
- Identifying AF patients at risk of stroke: can prothrombotic indices improve things? (2008) (0)
- 106 Stroke Prophylaxis and 30-Day Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation (2017) (0)
- Reply: To PMID 22858389. (2013) (0)
- Risk factors for mortality in acute myocardial infarction. Authors' reply (2002) (0)
- Atrial fibrillation in a cohort of patients with peripheral arterial disease. A retrospective study of a healthcare database in UK (2020) (0)
- AUTHOR COPY. Not for publication (2007) (0)
- Is That All That Can Be Achieved (2017) (0)
- Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation (2015) (0)
- Diurnal rhythms and hemostatic factors in atrial fibrillation: reply (2001) (0)
- University of Birmingham Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale (2007) (0)
- Why beta-blockers are good for some patients with hypertension: a case study of a hypertensive patient with adrenergic paroxysmal atrial fibrillation (1998) (0)
- Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study (2022) (0)
- Greatly Improved Exercise Test Information Content by Meticulous Pre-Test Preparation (1994) (0)
- Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials (2019) (0)
- P-91: ‘High risk’ hypertensive patients with target organ damage exhibit elevated markers of platelet and endothelial function (2001) (0)
- Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis (2022) (0)
- EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY (2017) (0)
- 202 MONOCYTE SUBSET PHENOTYPE IN CORONARY ARTERY DISEASE AND THEIR ASSOCIATIONS WITH MARKERS OF INFLAMMATION AND FIBRINOLYSIS (2013) (0)
- Circulating Levels of Vegf-D in Breast Cancer: A Comparison with Vegf-A (2002) (0)
- Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks (2018) (0)
- Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough? (2009) (0)
- Two-dimensional Motif Extraction from Images: A Study using an Electrocardiogram (2022) (0)
- C9orf72 and intracerebral hemorrhage (2019) (0)
- Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants versus warfarin (2021) (0)
- Correction: Blood pressure measurement in atrial fibrillation: goodbye mercury? (2020) (0)
- Artificial intelligence in radiology: trainees want more. (2023) (0)
- Does intensive antihypertensive therapy have an effect on von Willebrand factor as an index for vascular damage and vascular endothelial growth factor as an index for angiogenesis (2001) (0)
- Altered respiratory related bursting of muscle sympathetic nerve activity in humans with essential hypertension (2011) (0)
- Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach (2022) (0)
- Exercise-based cardiac rehabilitation for cardiac implantable electronic device recipients. (2021) (0)
- Pathophysiology of atrial fibrillation: haemodynamics, thromboembolic risk, hypercoagulability (2000) (0)
- Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. (2023) (0)
- A Comparison of Outcome following Primary Coronary Revascularisation in Patients of Indo-Asian and European Origin (1998) (0)
- 97 Total monocyte count as predictor of exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function – the west birmingham AF project (2018) (0)
- Utilising an iPad for improved on-call workflow (2013) (0)
- Alterations in the Peripheral Circulation in Heart Failure (2020) (0)
- University of Birmingham Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
- Impalpable Breast Cancer and Service Delivery During the COVID-19 Pandemic – the Role of Radiofrequency Tag localization (2021) (0)
- P3591Impact of changing European guideline oral anticoagulation treatment thresholds on stroke and mortality in patients with atrial fibrillation (2017) (0)
- Faculty Opinions recommendation of Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. (2016) (0)
- Does reader performance with digital breast tomosynthesis (DBT) vary with experience of 2D mammography (2017) (0)
- SHOULD WE REINTRODUCE PREVIOUS VENOUS THROMBOEMBOLISM INTO DECISION-MAKING FOR ANTICOAGULATION IN ATRIAL FIBRILLATION? A NATIONWIDE COHORT STUDY (2020) (0)
- Tamoxifen for breast-cancer prevention. Authors' reply (2003) (0)
- 113Mean blood pressures and visit to visit blood pressure variation as predictors of clinical outcomes in malignant hypertension: the west Birmingham malignant hypertension project (2018) (0)
- 255 The effect of hospital-based versus home-based cardiac rehabilitation programmes on left ventricular diastolic function in patients with coronary heart disease (2004) (0)
- P062. The use of radiofrequency tag localization of impalpable breast cancers during the COVID-19 pandemic (2021) (0)
- Alcohol, Hypertension and Cardiovascular Disease (2002) (0)
- 1161-175 Platelet-derived vascular endothelial growth factor in patients with hypertension: Relationship to platelet activation and plasma indices of angiogenesis (2004) (0)
- Venous thromboembolism and mortality in a multiethnic population: a report from the Birmingham Black Country VTE registry (BBC-VTE Investigators) (2022) (0)
- Development of Core Outcome Sets for trials on the management of Atrial fiBrillAtion in Critically Unwell patientS (COS-ABACUS): a protocol (2023) (0)
- Effects of the Atrial fibrillation Better Care (ABC) pathway on outcomes among clinically complex chinese patients with atrial fibrillation with multimorbidity and polypharmacy (2022) (0)
- 145 PREDICTION OF NEW ONSET ATRIAL FIBRILLATION IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION USING THE C2HEST AND MC2HEST SCORES A REPORT FROM THE MULTICENTER REALE-ACS REGISTRY (2022) (0)
- A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium. (2022) (0)
- Relationship of platelet P-selectin levels and platelet morphology to platelet activation in hypertensives (2003) (0)
- Female Sex Is Associated with a Lower Risk of Stroke in Patients with Heart Failure: A Nationwide Cohort Study (2014) (0)
- Warfarin and increased fracture risk? Answering the big question. (2022) (0)
- C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network. (2023) (0)
- Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening (2023) (0)
- AI in breast screening mammography: breast screening readers' perspectives (2022) (0)
- 67 Impact of weight reduction on ablation outcomes in obese patients with atrial fibrillation (2020) (0)
- Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry. (2023) (0)
- Improved collaboration within a radiology department using an integrated instant messaging system. (2013) (0)
- Hypertensive urgencies and emergencies (2010) (0)
- 5741Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials (2017) (0)
- Case study of nutritional management of a patient with a swallowing disorder (0)
- Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores (2023) (0)
- How safe is digoxin? (1998) (0)
- Radiofrequency Tag Localisation for Breast Lesions, A single center experience (2022) (0)
- The use of Radiofrequency Tag Localization of impalpable breast cancers during the COVID-19 pandemic (2021) (0)
- Stroke in Heart Failure (2020) (0)
- List of Contributors (2019) (0)
- Editorial commentary: COVID-19 and COVID-19 vaccination: Observations on thrombosis and thrombocytopenia (2022) (0)
- Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: A nationwide cohort study (2015) (0)
- 49Atrial Fibrillation and Dementia in the Oldest Old: An Analysis from the Population-Based Study 'Monzino-80 Plus' (2018) (0)
- Physical activity or fitness as medicine for your arteries? (2020) (0)
- P-277: A comparison of flow mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension (2002) (0)
- Stroke in AF: Additional Risk Factors, OAC, and LAA Occlusion (2015) (0)
- Chronic heart failure as a risk factor for ischemic stroke (2017) (0)
- IS THE GENDER SPECIFIC RISK OF ISCHEMIC STROKE IN ATRIAL FIBRILLATION RELATED TO DIFFERENCES IN ANTICOAGULATION (2011) (0)
- Endothelial Biomedicine: Circulating Markers of Endothelial Function (2007) (0)
- UK radiology trainees’ attitudes towards artificial intelligence in clinical radiology and its implementation in training and the curriculum (2022) (0)
- Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage (2020) (0)
- Association between atrial high rate episode burden and autonomic and vascular function in patients with implanted cardiac device (2021) (0)
- Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management. (2004) (0)
- 053 Factors affecting quality of warfarin anticoagulation in patients with atrial fibrillation: insights from affirm (2012) (0)
- CHADS2 and CHA2DS2-VASc scores as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013) (0)
- Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant. (2020) (0)
- P4765Men who live alone have poor anticoagulation control: results from Danish registries (2019) (0)
- P836Net clinical benefit of oral anticoagulation in very elderly patients with atrial fibrillation: something better than vitamin k antagonists needed? (2017) (0)
- Role of cardiorespiratory fitness in cancer development: time for an update. (2020) (0)
- 043 MONOCYTE SUBPOPULATION COUNTS AND ASSOCIATIONS WITH LEFT VENTRICULAR EJECTION FRACTION POST ST ELEVATION MYOCARDIAL INFARCTION (2013) (0)
- P2903Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study (2018) (0)
- P4795Dabigatran in real-world asian patients with atrial fibrillation with low body weight: nationwide cohort data covering the entire korean population (2018) (0)
- Epidemiology and importance (2020) (0)
- P6588Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study (2018) (0)
- Autonomic reflexes in heterotopic heart transplantation (2004) (0)
- Bleeding risk with oral anticoagulation – new frontiers and new questions (2011) (0)
- Comparative validation of the HAS-BLED and the GARFIELD-AF bleeding risk scores in Asian patients with atrial fibrillation: a report from the COOL-AF registry (2022) (0)
- Is atrial fibrillation an inflammatory disorder? Authors' reply (2006) (0)
- Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply. (2020) (0)
- Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants? (2012) (0)
- Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies. (2023) (0)
- ANTICOAGULATION THERAPY PATTERNS FOR VTE IN A MULTI-ETHNIC UK COHORT: A REPORT FROM THE BIRMINGHAM BLACK COUNTRY VTE REGISTRY (BBC-VTE INVESTIGATORS) (2022) (0)
- Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events. (2022) (0)
- A Happy New Year 2023 from Thrombosis and Haemostasis (2023) (0)
- 131 Ethnic differences in 5 year outcome following percutaneous coronary intervention (2010) (0)
- Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA2DS2-VASc and Support for CHADS-65. (2019) (0)
- A randomised controlled trial and cost effectiveness study of systematic screening ( targeted and total population screening ) versus routine practice for the detection of atrial fibrillation in the over 65 s : ( SAFE ) [ ISRCTN 19633732 ] (2015) (0)
- IMPORTANCE OF THE ANALYTIC APPROACH WHEN COMPARING THE EFFECTIVENESS OF TREATMENTS: AN APPLICATION TO REDUCED DOSE NOACS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2020) (0)
- Authors' reply (1996) (0)
- Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis. (2009) (0)
- Atrial fibrillation (acute). (2003) (0)
- Practice Guidelines Chest Physicians Evidence-Based Clinical Thrombosis, 9th ed: American College of : Antithrombotic Therapy and Prevention of Antithrombotic Therapy for Atrial Fibrillation (2012) (0)
- P1694The impact of incident atrial fibrillation on the risk of adverse events for patients with end-stage renal disease undergoing dialysis: a time-dependent analysis (2017) (0)
- 126 Dynamics of the three human monocyte subsets over 30 days in ST-elevation myocardial infarction (2012) (0)
- Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation (2008) (0)
- Nitrates and severe aortic stenosis. (1995) (0)
- Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events (2021) (0)
- 680Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome? (2018) (0)
- Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP‐AF general long‐term registry (2022) (0)
- A prophylactically implanted cardioverter defibrillator did not reduce all-cause mortality after a recent myocardial infarction. (2005) (0)
- Atrial fibrillation detected before or after stroke: role of anticoagulation. (2023) (0)
- Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review. (2021) (0)
- The associations between smoking and adverse outcomes in patients with atrial fibrillation: the Diet, Cancer and Health study (2013) (0)
- Anticoagulation for Stroke Prevention (2006) (0)
- Association between acute kidney injury and atrial fibrillation in patients undergoing cardiac surgery (2019) (0)
- 55 Use of the index beat method to improve the echocardiographic assessment of cardiac function in patients with atrial fibrillation (2020) (0)
- Faculty Opinions recommendation of Dabigatran in real-world atrial fibrillation. Meta-analysis of observational comparison studies with vitamin K antagonists. (2016) (0)
- P5831Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment (2017) (0)
- Reviewers for the Journal of Interventional Cardiac Electrophysiology 2013 (2014) (0)
- Ambulatory Blood Pressure Monitoring in Patients with Atrial Fibrillation (1995) (0)
- Adherence to the 4S-AF Scheme in the Balkan region: insights from the BALKAN-AF survey (2021) (0)
- Poster session 3 (2001) (0)
- The Coagulation Pathway and Approaches to Anticoagulation (2010) (0)
- Ethnic Variation in the Size of Coronary Arteries (1997) (0)
- P1923Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (2018) (0)
- Diabetesmellitusandriskofischemicstrokeinpatientswithheartfailure and no atrial fibrillation (2016) (0)
- 444 A randomised trial of home‐based exercise in patients with heart failure: results of the BRUM‐CHF study (2007) (0)
- University of Birmingham Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation Time to therapeutic range and atrial fibrillation (2018) (0)
- Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation (2014) (0)
- Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA2DS2-VASc scores (2023) (0)
- P-352: Circulating MMP-9, TIMP-1 and TIMP-2 in gestational hypertension (2004) (0)
- Clinical Phenotypes and Atrial Fibrillation Recurrences after Catheter Ablation: An Unsupervised Cluster Analysis. (2023) (0)
- Predictors for late recurrences of atrial fibrillation after catheter ablation in patients with early recurrences (2013) (0)
- Should antithrombotic therapy be different in patients with atrial fibrillation and a so-called temporary cause and especially after an acute coronary syndrome? (2019) (0)
- Cardiac arrhythmias (2020) (0)
- THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA (2014) (0)
- Catheter ablation of atrial fibrillation and thromboembolic risk. (2015) (0)
- Diagnosis andtreatment ofdigoxin toxicity (1993) (0)
- 243 MONOCYTE SUBPOPULATION COUNTS AND TNF ALPHA ASSOCIATIONS WITH CLINICAL OUTCOME POST ST ELEVATION MYOCARDIAL INFARCTION (2013) (0)
- 101 Role of cardiac autonomic function in pathophysiology of permanent AF (2021) (0)
- Platelet and Haemorheological Markers in High Risk Hypertensives are Improved by Tighter Blood Pressure Control and Risk Factor Modification (2000) (0)
- Haematocrit and plasma viscosity in atrial fibrillation. (2000) (0)
- 674Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials (2018) (0)
- Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (2022) (0)
- Coronary heart disease Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes (2007) (0)
- 196. BONE MARKER RESPONSE IN CHRONIC DIFFUSE SCLEROSING OSTEOMYELITIS TREATED WITH IBANDRONATE (2006) (0)
- -Blocker Use in Pregnancy and the Risk for Congenital Malformations (2019) (0)
- P-478: Ethnicity, blood pressure and all-cause mortality in the Birmingham Factory Screening Project (2003) (0)
- New antiarrhythmic agents for atrial fibrillation (2004) (0)
- 86 Cardiac autonomic function influences in atrial fibrillation and hypertension (2021) (0)
- Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry). (2022) (0)
- Endovascular treatment for ischemic stroke patients with and without atrial fibrillation, and the effects of adjunctive pharmacotherapy: a narrative review (2022) (0)
- ABC of antithrombotic therapy: Antithrombotic therapy in peripheral vascular disease (2002) (0)
- Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. (2023) (0)
- Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range. (2019) (0)
- All Types of Hemorrhagic Stroke Are Not Created Equally-Reply. (2017) (0)
- Abstract 14499: Impact of Pre-existing and New Incident Atrial Fibrillation on Outcomes of Patients With Acute Pulmonary Embolism: Findings From an International Registry (2020) (0)
- 96-72: Gender Differences in Atrial Fibrillation Patient's Knowledge and Perceptions about Oral Anticoagulation Therapy: Results from an International Survey (2016) (0)
- University of Birmingham Stroke and bleeding risk in atrial fibrillation (2014) (0)
- Does Hypertension Confer a Prothrombotic State? (1999) (0)
- A Comparison of Cardiovascular Risk Factors Amongst Indo-Asian Patients Admitted with Acute Myocardial Infarction in Kuala Lumpur, Malaysia and Birmingham, England (2000) (0)
- Darusentan (Abbott Laboratories). (2001) (0)
- Aalborg Universitet Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation propensity weighted nationwide cohort study (2016) (0)
- P3861Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden (2018) (0)
- 826 Abnormal platelet activation, adhesion and function in systolic heart failure (2005) (0)
- Age, sex and clinical outcomes with digoxin vs beta-blocker in permanent atrial fibrillation with heart failure. (2021) (0)
- University of Birmingham Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF: a randomised controlled trial) (2007) (0)
- Multimorbidity, frailty and malnutrition: moving beyond traditional risk factors for risk assessment in atrial fibrillation. The Murcia Atrial Fibrillation Project II (2022) (0)
- Antithrombotic therapy (2020) (0)
- In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y (2016) (0)
- Assessment of cardiac autonomic function in patients with permanent and paroxysmal atrial fibrillation (2021) (0)
- 2181What is the ideal blood pressure threshold and target for the management of high blood pressure in patients with atrial fibrillation? Nationwide cohort data covering the entire korean population (2018) (0)
- Antiplatelet agents and anticoagulants for hypertension. (2022) (0)
- Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2019) (0)
- Abstract TP428: Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA- AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II) (2016) (0)
- A colour handbook of heart failure : investigation, diagnosis, treatment (2006) (0)
- Multiple risk factors of atherosclerosis have been associated with increased risk of stroke in AF. Indices of arterial structure and function, such as carotid intima-media thickness (2014) (0)
- Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues (2013) (0)
- 058 The relationship of left atrial remodelling to atrial fibrillation burden in pacemaker population (2012) (0)
- Do Cardiovascular and Cerebrovascular Risk Scores Based on the Framingham Equation Correlate with von Willebrand Factor, a Marker for Endothelial Damage and Vascular Endothelial Growth Factor, a Marker for Angiogenesis? (2001) (0)
- Sex-based differences in risk of ischemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: A self-controlled case series and nested case-control study. (2023) (0)
- Does Vascular Endothelial Growth Factor Mediate the Hypercoagulable State in Atrial Fibrillation (2002) (0)
- BS58 Does change in renal function affect warfarin’s efficacy in patients with atrial fibrillation? (2019) (0)
- Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention (2015) (0)
- E010: Effect of antihypertensive drugs on foetal growth in hypertensive pregnant women (1998) (0)
- Atrial fibrillation (acute onset). (2008) (0)
- Ethnic differences in aortic aneurysm and peripheral vascular disease (1996) (0)
- P2900Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation (2018) (0)
- 054 Left ventricular geometry and outcome in patients with atrial fibrillation: insights from the affirm trial (2012) (0)
- Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. (2023) (0)
- A review of emerging factor XI inhibitors (2023) (0)
- Are abnormal homocysteine levels in essential hypertension related to prognosis and endothelial dysfunction (2000) (0)
- Therapy for atrial fibrillation: new challenges (2006) (0)
- Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA (2015) (0)
- 125 Monocyte subpopulation counts and functional characteristics predict adverse clinical events post ST elevation myocardial infarction (2012) (0)
- Tackling anti-coagulation under-prescription in the elderly (2019) (0)
- A case of breathlessness. (2003) (0)
- Role of the Renin-Angiotensin System in the Pathogenesis of Vascular Disease (2017) (0)
- Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’ (2008) (0)
- Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179] (2006) (0)
- Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence (2023) (0)
- Meet the Editorial Board (2015) (0)
- A discussion on network meta-analyses and risks of duplication bias. (2022) (0)
- Abstract 18609: Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients (2014) (0)
- Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass". (2008) (0)
- P-350: Plasma markers of angiogenesis in pregnancy induced hypertension (2004) (0)
- Faculty Opinions recommendation of Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. (2016) (0)
- Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants (2021) (0)
- Counselling and education of patients (2000) (0)
- Anticoagulation selection and stroke prevention (2014) (0)
- Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice (2008) (0)
- Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: a nationwide cohort study (2022) (0)
- Atrial fibrillation: Importance of real world data from regional registries. A focus on the BALKAN-AF registry (2020) (0)
- Antiarrhythmics in atrial fibrillation. (2002) (0)
- Vitamin K antagonists and changes in glomerular filtration rate in patients with atrial fibrillation (2019) (0)
- 444 Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression (2021) (0)
- The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials) (2021) (0)
- Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database (2022) (0)
- Monocyte subset phenotype in coronary artery disease and their associations with markers of inflammation and fibrinolysis (2013) (0)
- P3475Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry (2018) (0)
- Tamoxifen for breast-cancer prevention [3] (multiple letters) (2003) (0)
- Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review (2022) (0)
- The experiences of con sultations on oral anticoagula-tion for AF: the importance of qualitative research incardiovascular sciences (2014) (0)
- Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
- 124 South Asian Ethnicity is Independently Related to Diastolic Function in Hypertension (2015) (0)
- Faculty Opinions recommendation of Cryptogenic stroke and underlying atrial fibrillation. (2016) (0)
- Is Chlamydia pneumoniae Infection Associated with Hypertension and Left Ventricular Hypertrophy (1996) (0)
- Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure (2022) (0)
- TCT-294 A Novel Risk Score to Identify AF Patients Undergoing PCI at High Thrombotic Risk a RE-DUAL PCI Secondary Analysis (2021) (0)
- Abstract 13565: Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II (2015) (0)
- Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis (2022) (0)
- P515Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (2017) (0)
- Atrial fibrillation: current approaches to drug therapy (2008) (0)
- Impacts of hemoglobin levels and platelet counts on clinical outcomes in patients with atrial fibrillation: oral anticoagulant use for patients with anemia and/or thrombocytopenia (2021) (0)
- 73 Type of atrial fibrillation and its effect on endothelial function (2020) (0)
- Stroke prevention in atrial fibrillation: Where are we now? (2015) (0)
- Statins and prophylaxis of venous thrombosis – a further link between arterial and venous thrombosis (2010) (0)
- 32Development of new-onset atrial tachyarrhythmia and risk of stroke in the implantable cardiac device population (2014) (0)
- Relationship between coronary artery disease and atrial fibrillation still unclear. Authors' reply. (2020) (0)
- Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial (2020) (0)
- Dalteparin reduced death and MI at 1 but not 3 months in unstable coronary artery disease managed noninvasively (2000) (0)
- ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure. (2009) (0)
- 199 Challenges in identification of hypertension in children and young people with Turner Syndrome (2022) (0)
- Abstract 19280: Real World Comparisons of Major Bleeding Risk Stratified by CHA2DS2-VASc Scores Among Non-Valvular Atrial Fibrillation Patients Initiating Apixaban or Warfarin (2016) (0)
- Dronedarone: a new hope for stroke prevention in atrial fibrillation? (2011) (0)
- Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges (2022) (0)
- Comprar A Colour Handbook Of Heart Failure. Diagnosis, Investigation, Treatment | Gregory Lip | 9781840761375 | Manson Publishing (2010) (0)
- Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil (2022) (0)
- Abstract 15038: Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score (2016) (0)
- 1468Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study (2018) (0)
- Causes of death of patients with non-valvular atrial fibrillation in Asians (2023) (0)
- Can the NICE guidelines on the management of atrial fibrillation improve its management? (2009) (0)
- Endothelial dysfunction and platelet activation in patient with chronic atrial fibrillation: interactions leading to thrombogenesis? (1998) (0)
- Predictive role of specific monocyte subsets for major adverse cardiac events after ST-elevation myocardial infarction (2012) (0)
- Reply to ‘Comment on ‘Genotype‐guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta‐analysis of randomized clinical trials’ by Tse et al.’ (2018) (0)
- Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease. (2020) (0)
- Novel Oral Anticoagulants for Thromboprophylaxis in Non- Valvular Atrial Fibrillation: Focus on Randomized Clinical Trials (2015) (0)
- 200Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program (2018) (0)
- YOUNG INVESTIGATORS AWARDS SESSION: THROMBOSIS (0)
- Percutaneous Balloon Dilatation of Adult Coarctation of the Aorta (1995) (0)
- The Impact of Stroke Prophylaxis on Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation: 82 (2018) (0)
- Prevalence of atrial fibrillation in Northern Sri Lanka: a study protocol for a cross-sectional household survey (2022) (0)
- PM198 Antithrombotic Treatment in Relation to Age and Stroke Risk in Patients With Newly Diagnosed Atrial Fibrillation (Gloria-AF Phase II) (2016) (0)
- Chapter 6 Subsequent management (2008) (0)
- Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation: Response (2010) (0)
- Letter. Authors' reply (2000) (0)
- Abstract 13016: Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial (2016) (0)
- Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension (2006) (0)
- GW26-e2301 The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis (2015) (0)
- Faculty of 1000 evaluation for Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. (2016) (0)
- Mobile health-technology integrated care in elderly atrial fibrillation patients: a report from the mAFA-II randomized clinical trial (2022) (0)
- Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78] (2008) (0)
- Relationship of soluble angiopoietin receptor tie-2 to tissue factor, endothelial dysfunction, and vascular endothelial growth factor in hypertension (2003) (0)
- 88Quality of and predictors of anticoagulation control among multi ethnic cohorts receiving vka therapy for stroke prevention in atrial fibrillation (2018) (0)
- BS42 How warfarin and antiplatelets affect clot structure in atrial fibrillation (2019) (0)
- POSTER SESSION 2, HRC 2011 (2011) (0)
- P982Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry (2018) (0)
- Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease. (2022) (0)
- Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction (2016) (0)
- Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management (2021) (0)
This paper list is powered by the following services:
Other Resources About Gregory Lip
What Schools Are Affiliated With Gregory Lip?
Gregory Lip is affiliated with the following schools:
- Medical University of Silesia
- University of Birmingham
- Aston University
- Liverpool John Moores University
- Yonsei University
- University of Belgrade
- Seoul National University
- University of Liverpool
- National Yang Ming Chiao Tung University
- Soongsil University
- Aalborg University
- University of Oxford
- Imperial College London
